Biochemical, immunological and genetic characterisation of the major outer membrane protein from an ovine abortion strain of Chlamydia psittaci by Tan, Tin Wee
BIOCHEMICAL, IMMUNOLOGICAL AND GENETIC CHARACTERISATION
OF THE MAJOR OUTER MEMBRANE PROTEIN FROM









Thesis scanned from best copy available:
may contain faint or blurred text, and / or
cropped or missing pages.
Scanned as part of the PhD Thesis Digitisation project
http://libraryblogs.is.ed.ac.uk/phddigitisation
PhD Thesis Digitisation Project
Biochemical, Immunological and Genetic Characterisation of the Major Outer
Membrane Protein from an Ovine Abortion strain of Chlamydia psittaci.
by Tan Tin Wee, Moredun Research Institute, Edinburgh.
Abstract
Ovine enzootic abortion (OEA) is an economically important disease
of ewes caused by a type of Chlamydia psittaci. Vaccines have been
available to control this disease for more than 30 years. In the past
decade, vaccine efficacy has been poor despite efforts to improve the
inactivated whole organism vaccine currently in use.
The initial aim of this project was to characterise the antigenic
structure of OEA C.psittaci and to identify potentially immunoprotective
antigens. Retrospective analyses of sera taken from ewes of different
immune status were carried out using immunoblotting. A single 39 to 40
kDa antigen, thought to be the major outer membrane protein (MOMP) of OEA
C.psittaci, was implicated as an important immunogen.
A series of biochemical analyses including gel electrophoresis,
immunoblotting, peptide mapping, surface radio-iodination, detergent
fractionation, in vitro oligomerisation and protein microsequencing, as
well as electron microscopy, showed conclusively that this antigen was
indeed the MOMP of OEA C.psittaci, the analogue of well-characterised
MOMPs of other chlamydial strains. OEA MOMP was found to be a major
surface-exposed component of the outer membrane fraction of the chlamydial
elementary body (EB), and appeared as fine ultrastructural particles (3 to
4 nm in diameter) densely packed on the outermost surface of chlamydial
EBs. It possessed epitopes cross-reactive with other chlamydial MOMPs and
is a site of heterogeneity between ovine C.psittaci types. Its solubility
was enhanced in the presence of reducing agent and MOMP monomers formed
disulphide cross-linked oligomers under non-reducing conditions in vitro.
It was found to possess an N-terminus identical to C.trachomatis MOMP
indicating that cleavage of the signal sequence occurs at the same site to
produce a mature protein of 39.5kDa.
A method was adapted to isolate MOMP by detergent extraction. An
outer membrane fraction, highly enriched in MOMP, was prepared in
sufficient quantities for a vaccination-challenge experiment. The results
showed that both purified whole elementary bodies and the outer membrane
preparation, given in a single dose, could protect ewes from infection
and abortion. To test the hypothesis that MOMP was a protective component
in these vaccine preparations, sufficient quantities of purified MOMP were
needed. A recombinant DNA approach was taken.
Firstly, the MOMP gene from a vaccine strain, S26/3, was
completely sequenced and extensively analysed in order to develop good
strategies of expressing recombinant MOMP (rMOMP). This monocistronic gene
contained putative tandem promoter and rho-independent terminator
sequences flanking a 1,167 base-pair open reading frame. Comparison with
other MOMP gene sequences revealed four highly variable domains
interdigitating five constant domains.
Using the polymerase chain reaction and specially designed primers,
a specific sequence corresponding to the mature MOMP was amplified, cloned
into M13 mptacl8 viral expression vector and subcloned into three plasmid
vectors, pUC8, pRIT5 and pRIT2T, for expression. Several rMOMPs
representing the complete mature MOMP and a truncated MOMP were
successfully expressed in Escherichia coli. Finally, further analyses
showed that these rMOMPs retained antigenic properties of MOMP and that
large quantities could be obtained in a highly purified form. Such rMOMPs
can now be tested for the presence of epitopes which can protect pregnant
ewes from ovine enzootic abortion.
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CHAPTER 1
GENERAL INTRODUCTION AND AIMS
ECONOMIC, VETERINARY AND MEDICAL IMPORTANCE OF
CHLAMYDIAL ABORTION IN SHEEP
Ovine enzootic abortion (OEA), also known as enzootic
abortion of ewes, is a major infectious cause of lamb loss in
sheep farming (Aitken, 1983). The disease involves inflammation
and necrosis of the placental tissues in pregnant ewes resulting
in premature lambing, birth of weak lambs or abortion of the
infected fetus. In 1950, Stamp and colleagues at the Moredun
Research Institute (Edinburgh) identified the causative agent as
Chlamydia psittaci, now known to be an obligate intracellular
bacterium with a Gram-negative envelope. A series of studies
testing various forms of experimental vaccines culminated in the
development of an inactivated whole organism vaccine which has
formed the basis of a commercial product (McEwen et al, 1951a,
1951b and 1955; Littlejohn et al, 1952; Hepple, 1952; McEwen and
Foggie, 1954 and 1956; McEwen, 1954; Foggie, 1959). This
vaccine consisted of a crude suspension of egg-cultured
chlamydial organisms suitably inactivated and formulated as an
emulsion in oil. Although not entirely eliminating the disease,
the vaccine reduced the incidence of OEA to an economically
acceptable level for many years up to the mid-1970s (Foggie,
1973). Vaccines against OEA represent the most successful and
the only extensive application of immunoprophylaxis for any
disease of chlamydial aetiology.
Resurgence of ovine enzootic abortion
In recent years, however, OEA has re-emerged to become a
prevalent cause of infectious lamb loss. An epidemiological
study carried out between 1975 and 1978 by Linklater and Dyson
(1979) recorded an increase in outbreaks of OEA in south-east
Scotland. Some outbreaks had even occurred in regularly
vaccinated flocks. As no significant changes in sheep husbandry
took place in the region at that time, the vaccine, which was
virtually unchanged since the 1950s, was thought to be losing
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its potency; or else, new strains of C.psittaci were emerging
against which the vaccine offered little or no protection.
Owing to the lack of suitable potency tests, the quality of the
vaccine has been difficult to monitor. Heterologous challenge
experiments in sheep (Aitken et al, 1981) and toxicity tests in
mice (Russo et al, 1979; Johnson and Clarkson, 1986) have
provided some indication that there might be antigenic variation
in the field. In contrast, other studies on the virulence of
several abortion isolates in mice (Anderson, 1986b) and
comparisons of restriction endonuclease profiles of the
chlamydial genome (McClenaghan et al, 1984) did not reveal any
variations. Nevertheless, a second isolate (S26/3) obtained
from a severe outbreak in 1979 was added to the vaccine which
had contained only the original A22 vaccine strain.
A continuing problem
Despite the introduction of this bivalent vaccine,
Veterinary Investigation Centres throughout England, Scotland
and Wales have recorded a steady increase of ovine abortion due
to chlamydial infection in recent years (Wilsmore and Dawson,
1986). Furthermore, OEA has also arisen in parts of the country
previously free from the disease. Currently, about 20% of all
fetopathies per year are attributed to chlamydial infection. In
1988, this represents 46% of all diagnosed fetopathies
(Veterinary Investigation Data Analysis - V1DA). Such losses in
sheep production due to OEA amount to as much as £10 million per
year (I.D.Aitken, personal communication).
Within the European community, chlamydial infection in
ruminants has been identified as a disease of emerging
importance especially within member countries possessing large
sheep and goat populations, including Britain, France, Germany,
Greece and Italy (Aitken, 1986). Chlamydial abortion in sheep is
also a serious problem in North America (Storz, 1971; Shewen,
1980). There have been reports of this disease in Australia but
the situation is not as serious presumably because of
differences in animal husbandry and environmental factors
(Seaman, 1985) .
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Danger to pregnant women
The prevalence of C.psLttaci in sheep also serves as a
reservoir for zoonotic infection of humans. Such an infection is
more acute compared to OEA and has life-threatening sequelae
(see next section). In recent years, there has been an
increasing awareness of the infectious potential of ovine
abortion C.psittaci for pregnant women (Buxton, 1986; Helm et
al, 1989). Although a serological survey did not find the risk
of infection by C.psittaci in the farming populations of
north-west England to be high (Hobson and Morgan-Capner, 1988),
the lack of specificity for C.psittaci in the test reagents and
the limited scope of the survey are causes for speculation as to
the extent of infection among humans. Hence C.psittaci of ovine
origin should not be perceived solely as an animal pathogen.
Owing to its veterinary, economic and medical importance, this
type of C.psittaci and the diseases it causes warrant continued
surveillance and sustained research. In particular, modern
techniques of molecular biology should be brought to bear on the
problem in a concerted and systematic way.
THE NATURE OF THE DISEASE
OEA is a seasonal disease of ewes and is widespread
throughout flocks of all breeds in the UK. It occurs
predominantly in lowland flocks which are intensively managed at
lambing time (Aitken, 1983) . A high level of environmental
contamination by infected ewes in lambing fields or pens is
thought to be an important link in the infectious chain.
Susceptible lambs and ewes acquire latent infections which
emerge in the following lambing season (McEwen et al, 1951a;
Foggie, 1954). Early chlamydial abortions within a flock can
also be a source of infection for other pregnant ewes which
become infected and abort in the same lambing season (Blewett et
al, 1982). Excreted organisms and infected abortices
contaminate the soil and are thought to be sources of infection
through ingestion and inhalation.
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Clinical symptoms and diagnosis
There are rarely any signs of impending abortion.
Behavioural changes and occasional vulval discharge may be
present shortly before abortion but these signs are seldom
noticed under farming conditions. Ewes usually abort during
late gestation but cases as early as 70 - 100 days gestation
have been reported. The usual indicator is the discovery of
dead lambs 2-3 weeks before lambing. Initial diagnosis is made
on the appearance of the fetal membranes. Necrotic placental
cotyledons, oedematous thickening of the inter-cotyledonary
regions of the chorion and well-formed aborted fetuses are
typical signs of chlamydial abortion. Confirmation of diagnosis
is either by direct isolation of the organism in eggs or cell
culture, or more conveniently, by the demonstration of
chlamydial EBs in smears made from affected tissues (modified
Ziehl-Neelsen stain - Stamp et al, 1950). Retrospective
diagnosis by serology (complement fixation test - Stamp et al,
1952) can also be performed since post-abortion ewes tend to
possess high antibody titres.
Treatment and prevention
C.psittaci is sensitive to antibiotics such as tylosin,
erythromycin, tetracycline and oxytetracycline. Blanket
treatment can only moderate the severity of the incidence and in
any case is dependent on rapid and definitive diagnosis.
Therapy may reduce the number of organisms shed but does not
eliminate infection or reverse the damage already done to the
placenta.
Vigilance is necessary to detect an outbreak early. Proper
disposal of infected material, segregation of aborting ewes,
and hygiene will often prevent spread of the infection to other
susceptible animals. Care can be taken to select replacement
stock from sources with no known history of OEA but this does
not guarantee infection-free animals. Although previous
exposure to chlamydiae can be deduced serologically, there are
no tests that can distinguish infected animals from animals
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which are vaccinated and protected. Post-abortion ewes also
possess chlamydia-specific antibodies and are protected against
abortion in subsequent pregnancies (Stamp et al, 1950). They
may, however, continue to excrete infectious organism in vaginal
discharges or in the faeces, thereby contaminating the
environment.
The difficulty in identifying the immunological status of
sheep - whether naive and susceptible, vaccinated and protected,
infected and about to abort, or convalescent - justifies the use
of extensive vaccination as a long-term policy for disease
control; this had been practised from the 1950s to the 1970s
with success. In the past decade, however, reduction in vaccine
efficacy has been cause for concern. Attempts have been and are
being made to improve the quality of the current vaccine.
Complicating factors include the possible emergence of vaccine-
resistant or more virulent OEA strains, the lack of serotyping
tests to monitor the epidemiological aspects of the disease, and
a limited understanding of the pathogenetic events and the basis
of vaccine-induced immunity.
Pathology and pathogenesis
The anatomy of the ovine placenta with particular
reference to ovine abortion has been described in detail by
Studdert (1968). Chlamydiae colonise the chorionic epithelium
at a particular stage of gestation; from approximately the 70th
day of pregnancy, they can be detected in the placenta within
trophoblastic cells. The primary lesions are localised at the
chorionic epithelium, lining the sites of haematomas that are
normally found in the ovine placenta from 60 days gestation.
Presumably, infectious elementary bodies (EBs) of chlamydiae
are released from site(s) of "latency", migrate via a
haematogenous route, congregate at the haematomas and infect the
apposing trophoblastic cells (Figure 1.1ABC).
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Figure 1.1A. Schematic section of an ovine placentome.(Courtes
of Dr Gareth E. Jones).
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Figure 1.1B. Section of an infected ovine placentome
(haematoxylin and eosin stain; xl80). 1. Infectious elementary
bodies (EBs) arrive at the placentome via the maternal
circulation possibly from an initial tonsillar infection. 2. EBs
migrate (long arrow) across the placental tissues to infect the
trophoblastic epithelial cells. 3. Loss of infected cells and
progressive necrosis. 4. Release of cellular debris and more
infectious EBs. 5. Infection of apposing uterine epithelium and
lateral spread to the inter-cotyledonary regions (short arrow).
6. Local infiltration by fetal and maternal macrophages,
neutrophils and other lymphocytes. Maternal side (ma). Fetal
side (fe). Inset. Infected trophoblastic epithelium
immunostained with anti-chlamydial antibodies (Finlayson et al,
1985) showing large inclusion bodies full of chlamydial
organisms (x250); counterstained with haematoxylin. (Courtesy of
Dr David Buxton.)
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Figure 1.1C. Section of infected human chorionic villi (v)
immunostained with anti-chlamydial antibodies. Infected
trophoblastic epithelia are laden with stained chlamydial
organisms within large inclusion bodies (arrowed) (xl80).
Inset. Infected epithelial cells and cell debris (x250)
immunostained and counterstained with haematoxylin. (Courtesy of
Dr David Buxton.)
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After cycles of infection, the chorionic epithelial cells
appear sloughed. Damage to the basement membrane occurs. Fetal
inflammatory cells, predominantly the polymorphonuclear
neutrophils and some mononuclear cells, infiltrate the
subchorionic mesoderm. The lacunae fill with cell debris, lysed
red blood cells, infectious elementary bodies and considerable
amounts of inflammatory exudate as the infection spreads
laterally into the inter-cotyledonary chorion (Figure 1.1B).
Gross pathology include extensive necrosis of the
cotyledons, oedematous and haemorrhagic fetal membranes with
large amounts of thick, brown, bloody, mucus-containing exudate
adhering to the areas of placentitis on the chorionic surface.
Fetuses aborted before 120 days of gestation appear to be
retained for several days after death with consequent autolysis.
Fetuses from later abortions may show splenic and lymph node
enlargement, lesions of the liver, lung, kidney and heart muscle
with focal accumulations of hyperplastic reticulo-endothelial
cells. Infectious EBs, having penetrated the placental barrier,
enter the fetal circulation via the chorionic blood vessels to
infect these tissues. Nevertheless, fetal lesions in general
are relatively minor and secondary to the primary lesions of the
placenta.
Under natural conditions, ewes are believed to be infected
with C.psittaci either as newborn lambs or as mature ewes during
previous or current enzootics of abortion (McEwen et al, 1951a;
Blewett et al, 1982; Wilsmore et al, 1984b). A possible portal
of entry appears to be the nasal mucosa and the tonsils (Jones
and Anderson, 1988) , presumably through inhalation of
chlamydia-laden aerosols or through ingestion. These routes
may account for the observation that outbreaks of the disease
are rare in highland extensive sheep farming but common in the
lowlands where farming is more intensive. Studies of
experimental infection indicate that the agent can remain in the
infected lamb or sheep without overt symptoms for various
durations until colonisation of the placenta occurs from some




A vaccinationmay elicit mucosal immunity
B vaccination may inhibit migration to site of 'latency'
C vaccinationmay inhibit haematogenous migration of EBs to the placenta
D vaccinationmay induce immunity atthe placenta
E properdisposal of infected abortus
F mode ofhusbandry
Figure 1.2. The infectious cycle in ovine enzootic abortion.
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unknown site(s) of "latency" (McEwen et al, 1951a; Foggie,
1954; Munro and Hunter, 1981; Blewett et al, 1982; Wilsmore et
al, 1984b).
It has been proposed by Studdert (1968) that release of
infectious agent from the site of "latency" may be a periodic or
a fortuitous event. The recent work of Buxton et al (in press)
has demonstrated that no sign of placental pathology could be
detected in experimental infection prior to 90 days gestation
whereas infection after 60 days of gestation resulted in direct
colonisation of the placenta. One interpretation is that
periodically released organisms may reach the placenta but they
succeed in colonising the trophoblastic cells only after about
60 to 90 days gestation when the target cells become ready for
infection. Alternatively, some physiological signal coupled to
the progress of pregnancy might trigger the emergence of
chlamydiae from its quiescent state to infect the target cells.
Zoonotic infection in women
It had been suspected for many years that ovine C.psittaci
may be responsible for a number of spontaneous abortions and
perinatal deaths but evidence was largely circumstantial
(Roberts et al, 1967; Beer et al, 1982). Since then, it has
been established with clinical, serological, histopathological,
ultrastructural and molecular evidence that OEA strains of
C.psittaci have a strong predilection for the human placenta and
have caused abortion and severe illness in a number of women in
their second or third trimester of pregnancy (McKinlay et al,
1985; Wong et al, 1985; Johnson et al, 1985; Buxton, 1986;
Herring et al, 1987; Helm et al, 1989). Initial symptoms of the
zoonotic infection are influenza-like with fever, headache and
malaise followed within the next few days by spontaneous
contractions and abortion. Following abortion, patients show
symptoms of profound thrombocytopenia with disseminated
intravascular coagulation (DIC), renal and hepatic dysfunction
with myocardial involvement.
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Reminiscent of the pathology in sheep, degenerative loss
of trophoblast cells in the chorionic villi and inflammation of
the mesoderm are prominent histological characteristics with
chlamydia-laden trophoblastic cells frequently demonstrable. The
tissue damage and toxic products of the chlamydiae may then lead
to insufficiency of maternal-fetal transfer, subsequent fetal
death and abortion.
In contrast to the placentation in ewes, the human uterine
epithelium, the underlying tissue layers and the endothelium
are eroded so that the chorionic epithelium is in direct contact
with the maternal circulation (haemochorial placentation). Such
a placentation facilitates the spread of infectious chlamydiae,
chlamydial endotoxin, cellular debris and thromboplastic
factors into the maternal circulation which may account for the
severity of the sequelae mentioned above.
Concurrent infection with other zoonotic agents associated
with sheep farming e.g. Coxiella burnetii has also been recorded
and may result in abortion in the first trimester (McGivern et
al, 1988). In suspected cases, early delivery of the infant
before serious infection occurs may reduce the severity of
post-partal illness, save the infant, and assist a more rapid
recovery of the mother (Beer et al, 1982).
THE ORGANISM
Taxonomy
Chlamydia psittaci is assigned to the distinct order
Chlamydiales, which consists of one family, Chlamydiaceae, with
a single genus, Chlamydia (Moulder, 1988 - review). C.psittaci
and the only other currently recognised species in the genus,
C.trachomatis, are obligate intracellular prokaryotic parasites
of eukaryotes. They share many characteristics with
Gram-negative bacteria but possess a unique biphasic
developmental cycle which alternates between two forms, the
elementary body (EB) and the reticulate body (RB). Recently,
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the TWAR strain, a human respiratory pathogen, which was
originally classified as a type of C.psittaci, has been proposed
as a third species to be called C.pneumoniae (Grayston et al,
1989) .
Unlike C.trachomatis which consists of 15 human serotypes
and one murine strain, C.psittaci comprises a large and diverse
group of strains that have broad host range and pathogenic
potential (Storz, 1971). C.psittaci hosts include
invertebrates such as molluscs and arthropods, ectothermic
vertebrates, wild and domesticated birds, and mammals including
man. Diseases associated with C.psittaci are as varied, with
symptoms depending on factors such as virulence of the strain,
host species, age and sex of the animal, environment, farm
management, ecology and physiology. Among the ruminants, in
particular, the sheep, intestinal infection, diarrhoea,
pneumonia, abortion, urogenital infection, mastitis,
polyarthritis, encephalomyelitis, hepatitis and conjunctivitis
are typical of chlamydial infection (Storz, 1971; Shewan, 1980).
Criteria used to classify C.psittaci strains include
plaque reduction assay (Schachter et al, 1974), inclusion
morphology, response to different treatments in cell culture,
(Spears and Storz, 1979; Anderson and Baxter, 1986), amino
acid requirements (Allan and Pearce, 1983),
microimmunofluorescence (mIF) assay (Eb and Orfila, 1982) ,
indirect mIF assay (Perez-Martinez and Storz, 1985), tests using
monoclonal antibodies (Toyofuku et al, 1986; Delong and Magee,
1986; Fukushi et al, 1987; Andersen and van Deusen, 1988),
immunoblotting (Fukushi and Hirai, 1988), restriction
endonuclease profiles and DNA hybridisation (McClenaghan et al,
1984; McClenaghan et al, 1986; Herring et al, 1986; Timms et al,
1988; Fukushi and Hirai, 1989). The difficulty in classifying
such a highly heterogeneous species is evident. For instance,
up to 9 immunotypes of mammalian strains (Perez-Martinez and
Storz, 1985) and up to 7 avian strains (Toyofuku et al, 1986)
have been proposed; in addition, there are other types from
other studies mentioned above which may not belong to these
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categories. C.psittaci isolated from ruminants have been
grouped into immunotype 1 (abortion and some intestinal
isolates), immunotype 2 (polyarthritis, conjunctivitis,
encephalitis and enteritis isolates) and immunotypes 3 and 9
(strains occurring in bovine and ovine intestinal flora)
according to the scheme of Perez-Martinez and Storz (1985).
Life cycle
The EB is the extracellular infectious form. It is
metabolically inactive and resistant to osmotic lysis. Since
its Gram-negative envelope appears to lack peptidoglycan, it is
thought that the structural ri.gidity of the EB is provided by
cysteine-rich outer membrane proteins, highly cross-linked by
disulphide bonds (Newhall and Jones, 1983; Bavoil et al, 1984).
Surface determinants are also thought to assist the attachment
and entry of the infectious EB into eukaryotic cells (Wenman and
Meuser, 1986; Hackstadt, 1986a). However, the mechanism by
which chlamydial EBs enter host cells is not clear. Various
modes of entry into host cells have been proposed and these were
summarised by Wyrick et al (1989) recently. They include
phagocytosis that is parasite-directed, microfilament-dependent
or microfilament-independent, and pinocytosis via receptor-
mediated clathrin-coated pits or non-coated smooth pits. It is
possible that chlamydiae can exploit different mechanisms of
entry into target cells (Prain and Pearce, 1989) or that the
differing modes of entry reported in the literature may be due
to differences in the type and state of host cells used, in the
multiplicity of infection, in the technique of visualising
morphology and ultrastructure, and in the technique of
enhancing infectivity such as centrifugation.
Within the cytoplasm, the organism resides in a
topologically distinct vesicle and is able to escape destruction
by inhibiting fusion of the vesicle with lysosomes (Friis,
1972). In this protected environment, the EB transforms into
the metabolically active and lion-infectious RB which multiplies
by binary fission.
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Although fragments of various metabolic pathways are
present in chlamydiae, their metabolic capabilities are limited
(Hatch, 1988 - review). They cannot generate net ATP and possess
an ATP-uptake mechanism instead (Hatch et al, 1982); they have
been aptly called "energy parasites" by Moulder. Within the
cell, these organisms rely on the host cell for basic
metabolites and other factors to fuel the synthesis of
chlamydial products.
As the RBs proliferate, the vesicle expands, sometimes
fusing with other chlamydiae-laden vesicles to form a prominent
inclusion within the host cell. The RBs mature and and condense
into EBs which are eventually released into the surrounding
medium to infect other cells, thereby completing the cycle
(Ward, 1988 - review).
Morphology and ultrastructure
Elementary bodies of chlamydiae are coccoid in shape
(except TWAR strains which are pear-shaped) with a size close to
the limit of the light microscope. Each EB has a dense,
eccentric nucleus surrounded by cytoplasm that is composed of
ribosomes and moderately dense amorphous material. Scanning
electron micrographs show the presence of surface projections
hexagonally arranged with a centre-to-centre spacing of 35-50 nm
on the surface of the EBs (Matsumoto and Higashi, 1975; Gregory
et al, 1979). Each projection protrudes from a hole in the
middle of a 30nm wide "flower", so-called because of its
appearance under freeze-deep-etching (Matsumoto, 1982a). Each
flower, also called a rosette, is composed of nine regularly
arranged subunits. Measurements from negatively stained
membrane preparations reveal each rosette to be 19-20nm in
diameter with each subunit 3-5 nm wide surrounding the 10-12 nm
hole from which the projection emerges (Matsumoto, 1973). The
projections and the rosettes are localised in one patch per EB
(Matsumoto, 1982c). Projections are easily broken off the
rosettes; isolated projections (6nm diameter; 45nm long) appear
like hollow nail-shaped structures, each with a pointed end
(Matsumoto, 1988).
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Reticulate bodies are larger, more pleomorphic and
flexible, ranging in size from 300 to 800 nm in diameter. RBs
also possess projections identical to those of EBs. These
projections originate from the chlamydial cytoplasm, extend
beyond the cell envelope through a rosette in the cell wall and
appear to pierce the inclusion membrane, suggesting a role in
facilitating intercellular traffic (Matsumoto, 1981 and 1982b).
Chlamydial outer membrane preparations possess on the
inner surface a hexagonally arrayed, macromolecular structure
composed of particles about lOnm in diameter (Manire, 1966;
Matsumoto and Manire, 1970). The periodicity of these hexagonal
units was determined to be 16.7nm (Matsumoto, 1979). A three-
dimensional model of the hexagonal units has been proposed by
Chang et al (1982) . Protruding from the outer surface of the
outer membrane are fine particles 5-6 nm wide with a
centre-to-centre spacing of 7 - 8nm. These particles seem to be
a major structural component of the outermost surface of the EB
cell wall (Matsumoto, 1979; 1982c; 1988).
ANTIGENIC STRUCTURE OF CHLAMYDIAE
Historically, chlamydiae have been associated with viruses
because many of their characteristics are virus-like. EBs are
typically 200-400 nm in size, close to that of large pox
viruses. In comparison to typical bacterial genome sizes of
4000 kbp (Escherichia coli), the chlamydial genome is one of the
smallest estimated at approximately 1000 kbp, second only to the
mycoplasmas (750 kbp). The small genome is characteristic of
prokaryotes that live in or on eukaryotic cells such as Coxiella
(1560 kbp), Rickettsia (1650 kbp) and Neisseria (1950 kbp)
(Moulder, 1988). It corresponds to the capacity to encode 400 to
600 proteins (Stephens, 1988). Typically, more than 100 bands
consisting of resolved proteins and lipopolysaccharide may be
visualised by SDS-PAGE (Salari and Ward, 1981; Caldwell et al,
1981; Hatch et al, 1981) or by two-dimensional electrophoretic
systems (Batteiger et al, 1985). Of these components only a
limited number are known to be antigenic. For example, about
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16 antigens of C.psittaci (CallO meningopneumonitis strain) were
described by Caldwell et al (1975) using two-dimensional
Immunoelectrophoresis; about 15 bands could be detected by
immunoblotting with antisera raised against C.psittaci guinea
pig inclusion conjunctivitis (GPIC) strain (Batteiger and Rank,
1987); at least 14 bands of C.trachomatis were identified with
sera from infected human patients (Newhall et al, 1982); more
than three prominent antigens of C.psittaci ovine enzootic
strains have been demonstrated by McClenaghan et al (1986) in
preliminary immunoblotting experiments, including several high
molecular mass (M ) antigens (78-90 kDa).
Several chlamydial components appear to be common to both
C.psittaci and C.trachomatis: chlamydial lipopolysaccharide
(Nurminen et al, 1983; Caldwell and Hitchcock, 1984), major
outer membrane protein (Hatch et al, 1981; Caldwell et al,
1981) , 60kDa and 12kDa cysteine-rich proteins (CRPs) (Newhall et
al, 1982; Newhall and Jones, 1983), 57kDa protein (Morrison
et al, 1989; Menozzi et al, 1989), 45kDa protein (Morrison et
al, 1989), the 30-32kDa and 17-19kDa adhesins (Hackstadt,
1986a and 1986b; Wenman et al, 1986). Most of these are
antigenic and although they are present in both species, they
may possess species-, subspecies- or type-specific epitopes (see
below). Some of these and other antigens, including a 155kDa
C.trachomatis species-specific protein, a 30-32kDa C.trachomatis
type-specific protein and a glycolipid, have been described in
a recent review by Newhall (1988). Data pertaining to the more
important antigens are detailed below. Recent information will
also be dealt with in the discussion sections of the following
chapters.
Major outer membrane protein
The most striking component in the SDS-PAGE profiles of
EBs of all chlamydial strains is a protein of some 40 kDa. This
is the major outer membrane protein (MOMP) which comprises 60%
of the protein mass in the outer membrane (Caldwell et al, 1981;
Salari and Ward, 1981; Hatch et al, 1981) and is by far the
best characterised chlamydial antigen. This surface-exposed
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protein is vital for the structural integrity of the chlamydial
outer membrane. Unlike matrix proteins of Gram-negative
bacteria which can be solubilised without destroying the basic
morphology of the organism, detergent extraction of MOMP from
the outer membrane results in the total loss of structure. It
is an acidic protein (Batteiger et al, 1985) containing several
cysteine residues involved in inter-molecular disulphide
cross-linkages (see next section). These cross-linkages are
critical for the function of MOMP as a porin and for the role of
MOMP in the developmental cycle (Newhall and Jones, 1983;
Bavoil et al, 1984; Hatch et al, 1984; Hackstadt et al, 1985;
Hatch et al, 1986; Newhall, 1987). MOMP exhibits variation in
M^ among chlamydial strains (Salari and Ward, 1981; Hatch et al,
1981; Caldwell et al, 1981; Caldwell and Schachter, 1982;
Newhall et al, 1982; Vitu and Russo, 1984; Fukushi and Hirai,
1988; Herring et al, in preparation). These variations are
localised on four variable domains in the deduced amino acid
sequence of MOMPs (Stephens et al, 1986 and 1987; Yuan et al,
1989; Zhang et al, 1989a); these domains are also the location
of antigenic sites.
Antigenically, MOMP is very complex and possesses a
hierarchy of epitopes bearing genus-, species-, subspecies- and
serotype-specificity (Caldwell et al, 1981, Caldwell and
Schachter, 1982; Stephens et al, 1982; Newhall et al, 1986;
Batteiger et al, 1986). Structural studies of MOMPs from
various serovars of C. trachomatis and C.psittaci by peptide
mapping suggest that each MOMP represents a serological mosaic
of antigenic determinants located on conserved and variable
segments (Caldwell and Judd, 1982; Ma et al, 1987). Molecular
analyses of the MOMP gene of C. trachomatis serotypes have
essentially confirmed these findings and have located such
epitopes to specific variable domains of the MOMP (Baehr et al,
1988; Stephens et al, 1988b; Conlan et al, 1988).
Some epitopes on MOMP are important for neutralisation of
C.trachomatis infectivity since anti-MOMP IgG cross-linking of
MOMP at the EB surface demonstrably interfered with the
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infectious process at a stage after EB internalisation (Caldwell
and Perry, 1982). Such in vitro neutralisation of infectivity
has been shown with an anti-MOMP species-specific monoclonal
antibody (mAb) capable of neutralising more than one serovar of
C.trachomatis (Peeling et al, 1984). Neutralisation of
infectivity has also been demonstrated by Zhang et al (1987a and
1989b) using mAbs specific for immunoaccessible epitopes on
MOMP. Recently, Su et al (1988) have demonstrated that for
C.trachomatis serovar B, trypsin cleavage of specific variable
domains in the MOMP correlates with inhibition of infectivity.
Although MOMP is an important target for the neutralisation of
chlamydial infectivity, its value as an immunoprophylactic has
only been partially demonstrated (Taylor et al, 1988).
The usefulness of MOMP in serotyping and diagnosis is
clear from the literature. The antigenic and sequence diversity
of MOMPs reflect the diversity among serovars of C.trachomatis
(Batteiger et al, 1986; Yuan et al, 1989); whether the
analogous situation exists with C.psittaci has only been
recently studied (Fukushi and Hirai, 1988; Zhang et al,
1989a).
Cysteine-rich outer membrane proteins
C.psittaci and C. trachomatis possess outer membrane
proteins with relatively high cysteine content; in addition to
MOMP, they are polypeptides of M^ around 60 kDa and 12 kDa
(Newhall and Jones, 1983; Hatch et al, 1984; Newhall, 1988 -
review). The 60kDa protein exists as a single polypeptide in
trachoma biovars of C.trachomatis but is found as a doublet in
the lymphogranuloma venereum (LGV) biovar of C.trachomatis
(Batteiger et al, 1985) and in C.psittaci (Hatch et al, 1984).
These cysteine-rich proteins (CRPs) are extensively cross-linked
by disulphide bonds to form a supra-macromolecular network in
the outer membrane that confers structural rigidity and osmotic
stability to the EB (Newhall and Jones, 1983; Bavoil et al,
1984; Hatch et al, 1984 and 1986; Hackstadt et al, 1985;
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Newhall, 1987). The reduction or oxidation of this structural
network is thought to be involved in the respective transitions
of EB to RB and RB to EB during the developmental cycle of
chlamydiae.
The 60kDa CRPs are highly antigenic and possess both
species- and genus - specific epitopes (Newhall et al, 1982;
Newhall and Basinski, 1986; Newhall, 1988). The N-terminus of
the C.trachomatis 60kDa protein has been sequenced (Newhall and
Basinski, 1986) and recently, the gene has been cloned and
sequenced, revealing the presence of 24 cysteine residues
(Clarke and Lambden, 1988; Clarke et al, 1988; Allen and
Stephens, 1989). DNA hybridisation of a C.trachomatis
60kDa-CRP gene probe with C.psittaci DNA indicated the presence
of genus-conserved regions in the gene (Clarke et al, 1988).
The low molecular mass (12kDa) CRP is also antigenic and
possesses biovar- and species - specific epitopes (Zhang et al,
1987b; Newhall, 1988). The role of these CRPs in the
developmental cycle suggests that antibody cross-linking of
these CRPs may interrupt the infectious cycle; the CRPs are
therefore potential vaccine candidates. However, protection
against infectivity has not been reported with antibodies
directed to these antigens.
Adhesins
Investigations of the endocytic uptake of chlamydiae into
host cells suggest specific binding of EBs with host receptor
molecules (Byrne, 1976; Ward and Murray, 1984). The
chlamydial binding molecules or adhesins are likely to be cell
wall components (Levy and Moulder, 1982) and proteinaceous
(Byrne, 1976). Using radio-iodinated host cell membranes,
Wenman and Meuser (1986) have detected chlamydial adhesins, a
30-31kDa doublet and an 18kDa protein, in C.trachomatis by
ligand blotting. These adhesins were antigenic in rabbits and
specific antibodies were able to inhibit chlamydia-host cell
association. At the same time, Hackstadt (1986a) also detected
similar adhesins for both C.trachomatis and C.psittaci. In the
latter species, only an 18kDa adhesin was found. Further
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studies by Wenman and coworkers (1986) revealed a single 30kDa
adhesin in addition to a slightly smaller 16kDa adhesin for the
meningopneumonitis strain of C.psittaci. Antibody neutralisation
of infectivity against homologous or heterologous strains have
been demonstrated. In other studies, immunoblot profiles
commonly show antigens in the 30kDa and 18kDa region for the
GPIC agent (Batteiger and Rank, 1987) but whether these antigens
recognised in infection are the same as the adhesins has not
been shown. The 18kDa adhesin has been cloned (Kaul et al,
1987) and this should facilitate further analysis of the exact
role of the putative adhesins. Both adhesins were recently shown
to be synthesised late in the developmental cycle in relatively
small amounts (Newhall, 1987).
Lipopolysaccharide
All members of the genus Chlamydia share a common, heat-
stable, protease-resistant, periodate-sensitive antigen that
is the basis of the complement fixation test for chlamydial
infection (Schachter and Caldwell, 1980; Newhall, 1988 -
reviews). It is a glycolipid containing a 2-keto-deoxy-sugar as
the immunodominant moiety (Dhir et al, 1971; 1972). Evidence
to show that this carbohydrate antigen is indeed
lipopolysaccharide (LPS) include its surface location on the
outer leaflet of the outer membrane, its physico-chemical
properties during extraction, its mobility and staining in
SDS-PAGE gels, detailed analysis of chemical composition, its
serological cross-reaction with the LPS of Salmonella Re mutants
and Acinetobacter calcoaceticus, and its endotoxin-like
activity in the Limulus amoebocyte lysate assay (Nurminen et al,
1983, 1984 and 1985; Caldwell and Hitchcock, 1984). No mAb
reacting with LPS has been found to possess neutralising
activity.
Chlamydial LPS (M^ 3-4 kDa) contains typical bacterial LPS
constituents, namely, D-glucosamine, long chain fatty acids,
2-keto-3-deoxyoctonic acid (3-deoxy-D-manno-2-octulosonic acid;
KDO) and phosphates. Some of the fatty acids are novel
3-hydroxy fatty acids with 18 to 22 carbon atoms (Nurminen et
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al, 1985; Brade et al, 1986). Chlamydial LPS is structurally
divided into the lipid A moiety (which is made up of the amino
sugars and fatty acids) and the oligosaccharide core component
(formed from KDO). Lipid A intercalates with the outer leaflet
of the outer membrane while the KDO core is directed towards the
exterior. Chlamydial LPS lacks other sugar residues in the
oligosaccharide core and the O-antigen structure of "smooth" LPS
and appears to be similar to deeply truncated forms of LPS such
as that of Salmonella Re mutants (Nurminen et al, 1983).
The chemical composition of LPS differs between C.psittaci
and C.trachomatis, the fatty acid:D-glucosamine:D-galactosamine:
KDO:phosphate ratios being 6:2:1:5:2 and 5:2:0:3:2.6
respectively. The C.psittaci LPS contains D-galactosamine (not
found in C.trachomatis LPS) and more KDO residues suggesting
that the oligosaccharide core component of the respective
chlamydial LPS may have a different chemical structure (Nurminen
et al, 1985; Brade et al, 1985 and 1986).
Antigenic reactivities of the LPS can be divided into
epitopes specific to Chlamydia or epitopes cross-reactive with
enterobacterial Re LPS (Caldwell and Hitchcock, 1984). By
analysis of recombinant rough mutants expressing a chlamydial
KDO-glycosyl transferase, Brade et al (1988) have associated an
epitope of the first type with a unique a-2,8-linked KDO
disaccharide found on the oligosaccharide core of the LPS
molecule. Taylor and Prendergast (1987) did not find this
structure useful as an immunoprotective antigen. Two other
epitopes on the oligosaccharide belonging to the second type
have also been chemically characterised as a terminal
a-pyranoside KDO residue and an a-2,4-linked KDO disaccharide
A third epitope of the second type is thought to reside in the
lipid A portion of the LPS molecule because it cross-reacts with
enterobacterial lipid A and is unmasked only after acid
hydrolysis (Brade et al, 1985).
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AIMS OF THIS PROJECT
This project formed part of an inter-disciplinary research
collaboration, the aims of which are to understand the
pathogenic and immune mechanisms operating in OEA and to improve
existing OEA vaccines. Initially, the aim of the project was to
characterise various antigens of C.psittaci already identified
by preliminary immunoblotting studies. With the availability of
serum and lymph samples from ongoing experiments of the research
group, further immunoblotting was also carried out in tandem
with the characterisation work to fulfil the following aims:
a. to identify antigens of OEA strains of C.psittaci
recognised by sheep of different immune status and
b. to identify the potentially immunoprotective antigens
in vaccinated and protected ewes (CHAPTER 3);
c. to initiate characterisation of selected antigens and
d. to develop methods of purification (CHAPTER 4);
e. to test purified antigens for immunoprotective epitopes.
As the importance of the major outer membrane protein
gradually became evident from the immunoblot results and from
the data of other investigators, the characterisation work was
focussed on MOMP. An experiment was carried out to test
MOMP-enriched outer membrane complexes as an experimental
vaccine (CHAPTER 5). This revealed the potential of MOMP as an
immunogen. However, more rigorous studies to prove its role in
immunity were hampered by the difficulty in producing adequate
amounts of the purified protein. A recombinant DNA approach was
adopted. Relying on the availability of the MOMP gene cloned
from an abortion isolate of C.psittaci, subsequent aims were
f. to analyse the sequence of the MOMP gene (CHAPTER 6) and
g. to express recombinant MOMP (CHAPTER 7).
CHAPTER 2
MATERIALS AND METHODS
I. MICROBIOLOGICAL, IMMUNOLOGICAL AND BIOCHEMICAL TECHNIQUES









original reference strain used in
the commercial vaccine (Stamp et
al, 1950).
isolated from an outbreak (1979)
in a vaccinated flock (Anderson,
1984) - highly virulent.
subsequently isolated from the
same flock which S26/3 was
derived.
single sporadic abortion in a non-
experimental ewe at MRI (Anderson,
1984) -slightly less virulent than
S26/3.
isolated from a vaccinated flock -
low virulence.





isolated from vaccinated flock in
S.E. Scotland.
from a recently aborted ewe;
possessed inclusion morphology
similar to abortion isolates
(Anderson and Baxter, 1986).
from a lamb in a flock having had
abortion in the same season -
inclusion morphology similar to
arthritis isolates
(Anderson and Baxter, 1986).
P787 ovine polyarthritis isolated from synovial fluid of a
male lamb suffering from
arthritis (Anderson, 1984).
Chapter 2 Materials and Methods 25
CH1287 ovine conjunctivitis isolated from the eye of a sheep
with conjunctivitis in MRI
(Anderson and Baxter, 1986).
CallO laboratory strain from a case of presumptive
ornithosis (Francis and Magill,
1938).
725 avian strain isolate from a parakeet (gift of
Dr Bob Bevan).
C.trachomatis strain
L2 reference LGV strain gift of Dr I.W. Smith, Department
of Bacteriology, University of
Edinburgh.
CELL CULTURE OF CHLAMYDIAE AND MEDIA
Mycoplasma-free baby hamster kidney cells (BHK-21
heterodiploid cell line - Wellcome Foundation Laboratories,
Beckenham) were used for cell culture of chlamydial organisms.
The method of culture was performed according to Anderson (1984
- FIMLS thesis). Briefly, cells were seeded in 25 mis of Growth
Medium (GM) at a density of 150,000 - 200,000 cells/ml onto 75
sq cm plastic tissue culture bottles (Nunc) and incubated at
37"C overnight. Growth Medium (pH 7 - 7.2) contained 1 x BHK-21
Glasgow MEM medium (Gibco, Europe) with 10% newborn calf serum
(Gibco, Europe), 2.95 mg/ml tryptose phosphate broth (Difco
Laboratories, Surrey), 25 g/ml streptomycin sulphate (Evans
Medical Ltd, Middlesex), 25 U/ml mycostatin (E. R. Squibb &
Sons, Middlesex), 20 /ig/ml of gentimicin (Nicholas
Laboratories, Slough), 1.6 mg/ml sodium bicarbonate (BDH
Chemicals, Poole) and 0.4 JUg/ml phenyl red.
After overnight incubation to obtain confluent monolayers,
spent medium was replaced with fresh medium containing 80 jUg/ml
5-iodo-2'-deoxyuridine (IDU) (Sigma, Poole) in maintenance
medium (GM with 2% instead of 10% newborn calf serum) and the
culture incubated at 37°C. After three days, the spent medium
was exchanged for the inoculum medium containing 1% (v/v) of
chlamydial inoculum in maintenance medium (25ml). The Falcon
flasks were then centrifuged (2000 g) for 30 minutes at 20°C
using an adapted microplate carrier (MSE Scientific, Sussex) and
cultures were then left to incubate at 37°C for 3-7 days.
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To monitor the progress of a chlamydial culture, flat-
bottomed, glass universal bottles containing 16mm diameter
coverslips were also similarly seeded (2ml), treated,
inoculated and centrifuged (2000 g for 30 minutes). The
coverslips were removed daily and stained with Giemsa (see next
section) to assess the quality of the culture.
For preparing inocula, the same procedure was followed
using stock chlamydia held at the Moredun Institute except that
only monolayers with 50% or more cells infected were used and
harvested at 3 days post-inoculation (dpi) directly into sterile
transport medium (74.6 mg/ml sucrose, 0.512 mg/ml potassium
dihydrogen orthophosphate, 1.237mg/ml di-potassium hydrogen
orthophosphate, 0.721 mg/ml L-glutamic acid, 10% fetal bovine
serum, 150 U/ml mycostatin, 50 jLtg/ml gentimicin, 100/Lig/ml
streptomycin sulphate, 16 /ig/ml phenyl red) at roughly 3 ml per
Falcon flask of infected cell monolayer. Inocula were
immediately frozen at -70°C until use. For purification,
chlamydial cultures were harvested at 7 dpi with the medium and
frozen at -70°C until the purification procedure.
HISTOLOGICAL STAINING
Cell monolayers on coverslips were fixed in methanol for
10 minutes and stained in 5% (v/v) Giemsa solution (Gurr's
unproved R66, BDH, Poole) for 20 minutes. The coverslips were
then washed and dehydrated by sequential rinses in the following
5 solvents: acetone; 2:1; 1:1, 1:2 (v/v) acetone:xylene
mixtures; and xylene. Coverslips were then mounted onto
microscope slides using DPX mountant. The stained monolayers
were then examined under a light microscope for chlamydial
inclusions which appear violet against a pink background.
PURIFICATION OF CHLAMYDIAE
The method of purifying chlamydiae was carried out as
described in McClenaghan et al (1984) with only one
modification. Urografin 370 (Schering AG, FRG) was used in
centrifugation steps as the density medium instead of
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Renografin. Briefly, cell culture harvests were thawed and any
intact cells disrupted with a Jencons glass-Teflon homogeniser.
The culture was clarified by centrifugation (1500g) for 5
minutes at 4°C. Chlamydiae in the clarified supernatant were
pelleted through a 10 ml density cushion of 30% (v/v) Urografin
in TrisKCl (20 mM Tris-HCl pH 7.5 and 150 mM KC1) by
centrifugation at 53,000g for 45 minutes at 4°C. The crude
chlamydial pellet was resuspended in a small volume (about lml)
of TrisKCl and homogenised where necessary to disrupt aggregates
before layering onto a 30%-60% Urografin continuous density
gradient. Purification of chlamydial EBs and RBs was achieved
by ultracentrifugation at 53,000g for 2 hours at 4°C. Two
opalescent bands, the upper containing predominantly RBs and
the bottom containing EBs, could be seen after centrifugation.
Both bands were collected with a syringe and diluted in TrisKCl
and re-pelleted by centrifugation (53,000g at 4°C for 45
minutes). The pellets were then resuspended in TrisKCl
(100-500/il) with a homogeniser or by vigorous vortexing where
necessary before freezing at -70°C in small aliquots.
Preparations were routinely checked by electron microscopy.
ELECTRON MICROSCOPY
The carbon collodion-coated grid was first wetted with 3
/Lll of 0.01% poly-L-lysine (Sigma) solution for 20 seconds and
dried with the edge of a piece of blotting paper. The sample
(3)il) was then added to the grid and left for 20 seconds before
being similarly dried. The coated grid was washed twice with
distilled water (3jlll) to remove salts. The washed grid was then
treated with 3/il of the negative stain, either 1%
phosphotungstic acid (BDH) pH 7.0 or 1% ammonium molybdate (Taab
Laboratories, Reading) pH 5.3 for 20 seconds and dried, ready
for examination under the electron microscope (JEOL 1200EX). The
operating voltage was typically 80 kV.
POLYACRYLAMIDE GEL ELECTROPHORESIS OF PROTEINS (SDS-PAGE)
This procedure was carried out using a modification of the
method of Laemmli (1970) as described in Herring and Sharp
(1984). For mini-gels (80mm x 60mm), the BioRad apparatus
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(MiniProtean II) was used according to the manufacturers'
instruction. For large gels (150mm x 140mm), the BioRad
apparatus (Protean) was used. Gel loadings were typically 10-20
/Xg protein per track depending on the number of expected bands
and the method of staining. Before electrophoresis, samples
were boiled for 90 seconds with an equal volume of 2 x Sample
Buffer containing 20% sucrose, 2% SDS, 4% (v/v) 2-mercapto-
ethanol and 0.04% (w/v) bromophenol blue as tracker dye.
ELECTRO-TRANSFER AND IMMUNOBLOTTING
The electro-transfer was carried out according to Herring
and Sharp (1984) without modification. This procedure was based
on the method of Burnette (1981) using a
methanol(20%)-Tris(20mM)-glycine(150mM) blot buffer. The
immunoblotting procedure of Herring and Sharp (1984) was used
with the following modifications. The wash solution and diluent
were replaced with phosphate buffered saline pH 7.4 containing
0.5% Tween 20 (PBST). Blocking was achieved simply by a wash in
PBST. The membranes were immunologically probed with serum
samples diluted 1:100 in PBST for 1 h. Visualisation was either
carried out enzymically or by autoradiography. The
radio-iodinated rabbit anti-sheep FCab^ antibody and
radio-iodinated Protein A were obtained from the Moredun
Institute (gift of P.Dewar and A.Dawson). This second
incubation step was also reduced to 1 h at room temperature. The
horse-radish peroxidase-conjugates with antibodies to sheep IgG,
sheep IgM, human IgG and murine IgG were obtained from the
Scottish Antibody Production Unit (SAPU).
For protein microsequencing of MOMP, SDS-PAGE was carried
out as described above on a sample of outer membrane
preparation, highly enriched in MOMP. The gel was equilibrated
for 10 minutes in transfer buffer (50mM boric acid pH 9 20%
methanol) before electro-transfer onto a glass fibre support
(GLASSYBOND , Biometra Ltd, Manchester) by a semi-dry method
£
(Eckerskorn et al, 1988). Briefly, the "Glassybond " support was
cut to size, pre-wetted with methanol and equilibrated with
transfer buffer for 20 minutes with three buffer changes.
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Electro-transfer was carried out between pre-rinsed graphite
electrodes in a transfer sandwich containing the following
arranged from the anode to the cathode: 2 sheets of filter paper
(Whatman 3mm) pre-soaked in transfer buffer, 1 sheet of
pre-wetted "Glassybond equilibrated gel, 2 sheets of filter
paper pre-soaked in transfer buffer. Care was taken to eliminate
air bubbles between the individual layers. The transfer was
performed with a constant current density of ImA/square cm for
£
90 minutes. After the transfer, the blotted "Glassybond " was
rinsed with distilled water and stained in Coomassie blue as
described below. The MOMP band was identified and excised for
sequence analysis.
STAINING OF GELS AND BLOTS
Coomassie Blue staining of protein gels
The gel was incubated in Coomassie Blue stain (0.04% (w/v)
Coomassie brilliant blue R250 (Sigma), 50% (v/v) methanol, 7.4%
(v/v) glacial acetic acid, 1% (v/v) trichloroacetic acid) for 1
h with gentle shaking. To remove non-specific staining, the
gel was incubated a further 1 - 2 h in destain solution (7%
(v/v) glacial acetic acid, 23% (v/v) ethanol) with gentle
shaking. To assist stain removal, tissue paper was soaked in a
corner of the incubation tray to adsorb excess stain.
Silver staining of protein gels
This technique was used when a greater degree of
sensitivity was required (at least 10 ng of protein per band
detected). The method of Morrisey (1981) was used with slight
modifications. The gel was incubated for 20 minutes in each of
the following three solutions sequentially: 50% methanol 10%
acetic acid (v/v); 5% methanol 7% acetic acid (v/v); and 10%
glutaraldehyde (v/v). The gel was then washed in distilled water
for 4 hours (5-6 changes of 200ml per gel) or overnight (1L).
The washed gel was then incubated sequentially for 30
minutes in each of the following two freshly made solutions: 5
Jig/ml dithiothreitol; and 0.1% silver nitrate (w/v). The
treated gel was then rinsed quickly with distilled water once
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and then twice with freshly made developer solution (3% w/v
sodium carbonate containing 0.05% v/v formaldehyde 37-42%
solution) before being soaked in developer solution until the
desired intensity of staining was achieved. The reaction was
then stopped with 2.3M citric acid (5ml per 100ml of developer
solution used) and left for 30 minutes before storage. At all
stages, all containers used were thoroughly cleaned. Direct
contact with the gel was completely avoided by the use of
gloves. Typically, 200ml of each solution per stage was used
per gel (or 50ml per mini-gel). The gels were subjected to
gentle shaking at all incubation stages for even staining.
Preservation of gel
For short term storage (up to 6 months), polyacrylamide
gels were sealed in polythene bags. For longer term storage,
they were soaked in 4% glycerol for at least 1 h before drying
down onto filter paper or between two sheets of clear semi¬
permeable backing membrane (BioRad) in a BioRad slab gel dryer.
Coomassie Blue staining of nitrocellulose blots
Strips of nitrocellulose blots of SDS-PAGE gels were
incubated in Coomassie Blue stain solution diluted 1:40 with
blot destain solution containing 30% (v/v) methanol and 5% (v/v)
glacial acetic acid for 1 - 2 hours and destained with blot
destain solution as described above for gels.
£
Coomassie Blue staining of "Glassybond " blots
The blot was briefly rinsed in distilled water and soaked
for 5 minutes in Coomassie Blue stain solution (undiluted). The
stained blot was rinsed in water and destained in blot destain
solution until the background was colourless. The blot was then
dried between paper towels and stored until sequence analysis.
AuroDye staining of nitrocellulose blots
For increased sensitivity (10 ng of protein per band), the
AuroDye stain (Janssen) was used. Blots were blocked in PBS
containing 0.3% Tween for 30 minutes before being soaked for 30
minutes (or until desired colour intensity achieved) in AuroDye.
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PROTEOLYTIC PEPTIDE MAPPING
This procedure was carried out according to Cleveland et
al (1977). The protein sample was subjected to SDS-PAGE and the
protein bands stained by Coomassie Blue as described above. The
desired protein band was excised and incubated in Cleveland
buffer (lOOmM Tris pH 6.8 containing 0.1% SDS and 1 mM EDTA) for
30 minutes. The gel slice was trimmed and manually inserted
onto the bottom of a well of another PAGE gel that was cast with
a longer stacking gel (1cm). The gel slice was then overlayed
with protease dissolved in Cleveland Buffer containing 10%
glycerol to a predetermined concentration. Electrophoresis was
carried out until the protease and protein sample were stacked
closely at the interface of the stacking gel and resolving gel.
Proteolysis was allowed to take place in the gel for 1 hour. The
peptide fragments were separated by resuming electrophoresis and
the peptide profile visualised by silver staining or
immur.oblotting.
IMMUNO-DOT BLOTTING
For detection of specific antibodies in serum samples the
following method was used. Nitrocellulose paper (Schleicher and
Schuell) 0.45 pm wetted in distilled water was mounted on a
HybriDot manifold (BioRad Laboratories, FRG). One to five pi of
the sample was applied onto the nitrocellulose paper in each
well and vacuum applied gently to the manifold. Each well was
then rinsed with 200 pi of PBS containing 0.5% Tween 20. The
blotting procedure was then carried out according to the
manufacturer's recommendations. Serum dilution used was 1:100 in
PBST as in the immunoblotting procedure.
RADIO-IODINATION AND LIGAND BLOTTING
Purified chlamydial EBs were labelled using IodoBeads
(Pierce Chemical Coy, Rockford), non-porous polystyrene beads
derivatised with N-chlorobenzene sulphonamide (sodium salt), as
oxidising agent. Five pi of radioactive iodine-125 (0.5 mCi)
and 2 Iodobeads were mixed in lOOpl of TrisKCl for 5 minutes at
room temperature. lOOpl (about 80/lg) of chlamydial EBs suspended
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in TrisKCl were added and incubated for a further 15 minutes at
room temperature. The solution was separated from the beads and
the reaction quenched with either 2-mercaptoethanol (1% v/v
final concentration) or sodium metabisulphite (0.2% w/v - final
concentration). Carrier in the form of potassium iodide (1%
w/v) was added followed by sodium thiosulphate (1% w/v) before
the mixture was centrifuged at 53,000g for 30 minutes at 4°C to
pellet the labelled EBs. The pellet was washed once with
TrisKCl and similarly pelleted and finally resuspended in 100/Ul
of TrisKCl.
BHK21 cell monolayers were washed twice with PBS,
harvested with a rubber policeman into 10 ml of PBS, washed
again three times in PBS by repeated low speed centrifugation
(500g) at +4°C before being resuspended in PBS to give 3x10^
cells/ml. 200)Xl of the cell suspension were radiolabelled as
described above. Radiolabelled cells were washed four times
with PBS and resuspended in lOOjUl PBS. These cells (3x10^ cpm)
were then solubilised with 1% Triton X100 (Sigma) in lOOjLil PBS
for 2h at 37°C with constant agitation. Insoluble material was
pelleted (ll,000g), washed with PBS again and the two
supernatants pooled. The radiolabelled cell material (3x10^ cpm)
was diluted in PBST (the Triton X100 concentration was reduced
from 1% to 0.03%) and the radioactive solution (3ml) used to
probe pre-blocked nitrocellulose strips bearing electroblotted
chlamydial proteins (2h at 37°C with gentle shaking). The
probed strips were then washed with PBST, dried and
exposed to X-ray film as in the immunoblot procedure.
Radioactivity of the labelled preparations were measured in a
Packard counter 460CD (15-80keV).
PROTEIN MICROSEQUENCING
N-terminus amino acid sequencing was done automatically
with an Applied Biosystems gas-phase microsequencer 477A on a
piece of "Glassybond " containing MOMP. The procedure was
carried out according to the manufacturers' recommendations.
Briefly, polybrene (2mg - 30/Zl) was added to the sintered-glass
fibre sample disc, which was then subjected to a 3 h pre-cycle
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of washes before the "Glassybond " sample was loaded. The
microsequencer automatically carried out sequential Edman
degradation (Edman, 1950), conversion of amino acid-
thiazolinones to the corresponding phenylhydantoin derivatives
and chromatographic separation by high performance liquid
chromatography (HPLC) with on-line data collection and analysis
by a dedicated computer.
II. RECOMBINANT DNA TECHNIQUES
STRAINS OF ESCHERICHIA COLI USED
JM101 supE, thi, del(lac-proAB), [F', traD36, proA+B+, +lacl^, lacZ delM15]. Restriction (rk ,mk ), mcrA .
Yanisch-Perron et al (1985).
JM109 recAl, endAl, gyrA96, thi, hsdR17, supEAA, relAl
(\ ), del(lac-proAB), [F' traD36, proA^B , lacl^,
lacZ delM15].
A host for growth of the single-stranded phage M13 and
its recombinants that is recA , modification plus and
restriction minus.
TG-1 del(lac-proAB), thi, supE, hsd&5 (rk , mk )
[F' traD36, proA+B+, lacl , lacZ delM15]
An E.coli strain from LMB (Cambridge) maintained on M19
media plus vitamin B and glucose in order to retain the
F' episome.
HB101 hsd S20, supEAA, aralh, \ , galK2, lacYl
proA2, rspL20, xyl-5, mtl-1^ recA13.
Restriction: (rB ,mB ), mcrA , mcrB .
N99cl galK, strA, \cl . A K12 \ ly^ogen of N99 containing
containing the wild type cl \ repressor. N99 is
derived from MM28 (Pharmacia).
N4830-1 F , su , his , ilv , galKdelQ, del(chlD-pgl),
X, delBam, N , cI857, delHl. A Pi
transductant of N4830-1 screened for galK . It carries
the temperature-sensitive \ cI857 repressor integrated
into the genome. Useful for vectors with \ P^ or P^
promoter (Pharmacia).
Bacteria were propagated and maintained using standard
microbiological techniques as detailed in Maniatis et al (1982).
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RESTRICTION ENDONUCLEASES AND DNA MODIFYING ENZYMES
Restriction endonucleases (REs) and DNA-modifying enzymes
were purchased from various manufacturers (Gibco BRL, Boehringer
Mannheim, NBL, Pharmacia) and used according to the
manufacturers' recommendations where appropriate. The enzymatic
reactions were otherwise carried out according to standard
protocols detailed by Maniatis et al (1982). RE digestions were
typically carried out in buffers supplied by the manufacturer
and carried out at an enzyme concentration of 3-5 units//ig DNA
at the recommended temperatures for at least 2 hours., Reactions
were stopped either by phenol extraction or by heating to 60°C
for 10 minutes.
PURIFICATION OF NUCLEIC ACIDS
Nucleic acid solutions were deproteinised by extraction
with phenol:chloroform (6:4 v/v) equilibrated with 1.0M Tris-HCl
pH 8.0. The nucleic acid sample was mixed with an equal volume
of phenol:chloroform by gentle vortexing and the organic and
aqueous phases separated by centrifugation at ll,000g for 2
minutes at room temperature. The aqueous phase was carefully
removed and transferred into a sterile micro-centrifuge tube.
Where necessary, the phenol phase was back-extracted for
maximum recovery by the addition of an equal volume of TE buffer
pH 8.0 (lOmM Tris-HCl and lmM EDTA), mixing and centrifugation.
The aqueous phase was removed and combined with the initial
sample for concentration by ethanol precipitation.
DNA was precipitated from aqueous solutions by the
addition of 0.1 volume of 3M sodium acetate pH 5.2, 2 volumes
of ethanol (-20°C) and stored at -20°C for 2-16 hours. For
precipitating nanogram quantities of DNA,the same procedure was
used except for the addition of mussel glycogen (BRL) to 20jLtg/ml
as a carrier. For selectively precipitating DNA molecules
greater than 200bp, 0.1 volume of 3M sodium acetate and 0.6
volume of isopropanol were added to the aqueous DNA solution
instead and stored for 1 hour at -20°C. Precipitated nucleic
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acid was pelleted by centrifugation at ll,000g for 10 minutes at
room temperature. The supernatant was aspirated and the pellet
washed by vortexing in 1ml 70% (v/v) ethanol. Washed nucleic
acid was re-pelleted as before and the pellet dried briefly in a
vacuum desiccator. Dried DNA was resuspended in TE buffer,
usually at a concentration of 330/ig/ml and stored at -20°C or
4°C.
AGAROSE GEL ELECTROPHORESIS
DNA fragments greater than 200bp were separated by
horizontal agarose slab gel electrophoresis according to
standard procedures detailed by Maniatis et al (1982). A
mini-gel system (Pharmacia GNA-100) was used for casting 20ml
and 40ml gels containing 0.8% (w/v) nucleic acid grade
'ultrapure' agarose (BRL) dissolved in Loening 'E' buffer pH
7.6-7.8 (36mM Tris, ImM EDTA and 30mM sodium di-hydrogen
orthophosphate) and ethidium bromide at a concentration of
0.5/Xg/ml. The electrophoresis was carried out in Loening 'E'
buffer. DNA samples were mixed with 0.1 volume of loading
buffer (50mM EDTA, 0.1% (w/v) Bromophenol blue and 25% (w/v)
sucrose or Ficoll), applied to the wells and subjected to
electrophoresis for 1-2 hours at 3.75 volts/cm using a Pharmacia
EPS 500/400 power supply. Molecular mass standards used were
either ifindlll-restricted \ phage DNA or lkbp DNA ladder (BRL).
After electrophoresis, the DNA bands were visualised over an
ultraviolet wavelength transilluminator at wavelength 302nm.
GEL PHOTOGRAPHY
Ultraviolet-illuminated, ethidium bromide-stained agarose
gels were photographed with a Polaroid MP-4 Land camera, using
Polaroid 667 high speed positive or Polaroid 665
positive/negative film through a Kodak Wratten 9 UV filter.
Typical settings for 667 film were f8 for 1/2 second and f4.5
for 10 seconds with 665 film. Film was developed for 30 seconds
at room temperature.
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MEASUREMENT OF [a-32P]- ATP INCORPORATION INTO NUCLEIC ACID
This was performed by the quantitation of trichloroacetic
acid (TCA) - precipitable counts described in Maniatis et al
(1982) with the following modifications. Two pi of the labelling
reaction solution was removed and mixed with lOpl of sonicated
salmon sperm DNA (500/ig/ml in TE pH 7.5 and 0.1% (w/v) SDS).
Half the sample was spotted onto a Whatman glass fibre filter,
in a gamma counter tube and left to dry. The remainder of the
sample was spotted onto a Whatman glass fibre filter and wetted
with ice cold 5%(w/v)TCA. After 5 minutes incubation on ice,
the filter was given 10 x 2.0ml washes with 5% (w/v) TCA. The
washed and unwashed filters were counted in a gamma counter
(Packard Autogamma 5650, Packard Instruments, USA). Total
counts were compared to acid-precipitable counts and the
percentage incorporation calculated.
SYNTHESIS OF RADIOACTIVE RNA PROBES
The BLUESCRIBE vector system (Vector Cloning Systems, San
Diego) containing T3 and T7 viral transcriptional promoters in
the coding region of the lacZ gene of plasmid pUC19 was used to
generate specific ssDNA as radiolabelled probes in the hybrid¬
isation experiments. A BLUESCRIBE recombinant carrying the MOMP
gene was kindly provided by S. Baxter. The procedure was
carried out according to the manufacturer's instruction. Radio-
labelled MOMP gene probes were used in Southern hybridisations.
HYBRIDISATION OF NUCLEIC ACIDS
Pre-hybridisation blocks non-specific binding sites for
the probe on the membrane filter. Baked nitrocellulose filters
were briefly washed in 6 x SSC (standard sodium citrate buffer
pH 7 - lxSSC contains 150 mM sodium chloride and 15 mM sodium
citrate), then pre-hybridised for 2 hours at 42°C, with gentle
rolling, in 500ml or 1000ml Azlon, screw top, wide-mouth
polypropylene bottles containing 5 or 10ml of pre-hybridisation
fluid (50% (v/v) deionised formamide, 0.25 x Denhardt's
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solution (100 x Denhardt's solution is 2% (w/v) Ficoll, 2%
(w/v) polyvinylpyrrolidone - PVP-40), 1.25 x SSC, 0.001% SDS and
100/Lig/ml denatured salmon sperm DNA) .
The pre-hybridisation fluid was discarded and replaced
with an equal volume of fresh pre-warmed (42°C)
pre-hybridisation fluid containing denatured probe.
Radiolabelled probe was denatured by heating for 5 minutes in
50% (v/v) formamide, at 80°C. Hybridisation was performed
overnight at 42°C with gentle rolling of the polypropylene
bottles containing probe solution and filter.
Hybridisation fluid was aspirated and the unhybridised
probe was removed from the filters by two 15-minute washes in
lxSSC and 0.1% (w/v) SDS at 42°C, followed by two 30-minute
washes in 0.1 x SSC, 0.1% (w/v) SDS at 42°C.
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Autoradiography of P labelled nucleic acids was
performed using Fuji RX medical X-ray film. Filters or dried
gels were mounted between a piece of de-emulsified X-ray film
and a sheet of Saran wrap. The sandwich was exposed in an X-ray
exposure cassette fitted with a Dupont Cronex lightning plus HC
intensifying screen at -70°C. X-ray film was developed for 2-8
minutes in Photosol CDL8 X-ray developer, washed briefly in
water then fixed for 2 minutes in Photosol CF40 fixer.
POLYACRYLAMIDE GEL ELECTROPHORESIS OF NUCLEIC ACIDS
AND SILVER STAINING
For greater sensitivity in the detection of low amounts of
nucleic acid (<10ng) or low molecular mass nucleic acid (100
bases to 3 kb), polyacrylamide gel electrophoresis and silver
staining were used. Typically, 7.5% acrylamide solution in 1 x
Loening 'E' buffer was employed using a 'E' buffer system. Gel
apparatus used were the same as that for protein SDS-PAGE gels
as described above. Nucleic acid bands were visualised by
staining with silver (Herring et al, 1982). Gels were fixed in a
solution of 10% (v/v) ethanol and 0.5% (v/v) acetic acid for 20
minutes followed by a 20-minute incubation in 0.2% (w/v) silver
nitrate (BDH). The gel was rinsed in distilled water twice and
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developed in degassed 0.15M aqueous sodium hydroxide
supplemented with formaldehyde (0.3% v/v) until the desired
colour intensity. The reaction was halted by rinsing and
soaking the gel in 0.75% (w/v) sodium carbonate solution for lh.
POLYMERASE CHAIN REACTION (PCR)
This procedure was carried out as described by Saiki et al
(1985) on a Techne Programmable Heat/Cool Dri-Block (Cambridge)
using 30 cycles of the following incubations: 1.5 minutes 94°C;
2 minutes 37°C; 3.5 minutes 70°C. To complete the reaction, a
final incubation of 8 minutes at 70°C was carried out.
The reaction mixture (50/il) typically contained 50 pmol of
the appropriate synthetic oligonucleotide amplimers (OSWEL
service, University of Edinburgh) each, 10-50 ng of target DNA,
200 mM of each dNTP (BRL or Pharmacia), 2-3 units of Taq
polymerase (Cetus Corp) in buffer containing lOmM Tris pH 8.5
1.5 mM MgC^ 50mM KC1 (ultrapure, Aldrich) and 0.1% (w/v)
gelatine (biochemical- BDH). The reaction mixture was boiled
for 3 minutes before addition of the dNTPs and polymerase. To
prevent evaporation, a drop of mineral oil (400-5 Sigma) was
overlayed onto the reaction mixture before beginning the
incubation cycles.
SUBCLONING, LIGATION, TRANSFORMATION AND TRANSFECTI0N
The M13 clone containing the MOMP gene was subcloned for
sequencing according to Messing (1983) and Yanisch-Perron et al
(1985) . The essential items of an M13 Cloning Kit (Boehringer
Mannheim) were purchased and the cloning procedures recommended
by the manufacturer was followed with the exception that the
E.coli host strain JM101 was used for making competent cells.
M13 (+)ssDNA was prepared accordingly for analysis and for
sequencing.
For the construction of plasmids expressing MOMP, the
following vectors were used: pUC8, pRIT5 and pRIT2T
(Pharmacia). Restriction digestions, dephosphorylations and
ligations were carried using standard procedures described in
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Maniatis et al (1982). MOMP gene inserts were isolated by
preparative agarose electrophoresis and the excised bands
treated with the GENECLEAN kit (BiolOl, California) as per
instructions. The E.coli host strains used for the
transformation of MOMP constructs in these vectors were JM101,
HB101 and N99cl+ respectively.
MINI-PREPARATION OF DOUBLE STRANDED DNA
A variation of the rapid alkaline-SDS lysis method for
preparing dsDNA from the M13 cloning experiments was used
(Maniatis et al, 1982). Briefly, bacterial pellets (1.5ml
cultures) were resuspended in 100 /11 ice cold TEG buffer (25 mM
Tris pH 8.0, lOmM EDTA, 50 mM glucose) containing 5mg/ml of
lysozyme (Sigma) and incubated at room temperature for 5
minutes. 200 (JL1 of freshly prepared alkaline SDS (0.2M NaOH and
1% SDS) was mixed in by several rapid inversions of the tube.
The mixture was incubated at room temperature for 5 minutes.
Ice cold solution (150/il) of 3M potassium acetate and 11.5%
(v/v) glacial acetic acid was then mixed in and the mixture
incubated for 5 minutes on ice before centrifugation (15 minutes
at ll,000g). The supernatant was extracted with
phenol:chloroform (6:4 v/v) and precipitated with ethanol as
described above. To remove RNA, the DNA solution was either
treated with RNase (20 /ig/ml) for 30 minutes at 37°C or
purified using GENECLEAN (BiolOl, California) according to the
manufacturer's instructions.
GEL RETARDATION ASSAY
Equal amounts (100 ng) of test ssDNA and the complementary
probe ssDNA was mixed with 2% SDS (1 jdl), agarose
electrophoresis loading buffer (3 /i1) and TBE buffer (0.1M Tris
89mM boric acid 2 mM EDTA pH 8.3) (13 /il). The reaction mix was
incubated for 3 h at 65°C before being analysed by agarose gel
electrophoresis. The appropriate ssDNA controls were also run
for comparison. Test ssDNA containing sequences complementary
to the probe formed dsDNA at the relevant regions and migrated
at a much slower rate under electrophoresis compared to the
controls.
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Ml3 CHAIN TERMINATION METHOD FOR DNA SEQUENCING
The M13 sequencing kits from Boehringer Mannheim (DNA
polymerase Klenow fragment) or from Pharmacia (T7 DNA
polymerase) were used. The chain termination reactions were
carried out exactly according to the manufacturer's
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instructions. The radioactive label, [a- S]-dATP (Amersham, UK)
was used. Urea (50% w/v)-polyacrylamide (6%) sequencing gels
(0.4 mm) were cast and electrophoresis carried out on the
Sequencing Gel apparatus Model S2 (BRL) according to the
manufacturer's instructions. The electrophoresis buffer used was
Tris-borate-EDTA (TBE) buffer (see above section). Gels were
pre-run for 20 minutes before samples were loaded. For the
resolution of 20 to 200 bp fragments, 2h of electrophoresis at
a constant 60 W was sufficient. For larger fragments up to 500
bp, run times of 5 to 6 hours were commonly used. After
electrophoresis, the sequencing gel was agitated in a solution
containing 5% (v/v) acetic acid and 5% (v/v) methanol for 20
minutes to remove urea and to fix the gel. The gel was then
dried onto filter paper for 1 h at 80°C and exposed to X-ray
film in a light-tight cassette at room temperature overnight.
COMPUTER ANALYSIS OF DNA AND AMINO ACID SEQUENCE
The sequence analysis software package of the University
of Wisconsin Genetics Computer Group (UWGCG) as described in
Devereux et al (1984) was used extensively for the analysis of
DNA and deduced amino acid sequences. This package was
available on licence to the Edinburgh Regional Computer Centre
(ERCC) and was supported on the ERCC Vax 8500 mainframe
(ERCVAX). Programs used other than those mentioned below
included COMPARE, DOTPLOT, TERMINATOR, FOLD, MAPPLOT, FIND.
Secondary structure analysis
The deduced amino acid sequence of MOMP was subjected to
computer analysis using the algorithms of Chou and Fasman (1978)
and Garnier et al (1978) which were available in the GCG package
PEPPLOT, PEPTIDESTRUCTURE and PLOTSTRUCTURE programs. In
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addition, a combined secondary structure prediction
incorporating eight prediction methods was used (Sawyer et al,
1986 and references therein).
PEPPLOT shows several common measures of protein secondary
structures together on one coordinated plot (Gribskov et al,
1986). Generally, the curves are the average, sum or product of
a particular residue-specific, attribute within a window of
residues (w). The first part of the plot shows a representation
of the sequence according to the characteristics of each residue
using coloured vertical lines: red = hydrophilic charged
either up (basic) or down (acidic); blue - hydrophilic,
uncharged either short (amides) or long (hydroxyl); green =
hydrophobic either short (aliphatic) or long (aromatic); black =
proline; unmarked = alanine , glycine and cysteine. The next
five plots show the propensity measures for a-helix and /?-sheet
(w=4) (Chou and Fasman, 1978), the regions of the sequence
typically found at the amino- or carboxyl- ends of a-helix and
/3-sheet structures (w=6), and regions typically found in
(3- turns (w=4).
The seventh part of the plot shows the hydrophobic moment
(Eisenberg et al, 1984) at each residue if the sequence were
forming either helix or sheet structure respectively at that
position. The hydrophobic moment measures the amphiphilicity of
a protein segment and is useful for predicting sequences that
may be located at the interface of the surface and the interior
of the protein. In these curves, the magnitude of hydrophobic
moment of the protein segment is calculated by the modulus of
the Fourier transform of a one-dimensional hydrophobicity
function. This hydrophobicity function is the sum of the
magnitude of the hydrophobicity vector at each residue for each
residue of the protein segment, which is given by the sum of the
components of each hydrophobicity vector. The hydrophobicity
vector for a residue is the product of the numerical
hydrophobicity of the residue and the unit vector in the
direction from the nucleus of the a-carbon towards the
geometric centre of the side chain. Thus protein segments with
the most apolar side chains on one side are characterised by
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large values of the hydrophobiclty moment. In other words, the
hydrophobicity moment can be expressed as a function of the
periodicity of the protein segment, ie. the number of residues
per turn or alternatively, the inter-residue angle. For a
periodic structure, say a strand of beta structure, the number
of residues per turn is 2, ie., the inter-residue angle is 180°.
If the beta strand twists, then the inter-residue angle will not
be exactly 180° . To take into account such possible deviations
from the ideal structure, the beta hydrophobic moment in this
plot takes the maximum value for inter-residue angles from 140°
to 180° and calculates the sum over a window of six residues.
Similarly, the helix hydrophobic moment takes the maximum for
residue angles 90° to 110° over a window of eight residues (3.6
residues per turn is equivalent to an inter-residue angle of
100°).
The eighth part of the plot is composed of two curves. The
first is the hydrophobicity index averaged over nine residues
and is based on the method of Kyte and Doolittle (1982). The
second is another measure of hydrophobicity averaged over 20
residues called the GES curve (Goldman, Engelman and Steitz) for
identifying nonpolar transbilayer helices as reviewed by
Engelman et al (1986).
PEPTIDESTRUCTURE makes secondary structure predictions for
a peptide sequence. The predictions include, in addition to
alpha, beta, random coil and turn, measures for antigenicity,
flexibility, hydrophobicity and surface probability which
PLOTSTRUCTURE displays in a single coordinated plot. Two
secondary structure predictions are used: Chou and Fasman (1978)
and Garnier et al (1978). Hydrophilicity is calculated
according to the algorithm of Hopp and Woods (1981) or Kyte and
Doolittle (1982). Surface probability is calculated according to
a formula of Emini et al (1985). Flexibility is calculated
according to the Karplus-Schulz method (1985). The antigenic
index is calculated according to Jameson and Wolf (1988) .
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Multiple alignment of MOMP sequences
The multiple sequence alignment program, CLUSTAL, was
devised by Higgins and Sharp (1988). A version maintained on the
ERCVAX was used to align the amino acid sequences of C.psittaci
and C. trachomatis MOMPs. This method is based on first deriving
a phylogenetic tree from a matrix of pairwise sequence
similarity scores, obtained using a fast pairwise alignment
algorithm. The multiple alignment is then achieved from a
series of pairwise alignment of clusters of sequences, following
the order of branching in the tree.
Search of current protein sequence databases
Limited searches of the nucleic acid and protein sequence
databases (GENBANK, EMBL - European Molecular Biology
Laboratory, NBRF - National Biomedical Research Foundation)
available via the GCG program WORDSEARCH (Wilbur and Lipman,
1983) was carried out on the C.psittaci S26/3 MOMP sequence to
pick out any related sequences. Similar searches were carried
out using the FASTA and FASTP programs supported on the AFRC
network. In addition, an exhaustive search using fast database
searching programs based on a parallel processing supercomputer
(Active Memory Technology 510-4 32x32 Distributed Array
Processor) accessed through the ERCC Sequent (CASTLE). These
programs, PROSRCH and PATSRCH, were recently developed by the
Biocomputing Research Unit, Department of Molecular Biology,
University of Edinburgh (Coulson et al, 1987) and perform rapid
but exhaustive searches into current versions (September 1989)
of the major sequence databanks: NBRF-PIR (Protein




This chapter gathers the results of several immunoblotting
studies into two parts: data pertaining to the identification of
antigens of ovine abortion C.psittaci are presented in the first
part and include immunoblots of sera and lymph from sheep; the
second part describes the identification of an immunoprotective
antigen in ovine enzootic abortion. The third and final part
summarises the findings and includes further discussion.
PART 1: IDENTIFICATION OF CHLAMYDIAL ANTIGENS
The humoral immune response to infection by different
chlamydial strains has been studied in various hosts: in small
laboratory animals such as guinea pigs (Batteiger and Rank,
1987) and mice (Ramsey et al, 1989), in cynomolgus monkeys
(Caldwell et al, 1987), and in humans (Newhall et al, 1982).
These studies, most of which were reported during the course of
this project, used immunoblotting to characterise the antigenic
structure of these chlamydial strains, namely, the C.psittaci
guinea pig inclusion conjunctivitis (GPIC) strain, C. trachomatis
mouse pneumonitis (MoPn), trachoma and lymphogranuloma venereum
(LGV) biovars. Similarly, initial studies to define the
antigenic composition of OEA strains of C.psittaci with respect
to the sheep immune system have been carried out by McClenaghan
et al (1986; in preparation). Analysis of sera from
experimentally infected sheep by immunoblotting revealed mainly
high chlamydial components as antigens, including a 40 kDa
protein which was thought to be the major outer membrane protein
(MOMP). The antibody reactions to MOMP and lower antigens
were weak. Furthermore, variability in the antibody response
among animals was observed and this caused difficulties in
interpreting the immunoblotting data.
The immunoblotting analyses described in this part
followed from the work of McClenaghan et al and were aimed at
confirming the antigenic structure of OEA strains of C.psittaci.
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Figure 3.1. A. SDS-PAGE profile of EBs of an OEA strain of C.psittaci,
S26/3, stained with Coomassie Blue. B and C. Autoradiograra of
immunoblots of post-challenge (p-c) and post-parturition (p-p) sheep
sera from four ewes, two of which subsequently aborted (a) and two of
which lambed successfully despite the challenge (1). Panel B shows the
blots using A22 antigen and panel C, S26/3. Lane S shows the blot con¬
taining the S26/3 profile stained with Coomassie blue. Molecular
mass standards (M ) as listed from the top are -galactosidase (116kDa)
phosphorylase (?3) ovotransferrin (76-78), bovine serum albumin
(66-67), ovalbumin (45), carbonic arihydrase (30), myoglobin (17) and
cytochrome c (12).
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A broad spectrum of serum (Section I) and lymph samples from
animals with known immune status (Section II) was analysed to
determine if any antigenic specificities could be used as markers
of the immune status of an animal, that is, whether the animal
is susceptible, infected or protected. Sera from zoonotically
infected women were also tested (Section III). A simplified and
more rapid immunoblotting procedure was developed and used to
expedite the process (Chapter 2).
I. ANALYSIS OF SERUM SAMPLES FROM INFECTED SHEEP
A typical SDS-PAGE profile of OEA C.psittaci showed a very
complex pattern of more than 60 separate bands dominated by an
abundant 39-40 kDa protein (Figure 3.1A - arrowed; see also
Figure 4.1). This protein has been subsequently shown (Chapter
4) to be the major outer membrane protein (MOMP) of C.psittaci,
analogous to the MOMPs of other chlamydiae (Caldwell et al,
1981; Hatch et al, 1981). Silver staining also showed the
presence of a rapidly migrating species with an apparent of
less than 12 kDa often observed at the dye front of the SDS-PAGE
gel. This was presumed to be chlamydial lipopolysaccharide.
To identify the antigens of OEA C.psittaci, such SDS-PAGE
electrophoretograms were electroblotted onto nitrocellulose
paper and probed with sheep sera. Sera collected from control
ewes in a previous vaccination-challenge experiment were used
(gift of I.E.Anderson and A.J.Herring). These ewes were not
vaccinated but were infected with live organisms of OEA
C.psittaci A22 strain, the original commercial vaccine strain.
Figure 3.IB and C show the immunoblot profiles of sera taken
post-challenge and post-parturition. Antigens were identified
and listed in descending order of the apparent M^ in Table 3.1.
(Note that antigens listed in Table 3.1 have been compiled from
all immunoblots performed in this project and the approximate
apparent are indicated. For convenience in identifying
immunoblot profiles, these antigens have been divided into
several groups arbitrarily.) Initially, each serum sample was
tested against antigens from both C.psittaci strains S26/3 and
A22, the two strains currently used in the commercial bivalent
Chapter 3
Table 3.1
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OEA vaccine. No significant qualitative or quantitative
differences were detected in the immunoblot profiles and this
approach to identify any difference between the two strains was
discontinued. Subsequently, only the S26/3 strain was used as a
source of antigen for immunoblots unless stated.
II. ANTIBODY RESPONSE OF THE SHEEP LYMPH NODE TO
C.psittaci INFECTION
Immunoblotting was carried out retrospectively on sheep
serum and lymph samples taken from a study of the lymph node
response to C.psittaci infection (gift of H.-S.Huang and
D.Buxton). The experimental design and procedure as detailed by
Huang (1988 - MPhil thesis, University of Edinburgh) are
briefly outlined below. Four different groups of sheep
classified by their immune status had been used:
A. post-abortion ewes; B. sheep previously unexposed to
chlamydia; C. seroconverted sheep; and D. vaccinated sheep. The
efferent duct of the popliteal lymph node of each sheep had been
cannulated by the method of Hall and Morris (1962). Upon
subcutaneous deposition of live chlamydial organisms (1 ml of
4.5
10 50% egg lethal dose) in the draining region of the lymph
node, efferent lymph was collected continuously for one to four
weeks. Lymph samples were cleared of cellular material by low
speed centrifugation and aliquots of clarified lymph sera were
frozen at -20°C until analysis by immunoblotting. Some of the
data has been included in a paper that has been accepted for
publication (Huang et al, in press - see Appendix).
Post-abortion sheep - group A
Figure 3.2 shows the lymph node antibody response of three
post-abortion ewes. All three ewes possessed chlamydia-specific
antibodies at the beginning of the experiment as a result of
previous infection and abortion. Reinfection via the lymph node
boosted the prevailing antibody response where it had declined.
All three ewes produced antibodies to virtually the same set of
chlamydial antigens at one time or another. The apparent of
high antigens were more accurately estimated by using a low
percentage (7.5%) gel for the immunoblotting of lymph from ewe
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Figure 3.2. Immunoblot profiles of lymph (Panels a,b,c) and
blood serum (Panel d) samples of three post-abortion ewes at the
various days post inoculation as marked: Naturally infected ewes
(1358H - a and 1651J - b). Subcutaneously infected ewe
(2123K)(c). d. Day 0 blood sera from each ewe respectively. M
standards indicated are as given in Figure 3.1.
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2123K and correlated with those in blots of other serum samples
(data not shown). Low antigens were estimated directly from
the profiles of Figure 3.2.
Ewe 2123K (c) was subcutaneously infected with OEA
C.psittaci and had aborted some 2 months prior to cannulation.
This animal had a high antibody titre throughout the experiment
and this was reflected in the immunoblots. Lymph and blood
serum samples at the beginning of the experiment gave strong
• «*
antibody reactions to most of the listed chlamydial antigens. No
boost in antibody response was detected by immunoblotting either
because of limiting antigenic mass on the blots or because the
antibody response of the animal was already maximal.
Ewe 1651J(b) was a naturally infected post-abortion animal
Antibody response to certain antigens were not as strong as in
2123K. Besides some quantitative differences, the profile was
essentially the same as that of 2123K. The anti-62kDa response
was boosted at day 7.
Ewe 1358H (a) had the weakest immunoblot reactions.
Reinfection triggered a rapid and more dramatic secondary
response in the lymph node by day 4. This ewe had suffered from
a concurrent infection with C.psittaci and toxoplasma
(H.-S.Huang, personal communication). Toxoplasmal infection can
cause partial immunosuppression in sheep (Buxton et al, 1981)
and may account for the weaker immunoblot reactions at day 0.
The antigens identified from this group of animals were
consistent with those from the previous section and allowed a
more comprehensive list of chlamydial antigens to be compiled
(Table 3.1). The blots showed that recently aborted animals
maintained circulating antibodies in the vascular and lymphatic
systems specific to many chlamydial antigens. Where the immune
response was weak or had weakened possibly due to concurrent
infection, reinfection via the lymph node with C.psittaci could
induce a rapid secondary response to some but not all antigens.
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Figure 3.3. Immunoblot profiles of lymph and blood sera from
four seronegative sheep at the days post-infection indicated.
A. Sheep 1877J. B. Sheep 1778J. C. Sheep 1258J. D. Sheep 1889J.
M standards are marked in kDa.
r
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None of the three sheep in group A yielded chlamydiae from
the lymph throughout the experiment, or from the spleen or lymph
nodes samples at the end of the experiment (H.-S.Huang, personal
communication). The presence of circulating antibodies,
particularly those found at the beginning of the experiment,
namely anti-MOMP, -60kDa, and -120kDa antibodies, may be
partially responsible for inhibiting the spread of the
infectious chlamydiae via the lymphatics. Although the
possibility that these circulating antibodies were merely
coincident with an effective cellular response exists, the role
of their corresponding antigens in protection needs to be
investigated.
Seronegative non-immune sheep - group B
Figure 3.3 shows the immunoblot profiles of lymph and sera
from seronegative sheep in response to subcutaneous infection
with C.psittaci. In three sheep 1877J, 1778J, 1258J, there
was a strong but transient lymph node response to MOMP and a few
other antigens of apparent 50 kDa and 30 kDa. Depending on
the sheep, the MOMP response was present beginning d8 to dl4
post-infection. By dl5 to d21, the response was much reduced.
The antibody response in the sera lagged behind the lymph node
response by about one week and might indicate lymphocyte traffic
by routes other than the efferent duct. Alternatively,
infectious organisms deposited subcutaneously could have
eventually spread elsewhere other than via the popliteal lymph
node to evoke the delayed antibody response systemically.
In contrast to the first three sheep, sheep 1889Jgave very
strong but transient antibody reactions to the 91, 60, 58, 50
and 30 kDa antigens but only weak reactions to MOMP and 18K
antigens. The relatively strong reactions to other antigens
declined by 28 days. While the lymph node response was
detectable, no reactions above background were detected for the
serum samples.
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Figure 3.4. Immunblot profiles of lymph and blood sera from
seroconverted (Panel A) and vaccinated sheep (Panel B) taken at
the indicated days post-infection. M standards indicated are
the same as that in Figure 3.1, namely, 116, 93, 77, 67, 45, 30,
17 and 12 kDa from the top. Panel C shows the immunoblot
profiles of serum samples from women who suffered zoonotic
abortion, taken at the indicated days post-abortion. The
reactive antigens of each profile is given within the
parentheses:
Case a. - lane 1 (60,43,40,18kDa) and
lane 2 (43,40,30,18kDa,LPS);
Case b. - lane 3 (43,40kDa) and
lane 4 (120,100,89,78,58,54-56,50,43,40,32,30,23,18,LPS)
Case c. - lane 5 (60,58,54-56,50,43,40,30,18kDa) and
lane 6 (120,78,60,58,54-56,50,43,40,30,18kDa).
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A comparison of the IgG and IgM response of the lymph from
sheep 1778J was also carried out (data not shown). High
background with the HRP-conjugated anti-IgM probe was observed.
MOMP was the most clearly identified antigen. At day 14,
reactions were also visible to the high M^_ quartet, the 60, 50,
43, 18 and 12 kDa antigens. The IgG response was similar to
that observed when radio-iodinated anti-FCab^ antibodies were
used.
Lymph and blood samples collected from a fifth sheep 1764J
did not give any detectable antibody reactions by immunoblotting
(data not shown). The total absence of antibody reactions was
also observed in another experimental sheep (909H) which had
been vaccinated.
Seropositive infected sheep - group C
One sheep was found to have seroconverted by the CF test
before the cannulation experiment presumably because of a
natural infection. The serum antibody profile (Figure 3.4A)
resembled the post-abortion sera profiles and suggested that it
would not be easy to distinguish between infected and
post-abortion sheep by serological methods. It is not known why
the antibody profile of the lymph showed a slightly limited
range of antibody specificities compared to that of the serum at
day 0. On reinfection, the lymph node reacted to a more
restricted range of antibody responses, possibly because of a
limited repertoire of B-cells at the site.
Vaccinated sheep - group D
Two sheep 157J and 909H vaccinated with a commercial
vaccine were also used for the cannulation experiment. The
initial immunoblot profile of sheep 157J showed a relatively
limited range of antigens recognised by circulating antibodies.
(Figure 3.4B). Infection was able to boost the antibody response
but this did not reach the levels seen with post-abortion ewes.
No detectable antibody response whatsoever could be found in
sheep 909H (data not shown) despite a detectable cellular
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response, an observation similar to that of sheep 1764J. Error
in sampling is unlikely since multiple samples were carried out
over a week in both cases. Moreover, blood samples also did not
contain chlamydia-specific antibodies. Failure to deposit live
chlamydiae or vaccine is unlikely because of the detectable
histological and cellular changes (Huang, personal
communication). Repetition of the immunoblotting also gave
negative results despite positive blots with control sera. The
reason for the failure to respond serologically to chlamydial
vaccine is not known.
III. ANALYSIS OF SERUM SAMPLES FROM ZOONOTICALLY INFECTED WOMEN
Serum samples from three women suffering from zoonotic
infection with OEA strains of C.psittaci were obtained from
Dr I. W. Smith, Department of Bacteriology, University of
Edinburgh. These were probed using anti-human IgG-horse radish
peroxidase conjugates (SAPU). The results are shown in Figure
3.4C. Blots showed that the chlamydial components that are
antigenic in women were essentially the same as those antigenic
in sheep although the 43kDa antigen appeared more frequently.
The chlamydia-specific reactions were weak at the day of
abortion but became much stronger up to 21 days post abortion.
In case A, it appeared that the antibodies can last up to 10
months after the disease episode. The antibody response, as
measured by the immunofluorescence test, was also low prior to
abortion but peaked at or just after abortion (data from
I.W.Smith). Owing to the unavailability of prenatal serum
samples, it is not known whether specific antibodies can be
easily detected by immunoblotting before the crisis. Further
immunoblotting analyses of other serum samples were also done
but these gave a high non-specific background which has been
observed in previous studies on human sera (Newhall et al,
1982) . The amount of each serum sample available was not
sufficient to permit the determination of optimal blotting
conditions that may reduce the background for interpretable
results.
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PART 2: IDENTIFICATION OF MOMP AS A POTENTIALLY
IMMUNOPROTECTIVE ANTIGEN
The serum samples of sheep used in a vaccination-challenge
experiment (gift of I.E.Anderson, G.E.Jones and A.J.Herring)
were tested by immunoblotting to analyse the specific antibody
responses to an experimental vaccination procedure and to
identify antigens that might correlate with protection for
further evaluation as potential subunit vaccines. Details of
the experiment have been submitted for publication (Anderson et
al, submitted - see Appendix) and are briefly outlined below.
Seventeen ewes free from CF antibodies were selected for
mating, ten for the test group and seven as controls. Purified
EBs (800 micrograms) of C.psittaci S26/3 ovine abortion strain
were inactivated by glutaraldehyde treatment, precipitated with
aluminium hydroxide as an adjuvant and formulated into a
water-in-oil emulsion to make sufficient 1ml doses of vaccine
for the ten animals. Each ewe in the test group was vaccinated
subcutaneously with two doses of the vaccine preparation three
weeks apart. The ewes were bled at regular intervals and the
sera frozen at -20°C for subsequent analysis. Of the ten
vaccinated ewes, six became pregnant and were subsequently
challenged via a subcutaneous route with 10^'"* 50% chick embryo
lethal doses (CELD50) of live C.psittaci, S26/3 (1 ml each).
The seven control unvaccinated ewes were similarly challenged.
All six vaccinated sheep were protected against chlamydial
abortion and produced eight healthy lambs. No clinical signs of
OEA were detected. Chlamydiae could not be isolated from vaginal
swabs or fetal membranes. In contrast, chlamydiae could be
isolated from five of the seven unvaccinated sheep, four of
which suffered abortion. Five of the ten lambs produced were
dead. Thus administration of the experimental vaccine had
significantly reduced the incidence of abortion (P < 0.05 in the
Fisher's Exact one-tail test) and infection (P<0.02), and
significantly improved the lamb survival rate (P<0.03).
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Figure 3.5. Immunoblot profiles from purified EB
vaccination-challenge experiment. A. Sera from six vaccinated
sheep (a-f) taken 8 weeks post-vaccination but before challenge.
B. Antibody response of a non-pregnant unchallenged ewe.
C. Antibody response of a pregnant, vaccinated and protected
ewe. D. Antibody response of an unvaccinated, challenged and
aborted ewe. The numbers indicate the weeks post-vaccination.
The arrows marked indicate the time of vaccination (v), boost
(b), challenge (c), abortion (a) and lambing (1). M standards
are marked (from the top in kDa - 116,93,77,67,45^30,17,12).
MOMP is arrowed.
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Immunoblotting analysis was thus carried out on the serum
samples taken from these ewes to determine if any immunoreactive
antigen correlated with protection.
RESULTS AND DISCUSSION
Of the chlamydial antigens identified in Part I (Table
3.1), sera from the vaccinated sheep produced antibodies
predominantly against the putative major outer membrane protein,
MOMP (Figure 3.5A). This striking anti-MOMP response was
consistently found in the vaccinated sheep. Although antibody
responses to other antigens were also present, they were weak
reactions (50-60kDa diffuse band) and/or were not consistent
(for example, the 43kDa antigen). The response from a
non-pregnant and unchallenged ewe showed that this MOMP response
increased throughout the period of the experiment (Figure 3.5B).
Typical time-course profiles of pregnant ewes which were
subsequently challenged showed similar kinetics although the
increase in anti-MOMP reaction was not so pronounced (Figure
3.5C) .
Pre-challenge sera from the control group showed that all
unvaccinated sheep were relatively free from chlamydia-specific
CF antibodies (I.E.Anderson, personal communication);
post-infection sera showed very weakly reactive bands (data not
shown). A few days prior to or immediately after abortion, a
strong antibody response was mounted (Figure 3.5D), a finding
similar to that of McClenaghan et al from previous infection
studies (in preparation). Although the post-abortion response
included a reaction with MOMP, it was also strongly directed to
other chlamydial antigens, typically observed for post-abortion
sheep sera described in Part 1. Thus there was a difference in
the kinetics and in the nature of the immune response to
chlamydial infection between vaccinated and unvaccinated ewes
(see also CF data in Anderson et al, submitted - Appendix).
The immunoblotting results showed that the anti-MOMP
antibody response in vaccinated sheep correlated with protection
against chlamydial abortion under the vaccination-challenge
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procedure described. The circulating anti-MOMP antibodies
lasted throughout the period of the experiment without
diminution (Figure 3.5B and 3.5C). It is speculated that in
this experiment, anti-MOMP antibodies may have had a role in
protection. The data indicated strongly that the immunogenic
and protective properties of the MOMP ought to be investigated
further.
PART 3: FURTHER DISCUSSION AND SUMMARY OF THE IMMUNOBLOT ANALYSES
Similarity of immunoblot profiles
between OEA isolates, S26/3 and A22
The initial immunoblotting experiments that used both OEA
isolates, S26/3 and A22, showed no difference in any pair of
immunoblot profiles for each serum sample tested (more than a
dozen of either sheep or human serum samples). Consequently,
the data presented in this chapter only showed blots carried out
on S26/3 antigens. The similarity in these profiles suggested
that if there were any distinguishing epitopes between the two
isolates, these epitopes could not be resolved by SDS-PAGE. The
similarities in band intensities also suggested that if there
were any epitopic differences residing at each protein band,
these did not differ sufficiently in antigenicity or in
affinity. Alternatively, such differences could have been
obscured by common epitopes on the same band. McClenaghan et al
(1984) have already demonstrated that restriction endonuclease
analysis profiles of various C.psittaci isolates from ovine
abortions including S26/3 and A22 do not show any significant
differences. No differences between the SDS-PAGE profiles of
S26/3 and A22 elementary bodies has been detected (Herring et
al, manuscript in preparation; see Chapter 4) suggesting that
differences between the two isolates, as indicated by the
vaccination-challenge experiments of Aitken et al (1981), are
difficult to detect using biochemical or serological techniques.
Data on peptide mapping of MOMP presented in the next chapter
further illustrate this point.
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The role of antibody in protection
In a previous study, strong anti-MOMP antibody responses
could not be detected in post-abortion sheep (McClenaghan et al,
1986). However in this study, it was noted that several
post-abortion sheep maintained a high level of anti-chlamydial
antibodies, notably to MOMP, which persisted for some weeks or
even months after abortion and can also be detected in the lymph
of post-abortion sheep. Sheep once aborted are known nottoabort
again from chlamydial infection, not at least from the same
strain (Stamp et al, 1950; McEwen et al, 1951a). It is possible
that antibodies against MOMP may play a role in protection by
neutralising infectious EBs in the circulation thereby
preventing the haematogenous spread from the unknown "latent"
site to the placenta. How important antibodies are in immunity
may be assessed by experiments involving passive transfer of
antibodies from protected animals (see further discussion in
Chapter 5 and Chapter 8).
Caution in the interpretation of immunoblotting analyses
The immunoblotting data presented in this chapter should
be interpreted in the light of the fact that the electroblotted
antigens used in this study were treated by incubation in SDS
and 2-mercaptoethanol at 100°C. Therefore, any immunoreactive
epitope sensitive to this procedure will not be detected by
immunoblotting in the absence of renaturation. It is likely,
however, that each antigen carries linear epitopes
that are resistant to the denaturing treatment and that
renaturation and reformation of some conformational epitopes do
occur, both of which should be detected by this method.
Chlamydial lipopolysaccharide is a commonly detected
antigen (Batteiger and Rank, 1987; Caldwell et al, 1987; Ramsey
et al, 1989). In this study, it was not found to be a strong
antigen and in some cases, no reaction to LPS was detected. It
is possible that the immunoblotting procedure used does not
favour the detection of non-proteinaceous components such as
chlamydial lipopolysaccharide (Batteiger et al, 1982; Newhall
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et al, 1982). Nevertheless, it is generally thought that
chlamydial lipopolysaccharide bears epitopes reactive with CF
antibodies which do not appear to have a role in preventing
ovine abortion (McEwen and Foggie, 1954; Dawson et al, 1986a
and 1986b) . LPS itself is not thought to be an important
antigen in protective immunity, for example, in ocular
infection (Taylor and Prendergast, 1987; see discussion in
Chapter 5).
Since MOMP is present in greater abundance than other
chlamydial components, it could be argued that at the level of
sensitivity which the immunoblotting procedure was carried out,
antigens other than MOMP are at sub-optimal levels. Hence the
dominant MOMP response detected, particularly in the
vaccination-challenge experiment, could be due to an antigenic
mass effect. However, post-vaccination sera showed a lack of
strong reaction to other bands compared with post-abortion sera
probed under the same conditions. This would suggest that the
vaccinated ewes responded almost only to MOMP.
These caveats apart, the data reported here strongly
implicates MOMP as having a possible role in protection. The
weak diffuse antigen migrating between the 50kDa and 60kDa
antigens was also detected in sera from protected animals; it
may be analogous to the 54-64kDa chlamydial outer membrane
complex (COMC) antigen possessing cross-reactive epitopes
between strains of C.psittaci reported by Fukushi and Hirai
(1988). It is not certain if this diffuse band or the
occasionally observed 57kDa band (Table 3.1) is the same antigen
as the 57kDa antigen described by Morrison et al (1989) and
cloned by Menozzi et al (1989) . More investigations to
characterise its properties are needed.
Summary
In summary, ovine abortion C.psittaci has been shown to
possess many antigenic bands in the immunoblotting analyses,
including a predominant band with an apparent M^_ of 39kDa to
40kDa. This protein band is thought to be the major outer
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membrane protein (MOMP), an outer membrane protein which is
analogous to those of other chlamydial strains reported in the
literature (Salari and Ward, 1981; Caldwell et al, 1981; Hatch
et al, 1981; Newhall et al, 1982; Fukushi and Hirai, 1988;
Newhall, 1988 and references therein). A list of chlamydial
antigens has been compiled from immunoblotting data based on a
variety of lymph and blood serum samples from sheep and humans.
This list should form a basis for future investigation of
antigens from OEA C.psittaci.
The immunoblot profiles of sheep showed a degree of
variability in response within each immunological category such
that differentiation of immune status based on immunoblot
profiling may not be possible. The extent of variability,
however, should be confirmed with a larger sample size in each
category. Retrospective analysis of serum samples from
vaccinated and demonstrably protected ewes in a
vaccination-challenge experiment showed a remarkable lack of
reaction to chlamydial antigens other than to the 39-40kDa
antigen, the putative MOMP. This result has strongly implicated
the putative MOMP of OEA C.psittaci as a potential immunogen.
In view of the known properties of chlamydial MOMP, it was
considered a primary target for vaccine testing. The following
two chapters report on the characterisation of chlamydial
antigens, particularly MOMP, and on the adaptation of reported
techniques to prepare sufficient MOMP for a
vaccination-challenge experiment.
CHAPTER 4
SEVERAL CHARACTERISTICS OF MOMP AND OTHER
PROTEINS FROM OVINE ABORTION C.PSITTACI
INTRODUCTION
All chlamydial strains reported in the literature possess
a major outer membrane protein (MOMP) which dominates the
SDS-PAGE and immunoblot profiles by its abundance and
immunodominance. MOMPs from different strains are heterogeneous
in mobility in SDS-PAGE gels (Caldwell et al, 1981; Salari and
Ward, 1981; Fukushi and Hirai, 1988) and are the sites of
antigenic variation (Caldwell and Schachter, 1982; Stephens et
al, 1982; Newhall et al, 1982). MOMP is resistant to extraction
with detergents such as sodium N-lauroyl sarcosinate (Sarkosyl)
and remains with the outer membrane (OM) fraction. It is also
surface-exposed and can be radio-iodinated (Salari and Ward,
1981; Caldwell et al, 1981; Hatch et al, 1981; Caldwell and
Judd, 1982). At the beginning of this project, such data were
not available for ovine enzootic abortion (OEA) isolates of
C.psittaci. Moreover, in view of the increasing number of
reports on the functional, developmental and potentially
protective role of chlamydial MOMP, it was considered essential
that a better understanding of the characteristics of MOMP from
ovine abortion strains of C.psittaci should be attained.
Experiments presented in this chapter show that the 39 to
40 kDa putative MOMP antigen of C.psittaci S26/3 described in
the previous chapter bears characteristics similar to MOMPs from
other chlamydial strains. With a knowledge of these properties,
procedures could then be developed to purify MOMP for further
assessment of its role in immunoprotection against OEA. Some
preliminary data regarding other antigens such as the putative
adhesins are also presented.
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Figure 4.1. Comparison of the components of various C.psittaci and
C.trachomatis strains. Lane 1. Standards with M indicated in kDa.
Lane 2. C.trachomatis LGV serovar L2. Lanes 3 to 15 are all C.psittaci
strains: Avian 725 (3), CallO (4), CH1287 ovine conjunctivitis (5),
P787 ovine arthritis (6), ovine abortion isolates S26/3 (7), A22 (8),
84/501 (9), S124/3A (10), S152/3 (11), S507 (12), H574 (13), ovine
intestinal isolates from faeces 84/S604 (14) and 84/521F (15).
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RESULTS
Comparison of SDS-PAGE profiles of
C.psittaci and C.trachomatis
Elementary body preparations of various strains of
C.psittaci and C.trachomatis were solubilised in SDS and 2-ME
and their components separated by SDS-PAGE. Figure 4.1 shows
the MOMP of C.trachomatis and its analogues in C.psittaci
migrating with an apparent M^ ranging from 39 to 42 kDa. Owing
to their abundance, this band dominates the protein profiles. No
variations in the apparent M^ of the putative MOMPs (39.5 kDa)
from the OEA isolates were detected. These MOMPs were distinct
from that of other ovine strains such as P787 (ovine arthritis)
and CH1287 (ovine conjunctivitis). The two ovine faecal isolates
possessed MOMPs of different apparent M^, one of which
(84/521F) co-migrated with the MOMPs from the OEA isolates.
The SDS-PAGE profiles of all tested OEA isolates generally
appeared identical whereas differences with that of other ovine
strains and with C.trachomatis L2 were clearly visible. Besides
the difference in the mobility of MOMPs, there were complex
variations in the protein bands among the C.trachomatis, avian
C.psittaci, meningopneumonitis (Mn) C.psittaci (laboratory
strain CallO) and other ovine C.psittaci strains. For example,
there are slight variations in apparent M in a protein band
migrating at about 60kDa. Other striking differences include
protein bands below 20kDa for these representative groups
(Figure 4.1).
Comparison of immunoblot profiles of
C.psittaci and C.trachomatis
Electrophoretograms of solubilised EBs from the various
chlamydial strains used in the previous section were transferred
onto nitrocellulose paper and probed with a gnotobiotic lamb
antiserum raised by infection with S26/3 EBs (gift of Dr
J.M.Sharp). Initial immunoblotting profiles with the homologous
antigen showed that much of the reactivity was directed against
the 39.5 kDa MOMP antigen (data not shown). Figure 4.2A shows
that the polyclonal serum reacted with all ovine abortion MOMPs
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Figure 4.2A. Antigenic profile of various C.psittaci and C. trachomatis
strains by immunoblotting with a gnotobiotic lamb anti-S26/3 antiserum.
(From left to right) Lane 1. M standards are given in kDa.
Lane 2. C.trachomatis LGV serovar L2. Lanes 3 to 15 are all C.psittaci
strains: Avian 725 (3), laboratory strain CallO (4), CH1287 ovine
conjunctivitis (5), P787 ovine arthritis (6), ovine abortion isolates
A22 (8), S26/3 (9), 84/501 (10), H574 (11), S507 (12), S152/3 (13),
S124/3A (14), ovine intestinal isolates from faeces 84/S604 (7) and
84/521F (15).
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Figure 4.2B. Antigenic profile of various C.psittaci and C. trachomatis
strains by immunoblotting with a replica of the blot in Figure 4.2A
using a post-abortion sheep (2123K) anti-S26/3 antiserum. All
annotations are as given in Figure 4.2A.
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including S26/3 MOMP. Other antibody reactions which were
directed against the MOMP bands of other chlamydial strains were
barely detectable and indicated the variation in M . The
loadings in the lanes for the two intestinal strains and one OEA
strain (S124/3A) were much lower than for other strains because
of poor yields in culture. Consequently, some bands which are
probably present in their profiles were not clearly seen.
A replica of this blot was probed with a post-abortion
antiserum (2123K) from an ewe experimentally infected with a
yolk-sac inoculum of EBs (S26/3). Typical bands characteristic
of the OEA chlamydial antigens listed in Table 3.1 were observed
(Figure 4.2B). These bands were common throughout the ovine
abortion strains although their relative intensities differed.
This antiserum cross-reacted weakly with the MOMPs of other
ovine strains but reactions with that of C. trachomatis L2, avian
C.psittaci and CallO were hardly detectable. The blot also
showed that the MOMP of one intestinal strain, 84/521F,
co-migrated with OEA MOMPs while the other, 84/S604,
co-migrated with ovine arthritis or ovine conjunctivitis MOMPs.
Two or three bands of the high Mr quartet (see Table 3.1)
were visible in the OEA strain profiles (Figure 4.2B). One or
two were present in other chlamydial strains. The 77 kDa antigen
of S26/3 was also present in all strains with the same mobility.
The 60kDa bands appeared to cross-react throughout the genus
although there were variations in M as described in the
previous section. The 50 kDa antigen of OEA C.psittaci,
however, did not appear to have an analogue in the other
strains. A 30 kDa doublet of OEA C.psittaci was detected but
only one band was present in the corresponding region of the
profiles of other strains. The polyclonal serum of the ewe also
cross-reacted with marker proteins namely myosin (17kDa),
carbonic anhydrase (30kDa), ovalbumin (45kDa) and ovotransferrin
(77kDa) presumably because these were present in the yolk-sac
inoculum of EBs.
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Figure 4.3A. Partial proteolytic digestion of bovine serum albumin
(BSA) with a range of chymotrypsin concentrations. BSA (2/ig) was
incubated with chymotrypsin at 10/Xg (lane 1), 5/ig (lane 2), 500ng
(lane 3), 50ng (lane 4), 5ng (lane 7) and no chymotrypsin (lane 8).
Lane 5 contained only chymotrypsin (10^g). Lane 6 was a buffer blank.
The M standards are given in kDa. BSA and chymotrypsin are arrowed.
The SD?3-PAGE gel (12.5%) was stained with silver.
Figure 4.3B. SDS-PAGE comparison of partial chymotryptic profiles of
MOMP (arrowed) from C.psittaci ovine arthritis strain P787 (lane 4) and
C.psittaci OEA strains S26/3 (lane 5) and A22 (lane 6). Lanes 1 to 3
contained the respective MOMPs without chymotrypsin. Lane 7 contained
chymotrypsin - 25kDa (l/x$ only. The M standards are given in kDa.
The gel (15%) was stained with sifver.
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Peptide mapping of MOMP using the
method of Cleveland et al (1977)
Although MOMP is a main locus of heterogeneity among
chlamydial strains, no differences in the mobility of MOMP was
detected within OEA isolates of C.psittaci. Fragmentation of
MOMP peptides by partial proteolysis was carried out to
determine if any differences existed within the polypeptide.
This experiment was carried with S26/3 and A22 MOMP in
comparison with the MOMP from the ovine arthritis strain P787
which was already known to be different.
Typical results of the one-dimensional proteolytic mapping
experiment is shown in Figure 4.3. Panel A shows the
determination of a useful concentration range of chymotrypsin
that will result in partial proteolysis of a polypeptide such as
bovine serum albumin (BSA - 67 kDa) under the conditions of the
experiment described in Chapter 2. Lane 5 shows that
chymotrypsin migrated as a single dominant species at 25 kDa.
Lanes 8, 7, 4, 3, 2 and 1 show the effect of increasing amounts
of chymotrypsin on BSA. The results suggest that a useful range
of chymotrypsin to use for profiling MOMP would be about half a
microgram per lane.
Panel B (lanes 4, 5 and 6) of Figure 4.3 shows the partial
chymotryptic profile of MOMPs from P787, S26/3 and A22 (ovine
arthritis) . Lane 7 shows that the 25 kDa band in the
chymotryptic profile is due to chymotrypsin. Lanes 1, 2 and 3
are the substrate controls, containing the respective MOMP
slices without the addition of chymotrypsin. Comparison of
lanes 4, 5 and 6 showsthat the A22 MOMP and S26/3 MOMP peptide
profiles were identical while that of P787 was different. A 30
kDa band was missing in the P787 lane. The 18 kDa fragment in
the OEA MOMP profiles may be equivalent to the 20 kDa band in
the P787 profile.
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Figure 4.3C Immunoblot comparison of partial chymotryptic profiles of
MOMPs from C.psittaci OEA strains A22 (lane 2) and S26/3 (lane 3), and
ovine arthritis strain P787 (lane 4) using a gnotobiotic lamb
anti-S26/3 antiserum. Lanes 6 to 8 contained the respective MOMPs
without chymotrypsin. Lane 1 contained chymotrypsin only. The M
standards are marked in kDa (lane 5).
Figure 4.3D Densitometric scans of the autoradiogram shown in Figure
4.3C - lanes 2, 3 and 4. The extra band is marked by arrow.
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Similarly, these MOMPs were also digested with papain and
proteinase K (Sigma Chemical Co.). With both enzymes, the same
conclusion as that for chymotrypsin was reached, that the S26/3
MOMP profile was identical to the A22 MOMP profile but
significantly different from that of P787. These proteolytic
fragments are presented in Table 4.1.
Table 4.1. Proteolytic fragments of MOMPs (kDa) from papain and
proteinase K digestions.
Papain Proteinase K
A22 S26/3 P787 A22 S26/3 P787
39.8 39.8 41.6 39.8 39.8 40.3
31.6 31.6 - 38.3 38.3 -
28.1 28.1 - 35.0 35.0 33.5
22.9 22.9 - 31.0 31.0 -
19.0 19.0 19.0 28.0 28.0 25.5
17.4 17.4 - 23.8 23.8 24.8
13.2 13.2 14.8 21.4 21.4 23.4
10.5 10.5 10.0 19.5 19.5 19.5




A preliminary immunoblot of a replica of the chymotryptic
profiles (Figure 4.3B) using the gnotobiotic lamb anti-S26/3
serum showed that the serum reacted strongly with both OEA MOMPs
but gave a weak reaction to P787 MOMP (Figure 4.3C). Peptide
fragments of P787 did not react very well compared with those of
OEA MOMPs. Although the blot suggested that^mark at 28 kDa was
present in the S26/3 profile and not in the A22 profile, it was
difficult to decide whether it was an authentic band.
Densitometric scans of these profiles are shown in Figure 4.3D.
Chapter 4 Characteristics of MOMP 73
Figure 4.4. Oligomerisation experiment. A. Silver-stained SDS-PAGE
profile of MOMP-containing gel slices equilibrated in Cleveland buffer,
boiled in sample buffer (lane 1) and untreated (lane 2). The 120, 80
and 40 kDa bands in lane 2 were excised as shown. B. Silver-stained
SDS-PAGE profile of re-equilibrated gel slices containing the 120 kDa
band (lane 1), 80 kDa band (lane 2) and 40 kDa band (lane 3) boiled in
sample buffer to reduce the protein. Lane 4. The same material from
lane 3 was not treated in sample buffer. Lane 5. M^ standards in kDa.
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Oligomerisation of MOMP in vitro
In the course of the peptide mapping experiments, it was
noticed that specific high M^ bands always appeared in control
lanes containing undigested MOMPs from all three strains (Figure
4.3B lanes 1, 2, 3). These undigested MOMPs had been equili¬
brated in Cleveland buffer (Chapter 2) which did not contain any
reducing agent. These bands possessed an apparent M of
approximately 80kDa and 120kDa. Further experiments are
described in this section to test the hypothesis that these
bands are MOMP oligomers, formed as a result of disulphide
cross -linking between MOMP chains.
MOMP from A22 or S26/3 EBs was isolated by excision from
SDS-PAGE gels. The gel slices containing MOMP were allowed to
equilibrate in Cleveland buffer overnight. These slices were
then subjected to SDS-PAGE. Besides the MOMP monomer migrating
at the expected 39-40 kDa region, other bands were also observed
including the 80kDa and 120kDa bands. These three bands were
excised from the gel (Figure 4.4A - lane 2), boiled in sample
buffer containing (2% w/v) SDS and 4% (v/v) 2-ME for 5 minutes,
manually re-inserted into separate gel wells and subjected to
SDS-PAGE. Figure 4.4B showed that both the 120kDa and 80kDa gel
slices produced only the 40kDa monomeric MOMP band after boiling
in reducing agent (lanes 1 and 2). Residual bands corresponding
to 120 kDa and 80 kDa (solid triangles) in the respective lanes
showed that the reduction was incomplete. The 40kDa gel slice
was divided into two, one boiled in sample buffer (lane 3) and
the other not treated (lane 4). The profiles showed that the
untreated slice reproduced the 80kDa and 120kDa bands (solid
triangles) and a few higher M^ bands (small open triangles)
while the treated slice did not.
The extra bands at about 60-70 kDa in lanes 1, 2 and 3
were due to 2-ME. These bands were not in lane 4 because the
gel slice was not boiled in sample buffer. It was also noted
that migrating just in front of each 40kDa MOMP band was a
weaker band, particularly in lanes containing boiled gel slices.
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Figure 4.5A. Distribution of chlamydial components and antigens during
detergent-reducing agent extractions. SDS-PAGE profiles (10% gel) of
M standards (lane 1 - from the' top, 116, 93, 77, 67, 45, 30, 17, 12
k5a), whole EBs (lane 2), pooled washes (lane 3), PBE wash 1 (lane 4),
PBE wash 2 (lane 5), mock extracted EBs (lane 6), PBES supernatant -
extraction 1 (lane 7), PBESD supernatant - extraction 2 (lane 8),
two-step extracted OM preparation (lane 9), one-step PBESD extraction
supernatant (lane 10) and one-step extracted OM preparation (lane 11).
Lane 12 contained prestained M standards (Sigma) namely
a^-macroglobulin (180), )3-galactosidase (116), fructose 6-phosphate
kinase (84), pyruvate kinase (58), fumarase (48.5), lactate
dehydrogenase (36.5),triose phosphate isomerase (26.6 kDa) from the
top. Lane 13 contained the material from lane 7 not boiled in sample
buffer (see Discussion - oligomerisation). Figure 4.5B may be found two
pages forward.
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Fractionation of EBs and the enrichment of MOMP
Purified chlamydial elementary bodies (600/ig) were
resuspended in 6 ml of lOOmM phosphate buffer pH 7.4 containing
ImM EDTA (PBE) and divided into three aliquots. EBs were
pelleted (all centrifugation steps at 100,000g for lh) and the
wash supernatants pooled for SDS-PAGE analysis (Figure 4.5A
-lane 3). One EB pellet was resuspended in PBE-1% Sarkosyl
(PBES) to a final concentration of 0.3mg protein/ml, sonicated
in a bath sonicator for a 30 second burst, and incubated for 2
h at 37°C with occasional mixing. Detergent-soluble components
(lane 7) were separated from insoluble material by
centrifugation. The insoluble pellet was resuspended in
PBES-lmM DTT (PBESD), sonicated, incubated and centrifuged as
described to give a PBESD-soluble supernatant (lane 8) and the
insoluble outer membrane (OM) preparation (lane 9). The second
EB pellet was similarly treated except that PBE was used for
both incubation steps and yielded two PBE supernatants (lane 4
and 5) and the mock-treated EBs (lane 6). The third EB pellet
was subjected to only one incubation step in PBESD for 2 h
instead and yielded a PBESD supernatant (lane 10) and an OM
preparation (one-step extraction - lane 11).
The SDS-PAGE profiles showed that the mock-treated EBs
were identical to untreated EBs (lane 2). Some MOMP was lost
into the PBE supernatants (lanes 4 and 5). In the first step of
the two-step extraction, most chlamydial components were
solubilised (lane 7) and more, including some MOMP, were
solubilised in the second (lane 8) leaving MOMP highly enriched
in the OM preparation (lane 9). Other protein bands, as well as
LPS which migrated at the dye front, were also present in this
OM preparation. Lanes 10 and 11 showed that MOMP could also be
enriched in the OM in a one-step extraction.
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Figure 4.5B. Distribution of chlamydial components and antigens during
detergent-reducing agent extractions. Immunoblot of a replica of the
gel in Figure 4.5A probed with pooled sera from post-abortion ewes. The
M standards are identical to that in Figure 4.5A (two pages before).
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Immunoblotting of a replica of the electrophoretogram in
Figure 4.5A with a mixture of sera from two post-abortion ewes
(2123K and 303H) showed the distribution of chlamydial antigens
when subjected to detergent extraction (Figure 4.5B). Lanes 3,
4 and 5 showed that no detectable antigens were released into
the washes. The profiles of untreated EBs and mock-treated EBs
did not show that any antigen was lost. In contrast, both
extraction procedures solubilised most chlamydial antigens
leaving MOMP as the only detectable antigen in the OM
preparation. Further experiments showed that optimal
enrichment of MOMP in the OM could be achieved by l%-2% Sarkosyl
and 10 mM DTT with bath sonication to assist the resuspension
and disruption of EBs (Chapter 5).
Electron microscopy of EBs and outer membrane preparations
Chlamydial OMs were prepared by the two-step extraction
procedure described in the previous section using concentrations
of Sarkosyl and DTT at 2% and 10 mM respectively. At each stage,
the OM pellets were sampled for electron microscopic
examination. Intact chlamydial EBs were used as a positive
control.
Chlamydial EBs negatively stained and viewed under the
electron microscope showed a typical coccoid shape about 200 nm
to 400 nm across. In Figure 4.6A, a granularity of the surface
can be observed. On the edges of the EB, the particulate nature
of the general outline can be seen (Figure 4.6A). After the
one-step Sarkosyl-DTT extraction, broken membrane fragments may
be seen edge on with knob-like particles protruding from the
convex face (Figure 4.6B - arrowed). The electron micrograph of
the OM preparation after the two extractions (Sarkosyl and DTT)
revealed smaller membrane fragments with tightly packed, fine
particulate structures (4 nm diameter) on the surface (Figure
4.6C). In some fragments, a hexagonally packed array of such
particles may be detected. The centre-to-centre spacing of the
particles forming such arrays are approximately 5-6 nm. On
Chapter 4 Characteristics of MOMP 79
100nm
Figure 4.6A. Electron micrographs of negatively stained intact EBs a
OM preparations. Panel A. An intact EB. Magnification: x240,00
Bar: lOOnm. Knobs on the outer surface of the intact EB (solid arrow
fine particles densely packed on the surface of the OM clearly visibl
Chapter 4 Characteristics of MOMP 80
Figure 4.6B. Electron micrographs of negatively stained intact EBs and
OM preparations. Panel B. Insoluble OM preparation obtained after the
one-step PBE-Sarkosyl-DTT (lOmM) extraction. Magnification: x240,000.
Bar: lOOnm. Large fragments of OMs of chlamydial EBs showing some in
profile. Knobs protrude from the convexity of some fragments (arrow£.
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Figure 4.6C. Electron micrographs of negatively stained intact EBs and
OM preparations.. Panel C. Insoluble OM preparation obtained after the
two-step treatment. A nine-membered rosette is arrowed.
Magnification: x240,000. Bar: 50nm.
Insets show a. small fragments of OM bearing fine particles densely
packed in hexagonal array; b. profile of membrane fragments showing
knobs protruding from the convex edge. c. ring-like structure or
rosette ; d. rosette attached to membrane fragment . Magnification:
x480,000 each.
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other fragments, however, no such regularity could be
detected. Close inspection revealed a central dot of electron
opacity in some of the fine particles (see Figure 4.6C:inset a).
Some membrane fragments were visible edge on and knob-like
particles about 4 nm wide may be observed, (Figure 4.6C)
identical to those seen in Figure 4.6B. These knob-like
particles have a centre-to-centre spacing of 5 - 6 nm as
measured from the side elevation and projected from a continuous
substratum (6 - 8 nm thick). No central channel containing
electron-dense material which might correspond to the central
dots could be detected (see Figure 4.6C: inset b).
Attached to fragments of membrane, or in some cases
completely detached, were ring-like structures measuring about
14.5 nm in diameter (Figure 4.6C - arrowed) similar to those
described by Matsumoto (1973). These rosettes appeared to be
made up of 7 to 9 regularly arranged subunits about 3 - 4 nm in
diameter surrounding a central cavity (7 - 8 nm diameter) filled
with the electron dense material from the stain (inset c and d).
Protein microsequencing of MOMP
Towards the end of this project, the opportunity arose to
perform protein microsequencing of MOMP on an automatic protein
sequencer (Applied Biosystems). S26/3 MOMP was prepared by the
two-step Sarkosyl and DTT extraction procedure of a previous
section. (This preparation of MOMP was the same as that used for
the vaccination-challenge experiment used in Chapter 5.) About
10/ig of the material was resolved by SDS-PAGE and
R
electrophoretically transferred onto "Glassybond " (Chapter 2)
glass fibre support. Coomassie blue staining of the blot
revealed a dominant band at 40kDa relatively free of other
protein contaminants, similar to the profile in Figure 4.5 -
lanes 11. This band was excised and used for protein sequencing
as described in Chapter 2. After a calibration cycle with
phenylthiohydantoin-amino acid standards, the sample was loaded
and subjected to 10 cycles of Edman degradation.
Chapter 4 Characteristics of MOMP 83
The N-terminal sequence obtained was as follows
(chromatograms not shown):
NH2-L(D)P(G)VGNPAEPS...
In the first two cycles, there appeared, to be two
alternative residues, Leu or Asp, followed by Pro or Gly.
Comparison of this sequence with the N-terminus sequence of
C.trachomatis L2 MOMP (Nano et al, 1985) showed that residues 3
to 9 were identical and that residues 1 and 2 were Leu and Pro
respectively. This sequence was in complete agreement with the
amino acid sequence deduced from the nucleotide sequence of the
MOMP gene as described in Chapter 6. Further inspection of the
deduced amino acid sequence suggested that the two residues Asp
and Gly could have arisen from an alternative N-terminus
downstream of Leu and Pro. This N-terminus may have been
generated as a result of mild acid hydrolysis during the
staining procedure but the possibility of contamination could
not be excluded.
Surface labelling of elementary bodies
Chlamydial elementary bodies and BHK-21 host cells were
surface-labelled with radioactive iodine-125 using Iodobeads
(Chapter 2). Radiolabelled proteins were analysed by SDS-PAGE
and autoradiography. Figure 4.7A shows that a 40 kDa protein
band (arrowed) in the EB profile was the most strongly labelled.
Other bands were also present but in weaker amounts. Unreacted
radio-isotope that was not washed away migrated at the dye
front. The radiolabelled BHK-21 cells were subsequently used for
ligand blotting experiments to detect chlamydial adhesin which
is described next.
Identification of OEA C.psittaci adhesins
The method of identifying adhesins was based on the method
of Wenman and Meuser (1986). BHK-21 cells, routinely used for
the culture of OEA strains of C.psittaci, were surface-labelled
by the Iodobead method (Chapter 2). Labelled cell components
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Figure 4.7A. Surface radio-iodination of intact chlamydial EBs (lanes 1
and 2) and BHK-21 cells (lane 3). Autoradiogram of SDS-PAGE profiles
(15% gel). Lane 1. Reaction quenched with sodium metabisulphite.
Lane 2. Reaction quenched with 2-mercaptoethanol. Lane 3. Reaction not
quenched but cells washed extensively. M standards are marked from the
top in kDa, 116, 93, 77, 67, 45, 30,r 17, 14, 12, 8, 6, and 2.5.
The position of MOMP is arrowed.
Figure 4.7B. Identification of cell ligand that bound to putative
chlamydial adhesins. Composite autoradiograms of SDS-PAGE profiles
(15% gel) of radio-iodinated samples. Total BHK-21 cell lysate (1);
Triton X100 soluble supernatant from cell lysate used in binding
chlamydial adhesins in the ligand blot (2). The radioactive 18kDa
(lanes 3 to 5) and 32kDa bands (lanes 6 to 8) were excised from the
ligand blot and boiled in sample buffer (3 minutes) to elute the
radioactive ligand bound to the putative adhesins for SDS-PAGE
analysis. Lane 10 contained a similar eluate of a 32kDa band from an
immunoblot probed with radio-iodinated rabbit anti-sheep Ftab^
antibody. The M standards are marked in kDa (also in lane 9).
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Figure 4.8. Identification of putative chlamydial adhesins (arrowed)
from OEA C.psittaci. Alignment of densitometric scans of A. an
immunoblot using post-abortion sheep serum and B. a ligand blot using
Triton X100 soluble supernatant from radio-iodinated BHK-21 cells.
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were solubilised in PBS containing 1% Triton X100 and the
soluble material (3x10^ cpm) was diluted 1:30 in PBS containing
0.5% Tween 20 (PBST). This labelled solution used to probe
strips of nitrocellulose membrane bearing an electrophoretogram
of chlamydial EBs in a similar way to immunoblotting, a method
also known as ligand blotting (Chapter 2). The ligand blots
were washed as with the immunoblotting procedure and exposed to
X-ray film to identify any chlamydial adhesin that bound
labelled BHK-21 components. An adjacent strip of nitrocellulose
was immunoblotted with post-abortion sheep serum (2123K) as a
comparison.
Figure 4.8 shows a densitometric scan of the autoradiogram
of the ligand blot aligned with that of the immunoblot. The
peaks of the immunoblot are annotated to indicate the M . Two
bands of 32kDa and 18kDa were identified on the ligand blot
which appeared to co-migrate with the corresponding antigens.
These were the putative adhesins of OEA strains of C.psittaci.
Attempts to identify the host cell ligand that bound to
these putative adhesins included excision of the radioactive
bands at 32 kDa and 18 kDa for elution and SDS-PAGE analysis
(Figure 4.7B), and fractionation of labelled cell components by
gel filtration and using each fraction as probe in ligand blots
(data not shown). In the first approach, only a band migrating
close to the dye front was detected as the component(s) that
might have possibly bound to the adhesins (lanes 3 to 8). The
constituent(s) of this band has not been characterised. The
positive control in lane 10 showed that a smear at 25 to 30 kDa
had been eluted, probably the light chain of the antibody probe.
None of the fractions obtained in the second approach bound to
the putative adhesins.
Screening monoclonal antibodies for
MOMP specificity
As part of a wider team, the author was, at one stage of
the project, involved the screening of anti-chlamydial
monoclonal antibodies by the rapid immunoblotting method
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Figure 4.9. Screening of monoclonal antibodies for anti-MOMP
specificity by immunoblotting. Lanes 1-13 and 14-28 are immunoblot
profiles of hybridoma supernatants made up to the concentration of PBST.
Secondary probe was radio-iodinated Protein A. Positive controls were
immunoblot profiles of post-abortion sheep serum (A) and murine
anti-S507 antiserum (B,C). MAb specificities include 50kDa, 40kDa
(MOMP), 30kDa and LPS.
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developed for the studies described in Chapter 3. Initial
screens yielded several clones producing anti-50kDa, -MOMP,
-30kDa and -LPS mAb specificities by immunoblotting (Figure
4.9). All of these clones with the exception of the anti-LPS
mAb were eventually lost in the process of cloning stable
mAb-producing cell lines (C.Wilson and J.Dooley, personal
communication). Consequently, no probe specific for MOMP was




The SDS-PAGE profiles of OEA C.psittaci showed the
presence of a dominant 40 kDa band, similar to all C.psittaci
and C. trachomatis profiles published so far except those of
Rodolakis and co-workers (1989). In that report, the cell wall
or "surface" protein profiles of S26/3 and other C.psittaci
strains shown in a gradient SDS-PAGE gel did not possess this
dominant protein band. However, the published gel was
reproduced in another report with two lanes removed
(Buzoni-Gatel et al, 1989) but the profiles were referred to as
those of chlamydial lysates instead of cell wall proteins. The
method of lysis indicated that the lysates were soluble
supernatants of purified EBs incubated with PBS containing 4%
SDS and 3 mM EDTA; the insoluble material was removed by
centrifugation at ll,000g for 40 minutes. The latter
interpretation appears to resolve the apparent discrepancy
because under such conditions, it is unlikely that MOMP can be
extracted in any large quantity from the intact outer membrane
(OM) (Caldwell et al, 1981; Bavoil et al, 1984). It is also
favoured because the profiles resembled the supernatants of EBs
incubated in Sarkosyl and EDTA, shown in Figure 4.5A - lane 7
(or Figure 5.1 - lane 5). The band pattern, however, could not
be directly compared because the authors used a 8%-20% gradient
SDS-PAGE system. For convenience, the 40kDa protein is
referred to as MOMP in the discussion that follows.
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The heterogeneity in M of MOMPs from different strains is
a well-documented phenomenon (Caldwell et al, 1981; Salari and
Ward, 1981; Newhall et al, 1982; Batteiger et al, 1985;
Fukushi and Hirai, 1988). The M^ of OEA MOMP was estimated to
be 39.5kDa, slightly more than that of GPIC MOMP (Batteiger and
Rank, 1987) but well below the C.trachomatis MOMPs and avian
C.psittaci MOMPs (40-43kDa). The apparent lack of heterogeneity
of MOMPs from different OEA isolates and indeed the overall lack
of difference in the other proteins suggested that OEA isolates
were either identical or very closely related. This similarity
will be discussed further in Chapter 8.
The two ovine faecal isolates 84/S604 and 84/521F, which
were also analysed, were known to possess different inclusion
morphology and virulence characteristics, the former resembling
arthritis strains and the latter more like abortion isolates
(Anderson and Baxter, 1986). Their protein profiles showed
distinct differences particularly in the mobility of their
respective MOMPs. The 84/521F profile is similar to that of
abortion isolates (lanes 7-13, Figure 4.1) whereas the 84/S603
profile resembled that of P787 (lane 6), thus supporting the
conclusions of Anderson and Baxter (1986). In addition, the
difference in the profiles of ovine abortion and ovine arthritis
strains demonstrated here agreed with other reports that these
two strains can be distinguished (see below). These
observations suggest that SDS-PAGE can be used as a method for
differentiating ovine C.psittaci strains of different biological
characteristics and suggests that the MOMP may be conveniently
used as a distinguishing marker either at the protein level or
at the nucleic acid sequence level (see discussion in Chapter 6
and 8, and also Fukushi and Hirai, 1988; Baxter et al,
manuscript in preparation).
Further experiments analysed the partial proteolytic
profiles of MOMP from one ovine arthritis and two ovine abortion
isolates. These isolates represented two immunotypes of
C.psittaci as mentioned in Chapter 1. The ovine arthritis and
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abortion isolates have been distinguished by mAbs (Delong and
Magee, 1986; Anderson and van Deusen, 1988), and by
restriction endonuclease assay (McClenaghan et al, 1984; Timms
et al, 1988). The proteolytic profiles showed that the protein
sequence of the two ovine C.psittaci types are significantly
different such that all three proteases generated different
profiles. In contrast, if there are any differences between the
two ovine abortion isolates and if these differences are located
on MOMP, these are likely to be minor and may require
two-dimensional (2-D) gel electrophoresis or 2-D peptide mapping
to reveal any differences (Su et al, 1988).
Antigenic structure of C.psittaci
The cross-reaction of anti-S26/3 sera with antigens of
other chlamydial strains showed that certain chlamydial
components are conserved between types and species. Some
components such as the 75 kDa antigen do not show detectable
variation in M and appeared to cross-react in the
immunoblot with all representative chlamydial strains tested,
suggesting that it is a common genus-antigen. The 60 kDa
antigens cross - reacted well in the immunoblot but possess a
slight variation suggesting that while most of the
immunoblot-resistant antigenic epitopes may have been conserved,
the other structural domains have diverged. Others such as the
50kDa antigen appeared to contain type-specific epitopes
exclusively. Alternatively, this antigen does not have an
analogue in other strains. Within OEA C.psittaci strains, some
of the high antigens appeared to react more strongly with the
heterologous S26/3 antiserum. The reason for this is not known
although it might be speculated that the animal (2123K) may have
been exposed to these strains before. There were faint bands at
the 57kDa and 45kDa region but it is not known whether they are
the 57kDa genus-specific antigen which elicited ocular
hypersensitivity, and the 45kDa genus-specific antigen,
respectively, described by Morrison et al (1989). The partial
cross-reactivity exhibited by all the chlamydial MOMPs tested in
this study is consistent with the well-documented presence of
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genus-, species-, sub-species- and serotype-specific epitopes
on chlamydial MOMPs (Stephens et al, 1982; Ma et al, 1987;
Stephens et al, 1988b; Baehr et al, 1988; Conlan et al, 1988).
As a cautionary note for the interpretation of all
immunoblots, the differences in band intensity discussed above
need not necessarily suggest that there are epitopic variations
because variation in antigenic mass can give rise to such
differences. Post-staining of such bands would be useful but does
not conclusively prove that a putative band present on the blot
is indeed the same antigenic band in the autoradiogram because
of the complexity of the profile and also because highly
antigenic bands may not be present in quantities detectable by
post-staining procedures.
Disulphide linkages and MOMP oligomerisation
Chlamydial MOMPs are cysteine-rich proteins containing up
to nine cysteine residues per polypeptide chain (Hatch et al,
1984; Stephens et al, 1986; 1987). They form
disulphide-linked oligomers in the chlamydial OM (Newhall and
Jones, 1983; Hatch et al, 1984). The extensive network of
disulphide cross-linkages is thought to have a structural role
in the OM and is involved in permeability (Bavoil et al, 1984)
and in the developmental cycle (Hatch et al, 1984; Hackstadt et
al, 1985; Hatch et al, 1986; Newhall, 1987). However, the way
in which MOMP and other cysteine-rich proteins interact to form
such a network is not clearly understood.
The requirement for reduction and denaturation of EBs
before OEA MOMP can be solubilised suggested that it possessed
cysteine residues like other chlamydial MOMPs and formed part of
the network of disulphide! linkages. Addition of reducing agent
in the detergent extraction procedure resulted in the
solubilisation of a trace amount of MOMP, suggesting that some
MOMP polypeptides may be more susceptible to reduction and more
loosely attached to the OM. Such solubilised MOMP when analysed
by SDS-PAGE under non-reducing conditions, however, were not
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detected as MOMP monomers (Figure 4.5 lane A13 and B13).
Further experiments to discover the state of these soluble MOMPs
are required.
A preliminary liquid chromatographic separation of the
PBESD supernatant in a hydroxyapatite column was able to resolve
several peaks (R.Davies, personal communication). SDS-PAGE of
these fractions boiled in sample buffer (SDS and 2-ME) showed
that MOMP co-eluted with a 58kDa, 60kDa band and other faint but
high M^ bands in one broad peak (this work has not been repeated
and the data were consequently not shown). It is not known
whether the 58kDa/60kDa doublet is the 59/62kDa cysteine-rich
proteins described for other C.psittaci and C.trachomatis (Hatch
et al, 1984; Batteiger et al, 1985). When this fraction was not
boiled in the presence of 2-ME, only one strong band migrating
with apparent M of 85 to 90 kDa was observed. Upon storage at
+4°C, this band disappeared and a band reappeared at very high
M^ (> 200kDa); a similar observation was also reported by
Bavoil et al, 1984). These observations taken as a whole
suggest that OEA MOMP and other components are able to reform
hetero-oligomers in vitro.
Several studies have shown that MOMP can form
homo-oligomers by disulphide cross-linkages. Bavoil et al (1984)
observed that MOMP, when solubilised by a three-step
detergent-DTT extraction procedure, was able to re-form large
aggregates (size not disclosed) when reducing agent was removed
by dialysis. Similarly, Hackstadt et al (1985) demonstrated a
similar reaggregation effect of MOMP within the OM of
DTT-reduced intact EBs; DTT-reduced MOMPs formed monomers (a
compact conformation migrating at 36kDa), dimers, trimers and
higher order oligomers. Alkylating agents were able to inhibit
the oligomerisation.
The fortuitous observation in the peptide mapping
experiment in which MOMP gel slices exposed to non-reducing
conditions produced oligomers suggested that OEA MOMP is also
predisposed to aggregation. This property was manifested by
Chapter 4 Characteristics of HOMP 93
MOMPs of two ovine C.psittaci types. The oligomerisation
experiment using OEA MOMPs showed that denatured and reduced
MOMP monomers can aggregate in vitro and form putative dimers
and trimers of 80 and 120 kDa respectively. Higher order
oligomers were also detected but the sizes were not quantitated.
Such oligomers were linked by disulphide bridges since the
addition of 2-ME was able to separate the oligomers into
monomeric form. The compact oxidised monomeric MOMP species of
apparent M 36kDa (Hackstadt et al, 1985) was also observed in
this study.
It would be interesting to determine if oligomerisation of
MOMP and other CRPs in the chlamydial OM followed specific
assembly pathways. For example, it has been reported that E.coli
OmpF porin trimers appear to be assembled into the OM from
monomeric forms via a metastable dimer intermediate within a
minute of the processing of the precursor polypeptides (Reid et
al, 1988). Newhall (1987) has already suggested that
intracellular cross-linking mechanisms, possibly enzymatic,
may be involved in this process of cell wall formation in
chlamydial RBs.
Two types of approaches have been outlined above. One
took a reductionist approach from the in vivo situation, asking
the question: what are the fragments of the natural structure
made of? The other relied on taking each component as building
blocks and asking the questions: which components can be
reconstituted and to what extent do such reconstituents resemble
the in vivo situation? As will be discussed in Chapter 7, the
expression of rMOMP and its truncated form may provide
additional tools for elucidating the structure and assembly of a
unique form of OM in Gram-negative organisms. Other techniques,
in particular, electron microscopy, will be dealt with next.
Electron microscopy
Several structures of the OM of chlamydial organisms can
be detected by various electron microscopic techniques. Models
of the OM integrating and interpreting these findings have been
proposed by Matsumoto (1979; 1982c; 1988; see Chapter 1). The
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EM data presenttdin this chapter provide further evidence that
the Sarkosyl-DTT insoluble preparations, of which MOMP was a
major constituent, were OM preparations.
The 4 nm fine particles protruding from the OM as observed
in the OM preparations are likely to be the same as the 5 - 6nm
particles observed by Matsumoto (1979) which appear to protrude
from folded edges of the EB cell wall. These particles appeared
to be present as a fine granularity on the intact EB surface
(Matsumoto and Manire, 1970), supporting Matsumoto's (1988)
suggestion that such particles are a major structural component
of the outermost surface of the EB cell wall.
SDS-PAGE analysis showed that the protein composition of
the preparation is predominantly MOMP indicating that it is the
major constituent of these fine particles. The points of
electron opacity in the middle of these particles suggest a
depression or possibly a hole in each particle. The side
elevation of these particles however do not show any evidence
that these particles are hollow. Since MOMP is thought to
possess a porin-like function (Bavoil et al, 1984), it is
speculated that these particles might be formed from
macromolecular aggregates of MOMP with certain domains
protruding from the OM and that the holes mark the openings of
macromolecular pores. Whether these protruding domains
could be formed by immunoaccessible epitopes analogous to that
found for C. trachomatis (Zhang et al, 1987a) remains to be
tested.
The dense packing of these fine particles is reminiscent
of hexagonal structures that have been observed in reconstituted
E.coli membranes and thought to be formed by multimers of a
major outer membrane protein (OmpC porin) associated with LPS
(Yamada and Mizushima, 1978 and 1980). Birkelund and others
(1988) have shown that MOMP can be cross-linked to chlamydial
LPS by a comparatively short bifunctional cross-linking agent
suggesting that MOMP and LPS are closely located in the intact
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membrane. The detection of LPS in the OM preparations suggests
that these particulate membrane fragments are formed by the
close association of LPS and MOMP.
Rosettes of a similar size described by Matsumoto (1973)
were also observed in the OM preparation. They were found
either attached to small bits of membrane or totally detached
indicating that while the rosettes are usually found on the
membrane, they can exist stably as a separate structure. It is
possible that these rosettes might be formed from the high
molecular weight proteins detected by SDS-PAGE in the
preparation. It may be possible to optimise the conditions of
detergent extraction and differential centrifugation to separate
these rosettes from the larger membrane fragments so that the
biochemical composition of these structures can be determined.
It was noted that surface projections described in various
EM studies (Matsumoto and Higashi, 1975; Matsumoto et al, 1976;
Stokes, 1978; Gregory et al, 1979; Matsumoto, 1981a and
1981b; Matsumoto, 1982a and 1982b) were not detected in these
preparations. One reason could be that these structures were
susceptible to sonication and were broken into structures too
small to be sedimented by centrifugation at 100,000g.
Alternatively, they could have been solubilised by the
extraction buffer which contained detergent and reducing agent.
In summary, electron microscopic examination of the
MOMP-enriched OM preparation showed a retention of some
ultrastructural features of the intact outer membrane namely the
fine particles covering the outermost surface of the outer
membrane and rosettes as reviewed by Matsumoto (1988). This
approach of combining ultrastructural studies with biochemical
analysis complements the approaches outlined in the previous
section for the elucidation of the structure of the chlamydial
outer membrane. In the next chapter, the immunoprotective role
of these preparations will be described.
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Fractionation of chlamydial organisms and purification of
chlamydial MOMP
The success of the purified EB vaccine of Anderson et al
(submitted) has implicated MOMP and possibly a sub-60kDa diffuse
band as potential immunogens through the immunoblotting
experiments described in Chapter 3. To test the efficacy of
individual antigens for immunoprophylactic properties entails
the isolation of these antigens from whole organism
preparations. The experiments described in this chapter adapted
the methods of Caldwell et al (1981), Caldwell and Schachter
(1982) and Bavoil et al (1984) for fractionating chlamydial EBs
to obtain different mixtures of antigens which may be tested for
efficacy. These fractions could subsequently serve as starting
points for the purification of specific antigens such as MOMP.
Many mechanisms of chlamydial pathogenesis are thought to be
associated with the bacterial surface and hence the
immunoprotective antigens are most likely to be found there. As
a result, much work in the field has concentrated on the OM of
C.trachomatis and, to a lesser extent, on that of C.psittaci.
MOMP, being the predominant component in the OM, was thus an
obvious target in terms of purification compared to other
antigens.
Both Gram-negative bacteria and chlamydiae have OMs that
respond similarly to treatment with ethylenediamine tetraacetic
acid (EDTA) under alkaline conditions (Narita et al, 1976;
Narita and Manire, 1976). Detergents have been used as standard
reagents for the solubilisation of the inner membrane of
Gram-negative bacteria and the preparation of bacterial cell
envelopes. Various detergents have been applied to the
preparation of chlamydial envelopes including sodium
deoxycholate (Jenkin, 1960; Bavoil et al, 1984), SDSr sodium
N-lauroyl sarcosinate (Sarkosyl) (Hatch et al, 1981; Caldwell
et al, 1981; Caldwell and Schachter, 1982; Bavoil et al, 1984;
Batteiger et al, 1985), Triton X100, Zwittergent and
octylglucoside (Bavoil et al, 1984). By comparing the ability
of several detergents to extract MOMP from the OM, Caldwell et
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al (1981) reported that sequential anionic detergent treatment
of intact C.trachomatis EBs with Sarkosyl followed by SDS was
the most desirable method for isolating MOMP. They observed
that Sarkosyl, a detergent previously used for the
solubilisation of cytoplasmic proteins and cytoplasmic membrane
proteins of Gram-negative bacteria (Filip et al, 1973),
effected extensive solubilisation of proteins from the intact
EBs with the exception of MOMP. Electron microscopically,
Sarkosyl-insoluble fractions appeared as empty sacs of rigid OM
which they termed chlamydial outer membrane complexes (COMC).
These results were confirmed by later experiments by Bavoil et
al (1984) who succeeded in preparing purified MOMP in a
relatively undenatured state.
The detergent extraction procedure described in this
chapter was able to enrich for MOMP in the OM fraction
considerably. Further attempts to achieve a greater degree of
purity by solubilisation of MOMP with the non-ionic detergent,
octylglucoside, followed by liquid chromatography resulted in
negligible yields (data not shown). Alternative approaches at
obtaining pure MOMP required the use of strongly denaturing
detergents such as SDS, and were not considered appropriate for
vaccine efficacy studies. Consequently, the Sarkosyl-DTT-
insoluble OM preparation was used in the next stage of a logical
progression of vaccine testing at the Moredun Research Institute
as part of this project (see Chapter 5). In retrospect, this
was partly justified in view of the recent report that MOMP
purified by SDS extraction did not provide good protection
against C. trachomatis infection (Taylor et al, 1988).
Putative adhesins
It has been postulated that the surface components of
C.trachomatis play a role In the stimulation of phagocytosis
(Byrne and Moulder, 1978) and in the inhibition of phagosome-
lysosome fusion (Friis, 1972). The putative chlamydial adhesins
of Wenman and Meuser (1986) and Hackstadt (1986a) are of
particular interest since the attachment of the pathogen to its
host cell represents a critical point of interaction and is
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essential for successful entry. Moreover, antibodies directed
against these adhesins inhibit association of EB to host cells
and neutralise infectivity of homologous or heterologous strains
(Wenman and Meuser, 1986; Wenman et al, 1986), suggesting that
these adhesins should be characterised for immunoprotective
properties against chlamydial infections.
Two putative chlamydial adhesins of approximately 32 and
18 kDa were identified for OEA C.psittaci using the ligand
blotting method of Wenman and Meuser (1986). The adhesins were
similar in M to those of C.trachomatis (30-32 and 18
r
kDa)(Wenman and Meuser, 1986; Hackstadt, 1986a) and C.psittaci
Mn strain (30 and 16 kDa)(Wenman et al, 1986). Hackstadt
(1986a;b), however, could only identify one 17-19kDa adhesin
for a C.psittaci GPIC strain. These OEA adhesins co-migrated
with two antigens of similar M^, a finding consistent with the
immunological properties of the C.trachomatis adhesins mentioned
above. Further work is essential to determine if these two
antigens are the putative adhesins.
Allan and Pearce (1987) have shown that EBs can bind cells
lacking sialic acid moieties. A recent report by Kaul et al
(1989) indicated that host cell receptors are likely to be
proteinaceous. Allan and Pearce (1987) suggested that EB
adhesion to host cells may involve either non-specific
mechanisms or different receptors depending on the mode of
entry. Experiments to identify the BHK-21 host cell receptor(s)
that bound these adhesins were also carried out. However, only
low M components, possibly degradation products, were
identified. Although further work in identifying the receptor
was subsequently discontinued as the focus of the project
shifted to MOMP, identification of the receptor and further
characterisation of the adhesins are needed to assess their role
in pathogenicity and immunity in OEA.
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Surface labelling and monoclonal antibodies
Radio-iodination of intact EBs labelled MOMP as the
primary target, indicating that MOMP possessed reactive moieties
which were exposed on the OM surface. The Iodobead method used
for iodination is catalysed by N-chloro-benzenesulphonamide
groups coupled to polystyrene spheres (Markwell, 1982).
Radioactive iodinating species released into the solution,
although minimal as demonstrated by Markwell (1982) , may
penetrate the OM and prevent vectorial labelling. More rigorous
methods are therefore required to demonstrate surface exposure.
One way is to isolate anti-MOMP monoclonal antibodies to allow
surface tagging with electron-dense or fluorochrome conjugates
(Clark et al, 1982; Kuo and Chi, 1987). Since the initial
attempt to isolate such mAbs failed, it was not possible to
provide additional evidence that OEA MOMP moieties project from
the OM. The reason for the failure to isolate mAbs directed
against non-LPS epitopes was attributed to the dominance of
anti-LPS hybridoma clones (G.E.Jones, personal communication).
SUMMARY
In arriving at the conclusion that the 39 to 40 kDa
antigen identified in the previous chapter is unequivocally the
chlamydial MOMP of OEA isolates of C.psittaci, several lines of
evidence showing that it possessed properties of other
chlamydial MOMPs have been adduced.
(1) Firstly, it was shown that this 40 kDa antigen from OEA
isolates is the most dominant component in SDS-PAGE
profiles.
(2) The antigen could be enriched, together with chlamydial
LPS, in the outer membrane fraction by a detergent
extraction method typically used for preparing outer
membranes of Gram-negative bacteria.
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(3) Electron microscopy revealed that this antigen-enriched
outer membrane fraction possessed ultrastructural features
similar to the outermost layer of the intact elementary
body.
(4) Surface radio-iodination labelled a major 40 kDa protein.
(5) This polypeptide was only partially sensitive to the
reducing agent, dithiothreitol. Boiling in
2-mercaptoethanol and sodium dodecyl sulphate was required
to solubilise it, suggesting that it possessed
considerable inter-polypeptide disulphide cross-linkages.
Additional experiments showed that reduced and denatured
protein could re-form oligomers that were sensitive to
reducing agent.
(6) This antigen partially cross-reacted with C.trachomatis L2
MOMP and other C.psittaci MOMPs in immunoblots. The
cross-reactivity was stronger with related strains such as
ovine arthritis and ovine conjunctivitis C.psittaci but
very weak with C. trachomatis. This observation was
consistent with the general observation that MOMP is the
site of antigenic heterogeneity, bearing genus-,
species-, sub-species and serotype-specific epitopes.
(7) This heterogeneity was also reflected in the partial
proteolytic profiles within two types of ovine C.psittaci
MOMP although these MOMPs did not appear to be the site of
heterogeneity (if any) among OEA isolates.
(8) Finally and most conclusively, the N-terminus sequence of
this antigen was shown to be identical to that of
C.trachomatis MOMP.
Having accumulated satisfactory evidence as to the nature
and identity of the antigenic protein implicated as a potential
immunoprotective component in OEA vaccines, that it is the OEA
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C.psittaci equivalent of the major outer membrane protein in
other well-characterised chlamydiae, an experiment to test its
efficacy as a protective immunogen in the sheep was performed
and is described in the following chapter.
CHAPTER 5
PRODUCTION, ANALYSIS AND ASSESSMENT OF
A SUBCELLULAR VACCINE CONTAINING MOMP
INTRODUCTION
Evidence which suggested that the major outer membrane
protein (MOMP) of C.psittaci may be useful for protection in
sheep has been described in previous chapters and reported in
the literature (Tan et al, 1988, Huang et al, in press,
Anderson et al, submitted). For testing the hypothesis that
MOMP is an immunoprotective antigen, it would ideally require
large quantities of pure MOMP to vaccinate sheep in a
vaccination-challenge experiment. It was, however, difficult to
obtain pure MOMP in sufficient quantities without using strongly
denaturing procedures. A detergent extraction method was used
instead to produce an outer membrane preparation containing
enough MOMP in a highly enriched and undenatured state for a
vaccination experiment. To extend the previous observation that
an experimental two-dose vaccine comprising purified organisms
could protect sheep from OEA (Chapter 3; Anderson et al,
submitted), a similar preparation given in a single dose has
also been used. Owing to the prevalence of C.psittaci infection
in the sheep population, steps were also taken to ensure that
animals obtained for this study were immunologically naive.
MATERIALS AND METHODS
Preparation of Vaccines and Placebo
Chlamydial culture and purification of S26/3 organisms
were carried out as described in Chapter 2. Purified organisms
were divided into two equal aliquots of 2 mg each. One aliquot
(lml) was made up to 2 ml with standard phosphate buffered
saline pH7.4 (PBS) and inactivated by incubation for 5 minutes
at room temperature with an equal volume of PBS containing 0.15%
(v/v) glutaraldehyde (BDH). The reaction was quenched with 2 ml
of PBS containing 0.1M glycine (Sigma). The mixture was
centrifuged at 100,000g for 30 minutes at 4°C and the EB pellet
obtained was resuspended in physiological saline (0.15M NaCl).
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This preparation was then adsorbed with a 0.3% aluminium
hydroxide solution (Alhydrogel, Miles Laboratories, Slough)
until the mixture of chlamydial components and aluminium
hydroxide turned flocculent, typically 2:1 to 3:1 (v/v). The
suspension was emulsified with an equal volume of 9:1 (v/v) of
Bayol 82 and Arlacel A (Esso Petroleum Co.) to make the purified
EB vaccine of approximately 160/ig of protein per 1ml dose).
The other aliquot was subjected to a two-step detergent
extraction procedure, similar to a previously reported method
(Caldwell et al, 1981; Caldwell and Schachter, 1982; Bavoil, et
al, 1984). Elementary bodies of the second aliquot (2mg/ml) were
first washed in 12 ml of lOOmM phosphate buffer pH 7.4
containing 1 mM EDTA (PBE) and collected by centrifugation at
100,OOOg at 4°C for 30 minutes. The pellets were then
resuspended in PBE containing 2% Sarkosyl (PBES) to a final
protein concentration of 0.3mg/ml and incubated for one hour at
37°C with occasional mixing and bath sonication (2x30s bursts)
to prevent aggregation. The mixture was then centrifuged at
100,OOOg at 20°C for 60 minutes to pellet the insoluble
material. The PBES supernatant was removed and the pellet
resuspended in 5.6ml of PBES containing lOmM dithiothreitol
(PBESD) using a Teflon homogeniser. The suspension was
incubated at 37°C for 2 hours with occasional sonication as in
the previous step. The PBESD insoluble material was collected
by centrifugation as before and resuspended in PBS to make 1.5
ml containing about 200/Xg of protein. This subcellular outer
membrane preparation was added to 1.5 ml of PBS containing
0.15% (v/v) glutaraldehyde (BDH) and incubated for 5 minutes
before quenching with 1.5 ml of PBS containing 0.1M glycine.
This mixture was centrifuged as before. The supernatant was
removed and the pellet was resuspended in saline and formulated
into a vaccine as described for the purified EB vaccine. Each
dose of this subcellular vaccine contained approximately 20)ig
of protein.
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To produce the placebo vaccine, uninfected mycoplasma-
free BHK-21 cell monolayers from two Sani Glass bottles were
harvested in a similar way as chlamydial purification,
concentrated by low speed centrifugation (2000g at 4°C for 5
minutes) and resuspended with a Teflon homogeniser in PBS (1ml).
This solution (2 mg/ml) was inactivated and quenched with equal
volumes of PBS-glutaraldehyde and PBS-glycine respectively, and
formulated into a placebo vaccine as described above for the
purified EB vaccine. Each 1ml dose was estimated to contain
about 0.15 - 0.2 mg.
Protein estimation was carried out using the Bio-Rad
Protein Assay kit according to the manufacturer's
recommendations (Bio-Rad Laboratories, FRG). Electrophoresis,
immunoblotting, immunodot-blotting, and electron microscopy were
carried out as described in Chapter 2.
Animal procedure
Ewes were obtained from a flock with no known history of
OEA. These were screened by the CF test, immunodot-blot and
immunoblot analyses for chlamydia-specific antibodies as a crude
indicator for previous exposure to chlamydiae. Following
synchronisation of oestrus, selected ewes were mated and penned
separately in three groups. Within a month of mating, ewes
from each group were vaccinated subcutaneously with a single
dose of either the placebo (A), purified EB (B) or subcellular
(C) vaccines. Serum samples were taken at regular intervals for
analysis by the CF test (Stamp et al, 1952) and by
immunoblotting. At seventy days gestation, all animals were
challenged by subcutaneous injection with 1 ml of live S26/3
organisms (10"*'"* chick embryo lethal doses). At parturition,
vaginal swabs or placental tissues were taken for isolation of
chlamydiae as previously described (Anderson, 1986b; Chapter 2;
Anderson et al, submitted).
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RESULTS
Production of the vaccine
The procedure described in the methods section of this
chapter for producing the subcellular OM preparation was arrived
at after preliminary experiments were done to optimise
conditions of enrichment for MOMP. Several attempts were made
to solubilise the MOMP in these insoluble outer membrane
preparations using the non-ionic detergent, octylglucoside,
and dithiothreitol. Yields were low and further purification by
gel filtration column chromatography resulted in even lower
recovery. Consequently, no further attempt to purify MOMP from
the OM preparation was made.
The results of SDS-PAGE analysis of the vaccine
preparations and the intermediate stages of preparation were
shown in Figure 5.1. The two-step extraction procedure was able
to remove almost all low M^ proteins below 40kDa leaving MOMP in
a highly enriched state. Some high M components were still
present and were particularly visible when the well was
overloaded. Densitometric scanning showed that in the final
detergent insoluble preparation, MOMP comprised more than 90% of
total protein. Chlamydial lipopolysaccharide (LPS) was also
stained by silver in this gel and migrated as a band ahead of
the 14 kDa marker, just behind the dye front.
Kinetics of the antibody response
The serum samples of all experimental animals were taken
and monitored by the CF test at regular intervals during the
course of the study (Figure 5.2; Table 5.1). No antibody
response to chlamydial antigens was detected after control ewes
were vaccinated with a placebo vaccine (Figure 5.2A; Table
5.1A). In contrast, most control animals responded with log^ CF
antibody titres ranging from 4 to 6 within four weeks of
homologous challenge. Although three ewes had responded slowly,
all control animals except one eventually seroconverted (Table
5.IB). Only a weak CF response was detected in this sheep. It
was resistant to infection.
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Figure 5.1. SDS-PAGE profiles of the preparations used in the
vaccination-challenge experiment to test the efficacy of a purified EB
and a MOMP-subcellular vaccine. The 12.5% gel was stained with silver.
Key: M standards labelled in kDa (lane 1). BHK-21 cell preparation
used in Group A ewes as a placebo vaccine (lane 2). Purified EB
preparation used to vaccinate Group B ewes (lane 6). Outer membrane
preparation used to vaccinate Group C ewes (lane 3 - 3/ig and lane 7
1/ig). PBES-soluble components from the first detergent extraction of
EBs (lane 5). PBESD-soluble components from the second extraction
(lane 4).
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Figure 5.2. Kinetics of the complement fixing (CF) antibody respor
of each vaccine group: A. placebo vaccine group (n-12). B. purifi
vaccine group (n-7). C. MOMP-enriched subcellular group (n=ll). 1
day of subcutaneous challenge with live chlamydiae is indicated with
arrow on each abscissa. Mean log2 CF titres of all ewes in each grc
are displayed with error bars (+one standard deviation).
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Vaccination with purified EBs or the outer membrane
vaccines induced a primary response in most sheep within 42 days
(Figure 5.2B and 5.2C). Titres generally declined by the time of
challenge whereupon a secondary response was subsequently
induced in all vaccinated sheep. One ewe from group B and three
from group C did not produce a detectable CF titre before
challenge (Table 5.1A) but none of them became infected or
aborted. No significant correlation was found between the
presence of pre-challenge CF titres and immunity.
An immunoblot of the serum samples at week 4 post-
vaccination is shown in Figure 5.3. Nearly all vaccinated ewes
had by then produced a detectable antibody response particularly
to MOMP. No chlamydia-specific antibodies were detected in the
negative control animals.
Lambing results
Table 5.1C shows the protection results of the vaccines.
10 out of 11 animals in group C were protected against abortion.
No chlamydiae could be isolated from the vaginal swabs or fetal
membranes taken at parturition from these 11 ewes. Only one lamb
from the single ewe died. In group B, 6 out of 7 were protected
and a similar low ratio of lamb mortality was recorded. In
contrast, 7 out of 11 control animals were infected of which 5
subsequently aborted. The lamb mortality was significantly
higher (P < 0.5%).
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Figure 5.3. Immunoblot of sera from ewes of all groups, four weeks
post-vaccination. Panel A shows the immunoblot profiles of four sets
of pooled sera from three controls animals each. Each symbol (+) at
the bottom indicates an ewe which eventually became infected. Panel B
shows the profiles for the purified EB vaccine group. The letters (np)
stand for non-pregnant ewes which were not challenged and subsequently
not used in the experiment. Panel C shows the profiles for the
subcellular MOMP vaccine group. Panel + contains the profile of a
post-abortion sheep serum. The unmarked panel contains the profiles of
two ewes vaccinated with the PBESD supernatant as part of another
experiment outside the scope of this thesis.
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DISCUSSION
Experimental design
The widespread nature of chlamydial infection in sheep
flocks whether from abortigenic or non-abortigenic strains of
C.psittaci such as enteric strains necessitated stringency in
the selection of experimental animals for this study. In
addition to ensuring that animals were obtained from a source
with no known history of OEA, the CF test, immunodot-blot and
immunoblot analyses were carried out on the serum samples.
Although these criteria do not completely eliminate all
possibility of chlamydia-infected animals, it was thought
necessary at least to exclude from the study animals with
specific antibodies.
The purified EB vaccine described in Chapter 3 has been
incorporated in this study firstly as positive control and
secondly, to test its efficacy in a single dose. This
vaccination regime induced protection in 6 out of 7 animals and
a lamb survival count which was significantly better than the
placebo group thereby confirming and extending the previous
result. The use of a single dose in this study rather than the
two-dose regime of the previous experiment may have caused the
slightly reduced vaccine efficacy.
Previous vaccination-challenge experiments suggested that
a 55% to 70% rate of abortion could be expected from the
negative control ewes using the subcutaneous challenge procedure
described in this study (I.E.Anderson and G.E.Jones, personal
communication). Although the abortion rate of the control group
was not significantly different from previous results, a more
effective challenge would be desirable. It appears that in
future experiments a stronger challenge may be required,
possibly via a more natural route such as intra-tonsillar
instillation (Jones and Anderson, 1988). The lamb survival rate
in the control group was 47%, comparable to the 50% rate
obtained in a previous vaccination experiment.
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Vaccination in chlamydial infections
In contrast to attempts at vaccination against
C.trachomatis infections in humans (Grayston et al, 1963;
Woolridge et al 1967) and in animal models (Bell et al, 1959;
Collier and Blyth; 1966; Wang et al, 1967; Orenstein et al,
1973; Cui et al, 1989) using crude whole organisms as
immunogens, vaccination against chlamydial abortion in ewes has
had a long and successful history (reviewed by Foggie, 1973).
It was only in the past decade that signs of vaccine breakdown
emerged (Linklater and Dyson, 1979) which led to renewed
investigations. These included studies on cross-protection
between strains (Aitken et al, 1981; Aitken et al, 1986),
strain variation (McClenaghan et al, 1984; Anderson 1986a and
1986b; Anderson and Baxter, 1986; Johnson and Clarkson, 1986),
antigenic structure of C.psittaci (McClenaghan et al, 1986),
pathogenesis (Blewett et al, 1982; Jones and Anderson, 1988;
Buxton et al, in press) and the immune response (Dawson et al,
1986a and 1986b; Buzoni-Gatel et al, 1987; Huang, M.Phil,
thesis, 1988; Huang et al, in press).
The immunoprotective antigens in OEA, however, have not
been well characterised. In Chapter 3, a number of C.psittaci
antigens have been identified of which MOMP was implicated as a
promising candidate antigen for OEA vaccines. In this chapter
it has been demonstrated that a vaccine based on a subcellular
fraction can protect pregnant ewes against infection and
abortion from experimental subcutaneous challenge with a
virulent ovine abortion strain of C.psittaci - S26/3. The
efficacy of this subcellular vaccine compares favourably with
other experimental OEA vaccines and the commercial product
(G.E.Jones, personal communication). The subcellular outer
membrane fraction contained largely MOMP and LPS with trace
amounts of other chlamydial antigens. Being the main components
of the vaccine, MOMP and/or LPS are suspected to possess the
immunoprotective epitopes. Their relative importance in
immunoprotection are discussed in a following section.
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Outer membranes prepared from detergent extractions are
known to lose varying amounts of lipids, LPS and other
components, resulting in varying degrees of structural
reorganisation (Lugtenberg and van Alphen, 1983). However,
the detergent-extracted subcellular preparations appeared as
fine particles and rosettes under the electron microscope.
These structures corresponded to those in preparations not
treated with detergent as shown here and in the literature
(reviewed by Matsumoto, 1988). This suggested that, if
reorganisation of the outer membrane structure did occur during
detergent extraction, it was not sufficient to alter the
general morphology of the outer membrane preparations. The
retention of the three-dimensional structure and the membrane
context of MOMP in both vaccine preparations may have been
important for eliciting immunity. The loss of such structure
may be a possible explanation as to why a purified subunit MOMP
vaccine failed to induce an adequate antibody response and
elicited poor protection against eye infection in cynomolgus
monkeys (Taylor et al, 1988).
Immune response and immune mechanisms
The exact nature of the immune mechanisms which are
elicited by chlamydial infections is presently unclear. The
most detailed studies have been made with chlamydial infections
of small rodents, for example, with the C. trachomatis mouse
pneumonitis agent (MoPn) in a murine model for chlamydial
genital infection and with the C.psittaci guinea pig inclusion
conjunctivitis agent (GPIC) in guinea pigs (reviewed by
Williams, 1988 and Rank, 1988; Ramsey et al, 1988; Ramsey et
al, 1989; Rank and Batteiger, 1989; Rank et al, 1989).
In the mouse-MoPn model, infection can be resolved in the
absence of an antibody response (Ramsey et al, 1988) suggesting
that cell mediated immunity plays the dominant role in
resolution of infection and resistance to reinfection. Although
in vitro studies have established that antibodies do neutralise
C. trachomatis infectivity, for example with plasma (Barenfonger
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and MacDonald, 1974), with antiserum (Howard, 1975; Williams
et al, 1982), with anti-MOMP immunoglobulin (Caldwell and
Perry, 1982) and with monoclonal antibodies to MOMP (Peeling et
al, 1984; Lucero and Kuo, 1985), recent data question the value
of the humoral response in MoPn genital infections (Ramsey et
al, 1989).
A recent study of C.psittaci in a mouse model of systemic
infection has shown that T-cell mediated immunity was more
effectively transferred than humoral immunity (Buzoni-Gatel et
al, 1987). However, both humoral and cell mediated immune
responses have been shown to be essential in the guinea-pig-GPIC
model (Rank et al, 1979; Rank and Barron, 1983a and 1983b;
Rank and Batteiger, 1989; Rank et al, 1989). Any
extrapolation to the situation in sheep is presently premature
and should take into account that the immune mechanisms
responsible for resolution of the infection and resistance to
reinfection may differ between types of chlamydiae or between
host species.
Although studies of immune responses have been reported
for ovine abortion strains in sheep (Dawson et al, 1986a and
1986b; Huang, M.Phil. thesis, 1988; Huang et al, in press),
the immunological mechanisms for protection by vaccination
remain undefined. The results in this chapter has confirmed the
finding described in Chapter 3 that anti-MOMP antibodies feature
prominently in immunoblot profiles of vaccinated sheep. Whether
such antibodies are mediators of immunity or are merely
indicators of immunity needs to be resolved. Recently, these
sera were analysed by a newly developed microplate serum
neutralisation test and results showed that all animals which
possessed a neutralising titre were protected (I.E.Anderson,
personal communication). In contrast, the CF test did not show
such a correlation, confirming the findings of other
investigators (Dawson et al, 1986a and 1986b; Buzoni-Gatel et
al, 1987).
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The role of the antibody response in immunity to OEA was
recently assessed in a passive protection experiment. However,
initial findings did not show any evidence that post-abortion
serum antibodies could protect pregnant ewes against
experimental challenge with live organisms (G.E.Jones, personal
communication). Since C.psittacl is an intracellular parasite,
cellular immunity is probably involved. Some evidence for this
has been reported (Dawson et al, 1986a and 1986b; Huang,
M.Phil. thesis, 1988; Huang et al, in press). Studies are in
progress to characterise the cell mediated responses that may be
involved in immunity (C.M. McCafferty, D.Buxton and D.M.Haig,
personal communication).
The role of MOMP in immunoprotection
Having demonstrated though not exclusively that the
immunoprotective element of previous OEA vaccines resides on the
outer membrane preparation, the role of each chlamydial
constituent of the subcellular vaccine now remains to be
assessed. The chlamydial LPS carries genus - specific epitope(s)
(Caldwell and Hitchcock, 1984) and is not thought to be an
important antigen for protection in OEA or in other chlamydial
infections for the following reasons.
Serum prepared against
heat-killed organisms, which is likely to contain antibodies
against the thermostable genus-specific epitope of LPS, did not
confer protection in passive transfer experiments using a mouse
model of systemic infection (Buzoni-Gatel et al, 1987). A
monoclonal antibody which recognises a genus-specific epitope
located on chlamydial LPS could not protect mice from toxic
death or neutralise infectivity for the monkey eye by challenge
with a trachoma serovar (Zhang et al, 1987a; Zhang et al,
1989b). Oral immunisation with a recombinant lipopolysaccharide
bearing this genus-specific epitope of chlamydial LPS could not
protect monkeys against ocular infection (Taylor and
Prendergast, 1987).
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In the case of sheep, the CF test which is thought to
detect LPS-genus-specific epitope(s) did not correlate with
protection (Dawson et al, 1986a and 1986b; Buzoni-Gatel et al,
1987) . The immunoblotting technique used in this study or in
previous studies on OEA (McClenaghan et al, 1986) did not
detect a strong antibody reaction against LPS. Although
chlamydial LPS is unlikely to carry protective epitopes, it may
play a role in enhancing the immunogenicity of OEA vaccines in
view of the well-known properties of LPS as an adjuvant (Johnson
et al, 1956).
SDS-PAGE analysis showed the presence of 10 to 15 minor
proteins in the subcellular outer membrane vaccine. Only one or
two of these contaminants were weakly reactive by immunoblotting
(Figure 4.5B and Figure 5.3). Since the total administered dose
was estimated at 20 Hg of protein, each component was present in
submicrogram quantities. For large animals such as sheep, such
amounts are unlikely to constitute sufficient antigenic mass to
contribute a significant effect in protection. MOMP, in
contrast, was the major protein component. Several lines of
evidence suggested that it was the immunoprotective element of
the subcellular vaccine used in this study.
Functionally, MOMP has been shown to be involved in
structural rigidity of the EB (Caldwell et al, 1981), in the
developmental cycle and in the permeability of the outer
membrane (Newhall and Jones, 1983; Hatch et al, 1984; Bavoil
et al, 1984) and in infectivity (Su et al, 1988). A complex
hierarchy of antigenic epitopes has been shown to reside on MOMP
(Stephens et al, 1982; Ma et al, 1987). Polyclonal and
serovar-specific monoclonal antibodies raised against MOMP have
been demonstrated to neutralise chlamydial infectivity in vitro
(Caldwell and Perry, 1982; Peeling et al, 1984; Lucero and
Kuo, 1985) and in vivo (Zhang et al, 1987a; Zhang et al,
1989b) . Sheep lymph node cannulation experiments described in
Chapter 3 (reported in Huang et al, in press) have indicated
that MOMP is an immunodominant antigen against which the lymph
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node response is initially directed. The vaccination-challenge
experiment also described in Chapter 3 showed that all protected
animals directed a strong antibody response almost only to MOMP
(Anderson et al, submitted). Although a recent experiment
testing purified MOMP as a vaccine demonstrated only a partial
effect against ocular C. trachomatis infection in monkeys (Taylor
et al, 1988), it is possible that the use of strong detergent
in their preparation of MOMP may have destroyed some protective
epitopes.
Taken as a whole, a body of data has accumulated in the
literature and in this thesis that strongly implicates MOMP as a
useful immunogen. A definitive experiment to determine if MOMP
alone is sufficient for protection would require a stringent
purification procedure to eliminate all contaminating antigens.
This has so far been difficult to achieve in quantity without
denaturing conditions. Consequently, a recombinant DNA approach
to produce a MOMP subunit vaccine was undertaken. This entailed
the characterisation of the structure of the MOMP gene and its
subsequent manipulation into vectors for expression, the results
of which are described and discussed in the following chapters.
CHAPTER 6
ANALYSIS OF THE MAJOR OUTER MEMBRANE PROTEIN GENE
INTRODUCTION
The data presented in the previous chapters have shown
that the ovine immune system recognises the major outer membrane
protein of OEA strains of C.psittaci as a dominant antigen. A
further experiment has provided evidence that MOMP is
immunogenic and is likely to contain protective epitopes. It
was at this point in the project that the characterisation of
the MOMP gene was made an important priority for the research
group as a whole. The author of this thesis became involved in
the sequencing of the MOMP gene already cloned by the other
members of this group (Herring et al, 1989), specifically in
mapping the restriction sites of the gene, sequencing the 5' end
and other segments of the MOMP gene, as well as reading and
checking the complete DNA sequence as presented in this chapter
and in Herring et al (1989; see Appendix).
In order to obtain a better understanding of the structure
of the gene and its encoded product, the sequence data thus
obtained was analysed by using various computer programs for DNA
sequence analysis, and was compared with other published
sequences of chlamydial MOMPs and with outer membrane proteins
of other bacteria. Such a knowledge is essential for the design
of strategies to express the C.psittaci S26/3 MOMP gene. The
derivation of a viral vector containing the MOMP gene is briefly
described below.
A \EMBL3 library was made from a partial HboI digest of
the S26/3 genome. A positive clone carrying the S26/3 MOMP gene
was selected using gene probes (gift of Dr R.Stephens,
University of California, San Francisco) made from two pUC9
plasmid clones containing the 5' and 3' ends of the MOMP gene
from C.trachomatis serovar L2 (A.J.Herring and N.F.Inglis,
personal communication). Apparently, there is DNA homology
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within the MOMP gene family (Stephens et al, 1985) even though
the two chlamydial species share very little DNA homology at the
genomic level (Kingsbury and Weiss, 1968). The positive clone
thus identified had hybridised with both probes and further
analysis showed that this hybridisation was restricted to a
2.6kb SstI fragment. To avoid potential problems of plasmid
instability when cloning outer membrane proteins (Clarke and
Lambden, 1988), this SstI fragment was subcloned into the viral
vector, M13 mpl9 to produce clone Al/4.
RESULTS
Restriction Endonuclease Analysis
The 2.6 kb SstI fragment was subjected to digestion with a
panel of restriction endonucleases (REs) namely, EcoRI, Hindlll,
Clal, PvuII, MspI, Alul, MboI and AccI. Restriction sites were
identified and mapped on the SstI fragment by double RE digests.
Some of these restriction sites and other important sites
deduced subsequently from the DNA sequence are shown in Figure
6.1A. The sizes of the restriction fragments were estimated by
interpolation from a log-linear calibration curve derived from
DNA standards.
DNA sequencing
The M13 mpl9-derived clone carrying the SstI insert (Al/4)
was sequenced using the M13 universal primer in a chain
termination reaction (see Chapter 2). Initial sequence data
from the 3' end of the insert matched the 3' end of the MOMP
genes from C.trachomatis L2 (Stephens et al, 1986) and the
C.psittaci A22/M (Pickett et al, 1988a). Thus the S26/3 MOMP
gene is located on the 3' end of the SstI insert. A method for
making a library of nested deletions from the 3' end of the MOMP
gene was attempted but without success. Consequently, ScoRI,
tfindlll, Clal and Mspl RE fragments derived from the 2.6 kb
SstI fragment were subcloned into M13 mpl8 and mpl9 vectors for
sequencing. The sequencing strategy is illustrated in Figure
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D. Sequence 5' to 3'Primers
288C ttg cct gta ggg aac cca gct
289C acc aac agc tac acc aca agc t
61 2C ttt cac tgc agg ttg tca atc tct agg ttt caa gc
644C cct gat cag tac cag c
645C tgc acc tac act cca ag
844c tgg tga acc att cgg cg









Figure 6.1 The 2.6 kbSstl-Sstl fragment containing the MOMPgeneofC.psittaciS26/3.
A. GeneStructure and. RestrictionMap; B. Sequencing Strategy; C. Positions of
oligonucleotide primers; D. Sequences of the primers. Abbreviations: Promoters-
P1 and P2; inverted repeat - IR; Shine-Dalgarno translation recognition site - S-D;
putative signal peptide-SIG; variable domains -VD1 toVD4; putative transcription
terminator-TER; restriction endonuclease sites - BamHI, Clal, EcoRI, Hindlll, Mspl,
Pvull, Sstl.
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set of synthetic oligonucleotides including 288C, 289C, 612C,
644C and 645C for priming the sequencing reaction (Figure 6.1C).
The sequences of the synthetic oligonucleotides are listed in
Figure 6.ID. In total, approximately 2 kb from the 3' end of
the 2.6 kb fragment were sequenced (Figure 6.2).
Gene structure
The DNA sequence revealed one long open reading frame
(ORF) which consisted of 1170 bp beginning with a codon for
methionine (ATG) and ending with a stop codon TAA. The ORF
encoded 389 amino acids and was preceded by promoter-like
sequences and a ribosome-binding site AGAGG (Shine and Dalgarno
(1974). Further upstream of these regulatory sequences, more
promoter-like sequences and a perfect 9 bp inverted repeat (IR)
were detected (Figure 6.2).
Downstream of the ORF, another IR followed by 8 thymine
residues was also found by comparison with the L2 MOMP sequence
and by using the TERMINATOR program (Brendel and Trifonov,
1984) of UWGCG sequence analysis package (Devereux et al,
1984) . The RNA transcript of this IR may form a stable RNA
stem-loop structure followed by seven uridine residues (Figure
6.3; Table 6.1). The free energy of formation of this 13 bp
stem and 4-base hairpin loop structure was estimated to be -14.5
kcal/mol using the FOLD program (UWGCG) which is based on the
method of Zuker and Stiegler (1981). This stable stem-loop
structure followed by a poly-U tail is characteristic of

























TACACTCTTC TATGAGGTAA TTCCAACTTA TTCTAAGTGC ATAAGAAAAT AAAAATGTGT ACAAAAATCT AATAGCTCTC TTATTAGCAA
P2 -35
GTATAAGGAG TTATTGCTTG AAATCTGTGC CTGAAACAGT CTTTTTTCTT ATCGTCTTTA CTATAATAAG AAAAGTTTGT TATGTTTTCG
P2 -10 >InvertedRepeat<
AATAATGAAC TGTATGTTCA TGCTTAAGGC TGTTTTCACT TGCAAGACAC TCCTCAAAGC CATTAATTGC CTACAGGATA TCTTGTCTGG
CTTTAACTTG GACGTGGTGC CGCCAGAAGA GCAAATTAGA ATAGCGAGCA CAAAAAGAAA AGATACTAAG CATAATCTTT AGAGGTGAGT
P1 -35 P1 -10 -S-D-
Met Lys Lys Leu Leu Lys Ser ALA Leu Leu Phe Ala Ala Thr Gly Ser Ala Leu Ser Leu Gin Ala Leu Pro Val
ATG AAA AAA CTC TTG AAA TCG GCA TTA TTG TTT GCC GCT ACG GGT TCC GCT CTC TCC TTA CAA GCC TTG CCT GTA
288Cprimer
Gly Asn Pro Ala Glu Pro Ser Leu Leu lie Asp Gty Thr Met Trp Glu Gly Ala Ser Gly Asp Pro Cys Asp Pro
GGG AAC CCA GCT GAA CCA AGT TTA TTA ATC GAT GGC ACT ATG TGG GAA GGT GCT TCA GGT GAT CCT TGC GAT CCT
Pvull^ Clal/ 845Cprimer
Cys Ser Thr Trp Cys Asp Ala lie Ser lie Arg Ala Gly Tyr Tyr Gly Asp Tyr Val Phe Asp Arg Val Leu Lys
TGC TCT ACT TGG TGT GAT GCT ATC AGC ATC CGC GCA GGA TAC TAC GGA GAT TAT GTT TTC GAT CGT GTA TTA AAA
Val Asp Val Asn Lys Thr He Thr Gly Met Gly Ala Val Pro Thr Gly Thr Ala Ala Ala Asn Tyr Lys Thr Pro
GTT GAT GTG AAT AAA ACT ATC ACC GGC ATG GGT GCA GTT CCT ACA GGA ACC GCA GCA GCT AAT TAC AAA ACT CCT
»>VD1 Mspl
Thr Asp Arg Pro Asn He Ala Tyr Gly Lys His Leu Gin Asp Ala Glu Trp Phe Thr Asn Ala Ala Phe Leu Ala
ACG GAT AGA CCC AAC ATC GCT TAC GGC AAA CAC TTA CAA GAC GCC GAA TGG TTC ACC AAT GCA GCT TTC CTC GCA
VD1«< / 844Cprimer
Leu Asn He Trp Asp Arg Phe Asp He Phe Cys Thr Leu Gly Ala Ser Asn Gly Tyr Phe Lys Ala Ser Ser Ala
TTG AAT ATC TGG GAT CGC TTT GAT ATT TTC TGC ACA TTA GGC GCT TCT AAT GGG TAC TTC AAA GCT AGT TCT GCG
Ala Phe Asn Leu Val Gly Leu lie Gly Val Lys Gly Ser
GCA TTC AAC CTC GTT GGT TTG ATT GGT GTT AAA GGA TCC
»>VD2 BamHI
Thr Gin Gly He Val Glu Phe Tyr Thr Asp Thr The Phe
ACT CAA GGA ATC GTT GAA TTT TAT ACA GAT ACA ACA TTC
VD2«<
Cys Gly Cys Ala Thr Leu Gly Ala Glu Phe Gin Tyr Ala
TGT GGT TGT GCG ACT TTA GGA GCA GAG TTC CAA TAC GCT
Ser He Ala Ala Asp Gin Leu Pro Asn Val Gly He
TCC ATA GCA GCT GAT CAG CTT CCC AAT GTA GGC ATC
PvuII
Ser Trp Ser Val Gly Ala Arg Gly Ala Leu Trp Glu
TCT TGG AGT GTA GGT GCA CGC GGA GCT TTA TGG GAG
i 645Cprimer
Gin Ser Asn Pro Lys He Glu Met Leu Asn Val Val
CAG TCT AAT CCT AAA ATT GAA ATG TTG AAT GTA GTC
I
204 Ser Ser Pro Ala Gin Phe Val Val His Lys Pro Arg Gly Tyr Lys Gly Thr Ala Phe Pro Leu Pro Leu Thr Ala
676 TCC AGC CCA GCA CAA TTT GTG GTT CAC AAG CCT AGA GGA TAC AAG GGA ACA GCA TTT CCT TTA CCT CTA ACA GCT
»>VD3 Pvull/
229 Gly Thr Asp Gin Ala Thr Asp Thr Lys Ser Ala Thr lie Lys Tyr His Glu Trp Gin Val Gly Leu Ala Leu Ser
751 GGT ACT GAT CAG GCA ACT GAC ACT AAG TCG GCT ACA ATT AAA TAC CAC GAA TGG CAA GTT GGT TTA GCG CTC TCT
644CprimerVD3<«
254 Tyr Arg Leu Asn Met Leu Val Pro Tyr lie Ser Val Asn Trp Ser Arg Ala Thr Phe Asp Ala Asp Ala lie Arg
826 TAT CGA TTG AAC ATG CTT GTT CCT TAC ATT AGC GTA AAC TGG TCA CGA GCA ACT TTT GAT GCT GAC GCT ATC CGC
Clal
279 lie Ala Gin Pro Lys Leu Ala Ala Ala Val Leu Asn Leu Thr Thr Trp Asn Pro Thr Leu Leu Gly Glu Ala Thr
901 ATC GCT CAA CCT AAA TTA GCT GCT GCT GTG TTA AAC TTG ACC ACA TGG AAC CCA ACC CTT TTA GGA GAA GCT ACA
»>VD4
304 Ala Leu Asp Thr Ser Asn Lys Phe Ala Asp Phe Leu Gin lie Ala Ser lie Gin lie Asn Lys Met Lys Ser Arg
976 GCT TTA GAT ACT AGC AAC AAA TTC GCT GAC TTC TTG CAA ATT GCT TCG ATT CAG ATC AAC AAA ATG AAG TCT AGA
Alul VD4<«
329 Lys Ala Cys Gly Val Ala Val Gly Ala Thr Leu He Asp Ala Asp Lys Trp Ser He Thr Gly Glu Ala Arg Leu
1051 AAA GCT TGT GGT GTA GCT GTT GGT GCA ACG TTA ATC GAC GCT GAC AAA TGG TCA ATC ACT GGT GAA GCA CGC TTA
/Hindi 11 primer289C
354 He Asn Glu Arg Ala Ala His Met Asn Ala Gin Phe Arg Phe 367
1126 ATC AAT GAA AGA GCC GCT CAC ATG AAT GCT CAA TTC AGA TTC TAA GGATTTA GTTTATACTA TCCTAACTTT TTGTCCCGCT
1167
rho-independent terminator
+41 ATCAGAACCT AGGAATCTCT GGGTTCTGAT TTTTTTTGCT CTCATCCTTT TGTAGAGCTT CAAATCTCTT TTCTAAAATC CATTCGCATA
> -> <■ < Alul/ 612Cprimer
+131 AGAATTCACT GATTATCTAA AATTTTCTAG AAGCTTGAAA CCTAGAGATT ACAACCTTGC GTAAAAAGCA TTATTAAATT AACATCTCTA
EcoRI Hindi 11/Alul
+221 TTCTTAGCAC GCGCCCGTAG CTCAATGGTA GAGCTGTAGC CTTCCAAGCT ACCGGTGTCA GTTCGATTCT GATCGGGCGC TTTCTGAACA
Alul Alul Mspl
+311 CCACCAAGAC TGAAATCTTG ACATCGGTTC AAGATGCCAT TGTTAACATA TTCAAGAAAT AGAGGTACAA AGCTTGGAAG AACAACCACT
+401 ATGCAATCTT TCAGTTAAAG ACTTAATGGA AGCGGGAGCT +440
SstI
Figure 6.2. DNA sequence and deduced amino acid sequence of the major outer membrane protein gene from
Chlamydia psittaci (ovine abortion strain S26/3). Putative promoters (P1 and P2). Shine-Dalgarno























































5' +31 -U-U-G-U-C-C-C-G-C-U U-U-U-U-U-U-U-G-C-U- +80 3'
Figure 6.3 Potential secondary structure ofthe inverted repeats located 5' (A) and3'(B) of
the S26/3MOMPgene. The stem-loop sturctures shown begin and end atthe
nucleotides corresponding to theDNA sequence. The RNA sequence is shown
here in the based paired conformation with the minimum free energy as deduced
by the computerprogram ofZuker andStiegler. The free energies of formation
are -5.9kcal/moland -14.5kcal/mol respectively.
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Table 6.1. Calculated free energies of formation (kcal/mol) .
Comparison of the IR and the putative terminators
of S26/3, A22/M and L2 MOMP genes.
S26/3 A22/M L2
3' IR -14.5 -16.5 -12.9
5' IR -9.5 - -7.2
Note that these values were calculated only for the underlined
regions of the IR and terminator of S26/3 MOMP gene (Figure 6.2)
and the corresponding sequences of A22/M (Pickett et al, 1988a)
and L2 (Stephens et al, 1986). More stabler conformations or
alternative folding patterns may be formed if more bases are
taken into account.
putative rho-independent terminators.
MOMP 5' and 3' regulatory sequences
The 5' flanking regions of the MOMP genes of the following
chlamydial strains have been aligned and displayed in Figure
6.4: C.psittaci strains S26/3 (OEA) (this thesis; Herring et al,
1989), A22/M (putative OEA) (Pickett et al, 1988a), CallO
(meningopneumonitis Mn), GPIC strain 1 (guinea pig inclusion
conjunctivitis) (Zhang et al, 1989a) C. trachomatis serovars L2,
B and C (Stephens et al, 1987). The sequence of the C.psittaci
strains from -1 to -227 were identical except for two A->T base
substitutions in the GPIC sequence (-56T and -179T) and an extra
base (-186T) in the S26/3 sequence. Comparison of the S26/3
sequence farther upstream with that of C.trachomatis serovars B,
C and L2 showed that while the C.trachomatis sequences were
virtually identical, only specific boxes of conservation were
present across species. Thus there were several more
genus-conserved regions than the twelve control regions, CR1 to
CR12, previously designated by Pickett et al (1988a) for a
putative ewe abortion agent, A22/M.
-381
12 TCAACAATCA ACATATTGCC AATATGGCTT TTGCTCTCGG
B TCAATCACCA ACATCTTGCT AAGATGGCTT TTGCACTCGT
C TCAATCACCA ACATCTTGCT AAGATGGCTT TTGCACTCGT
S26/3 CA ATATAATATA AGAA..GCCT GTACACTC..
P2 -35?
-315
TTTCAGAGCG ATTTTTTTCG CAAAAAC.AA GAACATAA.A
TTTCAGAGCG ATTTTTTTCG CAAAAA.AAA GAATATAAAA
TTTCAGAGCG ATTTTTTTCG CAAAAA.AAA GAATATAAAA
.TTCTATGAG GTAATTCCAA CTTATTCTAA GTGCATAAGA
P2 -10?
-314 P2 -35 P2 -10 -iyj
L2 acataaaaajb ata tacaaaa ati gc tctctgcttt atcgcta.aa tcaggaggcg cttaaagggc ttcttcctgg
b acataaaaag at^ tacaaaa at gc tctctgcttt attgcta.aa tcaggaagcg cttaaa.ggc ttcttcctgg
c acataaaaag ata^acaaaa at gc tctctgcttt attgcta.aa tcaggaagcg cttaaa.ggc ttcttcctgg
S26/3 aaataaaaa
T
t gtg)tacaaaa at ctaata gc tctct tatta gcaagtataa ggagttattg cttgaa..at ctgtgcctga
P2 -35? P2 -10? P2 -10? P2 -10? P2 -10?


































































































L2 CAbTGCCGCC AGAA ...AAC /(TAG CGAGCACAAA
B CAGTGCCGCC AGAA AAGATAG CGAGCACAAA
C CAGTGCCGCC AGAA AAG ATAG CGAGCACAAA
S26/3 TG GTGCCGCC AGAAGAGCAA ATTAGA ATAG CGAGCACAAA
A22/M TG GTGCCGCC AGAAGAGCAA ATTAGAATAG CGAGCACAAA
CAL10 TC GTGCCGCC AGAAGAGCAA ATTAGA ATAG CGAGCACAAA
GPIC TG GTGCCGCC AGAAGAGCAA TTTAGA ATAG CGAGCACAAA
PI -10 S-D -1
GAGA GCTAATTATA CAAT.TTAGA GGTAAGAATG
GAGA GCTAATTATA CAATCTTAGA GGTAAGAATG
GAGA GCTAATTATA CAATCTTAGA GGTAAGAATG
AAGAAAAGAT ACTAAGCATA .ATCTTTAGA GGTGAGTATG
AAGAAAAGAT ACTAAGCATA .ATCTTTxGA GGTGAGTATG
AAGAAAAGAT ACTAAGCATA .ATCTTTAGA GGTGAGTATG
AAGAAAAGAT ACTAAGCATA .ATCTTTAGA GGTGAGTATG
Figure 6.4. Comparison of the 5' regulatory sequences of C.psittac? strains S26/3 (OEA)
A22/M (putative OEA), GPIC (strain 1), Cal10 (meningopneumonitis) and C.trachomatis
serotypes L2, B, C. To optimise alignment, gaps have been inserted as indicated by dots.
The numbering begins backwards from the start codon of the ORF of the S26/3 sequence.
Putative promoter sequences (P1 and P2 - underlined). Shine-Dalgarno box (S-D). Sequences
of complete identity analogous to CR1 to CR12 of Pickett et al (1988a) are boxed.
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Potential promoter elements of the S26/3 MOMP gene were
located by correspondence of position and sequence similarity to
that of published chlamydial promoters (Engel and Ganem, 1987;
Stephens et al, 1988a), assuming that chlamydial promoters
follow the basic motif of E.coli promoters (Hawley and McClure,
1983) . The putative -10 and -35 hexamers (CACAAA and GTGCCG) of
the first promoter (PI) were found in conserved regions,
identical to those proposed by Stephens et al (1988a) for
C.trachomatis MOMP genes. The spacing between these elements,
however, was 26 bases, 8 more than that of the C.trachomatis
PI promoter. The PI promoters for C.psittaci MOMPs were 5 - 6
bases farther from the initiation codon than that of
C.trachomatis MOMPs.
About 120 bp upstream of all the putative chlamydial PI
promoter elements was an inverted repeat (IR) theoretically
capable of coding for an RNA stem loop and previously described
only for C.trachomatis MOMPs (Stephens et al, 1988a) (Figures
6.3A and 6.4). Sequences identical to this dyad symmetry were
present in GPIC and CallO MOMP sequences and were followed by a
T-rich region as shown, but not described, in the data of Zhang
et al (1989a). Only half the structure was provided by Pickett
et al (1988a) who sequenced the A22/M MOMP gene.
Several regions resembling chlamydial promoter sequences
for the S26/3 sequence were present upstream of this IR and are
underlined and designated as the putative second promoter (P2)
in Figure 6.4. Except for one base, the putative P2 -35
hexamer is identical to the analogous structure in the P2
promoter of C.trachomatis MOMP gene. These sequences matched
the E.coli -35 consensus sequence (TTGACA) in 4 out of 6 bases.
Several hexamers similar to the E.coli -10 consensus sequence
(TATAAT) were present 4 bp (TCTAAT), 18 bp (TATTAG) , 28bp
(TATAAG) and 38 bp (TATTGC) downstream. An alternative pair of
-35 and -10 hexamers are also shown.
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Comparison of the 3' flanking region showed that the
putative rho-independent terminators for C.psittaci MOMPs were
38 bp downstream of the termination codon whilst those of
C. trachomatis were an additional 34 bp downstream (Figure 6.5
see next section for details of the sequence alignment). The
terminator IRs followed by 8Ts (Figure 6.3B) were conserved in
C.psittaci MOMP sequences but were fairly divergent from that of
C.trachomatis. Within the C.psittaci terminator IR, part of the
downstream arm TCYGGGTTC was very similar to the upstream arm of
the C.trachomatis L2 MOMP IR, TCTGGGCTC, as shown aligned in
Figure 6.5 (see Appendix for ambiguity code).
MOMP ORFs
A comparison of the S26/3 MOMP ORF sequence with the
corresponding sequences from three other C.psittaci strains
(Pickett et al, 1988a - putative ovine abortion isolate, A22/M;
Zhang et al, 1989a - CallO and GPIC) and a representative
C.trachomatis serovar (Stephens et al, 1986 - L2) was made. The
sequences were optimally aligned to S26/3 by the GAP program
(UWGCG package) with gap weight of 1.5 and gap length weight
0.15. These gapped sequences were then realigned with each other
by inspection and by correlation with conservation in the amino
acid sequence (Figure 6.5). Differences in nucleotides at each
position in Figure 6.5 were counted for each pair of ORFs and
displayed in Table 6.2.
Pickett et al (1988a) reported A22/M as an ovine abortion
strain, thought to be derived from the Moredun Research
Institute (personal communication to Dr A.J.Herring). However,
the reported A22/M MOMP sequence was quite different from the
S26/3 MOMP sequence (Table 6.2). Instead, the A22/M sequence was
strikingly similar to the CallO (meningopneumonitis) sequence,
differing only at 12 nucleotides. Differences between other
pairs of MOMP sequences were more than an order of magnitude
greater than that between A22/M and CallO. The next most
















































T G T T.A T.. .TC G 60
288C PvuII^ Clal^ 845 C




TCi G T..T CC.TA .G C.. A.T.C.A... 120
GAAGGTGCTT CAGGTGATCC TTGCGATCCT TGCTCTACTT GGTGTGATGC TATCAGCATC 180
C C T 180
A G C.. C..T 180
A G C.. C..T 180
TTCG GC..A A.C C G 180
CGCGCAGGAT ACTACGGAGA TTATGTTTTC GATCGTGTAT TAAAAGTTGA TGTGAATAAA 240
G CA.C T 240
240
240
..TATG..T T..T.. C.T C T. .GC..ACA 240
»> VS1 Mspl
ACTATCACCG GCATGGGTGC AGTTCCT ACAG GAACCGCA-- -GCAGCTAAT 288
G.- -- GA. ..C...A ..T. .T.AT... - - -..T...G.C 285
...T.T.G C... .AC ACG CAGGCT T.A AG TAATA 300
...T.T.G C... .AC ACG CAGGCT T.A AG TAATA 300
GAAT..CAA- -- CAAG...ACA ACTGCT C.AT..T-- - CCA 294
«<
TACAAAACTC CTACGGATAG ACCCAACATC





GCTTACGGCA AACACTTACA AGACGCCGAA 348
..C TA.G T..A... 345
........A. GG..TA.G.. ...T..A..G 360
........A. GG..TA.GG. ...T..A..G 360
.........C G...TA.G.. G..T..T..G 351
844C
TGGTTCACCA ATGCAGCTTT CCTCGCATTG AATATCTGGG ATCGCTTTGA TATTTTCTGC 408
C...A. .C..G T.A A ..C..T T G.C 405
TT .A C A..C..A ..C..T C.. C 420
TT.A C A..C..A ..C..T C.. C 420
AT...T..A T A .A.G T T G.A T 411
ACATTAGGCG CTTCTAATGG GTACTTCAAA GCTAGTTCTG CGGCATTCAA CCTCGTTGGT 468
G. -A C.. C. .TC A.A.G... .A..T T..A..C..C 465
..C G. .A..C A T.A G. .T T.G G 480
..C G. .A..C A A G. .T T.G G 480
A. .CA.C.G... A..TC.T... -GA.A...A. .AT.T T.A C 471
130
»> VS2 BamHI PvuII
S26/3 TTGATTGGTG TTAAAGGATC C TCCATA GCAGCTGAT CA GCTTCCCAAT 516
GPIC ..AC G. .A.C .C. ...C TTCAAGGC.. ATA...A..C 510
A22/M ..A..A..GT ..TC..CTA. .AGC..A.CC T.TA.C..GC TTCCAATG.. AC T..C 540
CAL10 ..A..A..GT ..TC..CTG. AAGC..A..C T.TA.C...C TTCCAACG.. AC T..C 540
L2 ..AT.C..A. A...T.AGAA .—CATGCT A...T.TCAG ATAGTAAG.T TG.A 528
S26/3 GTAGGCATCA CTCAAGGAAT CGTTGAATTT TATACAGATA CAACATTCTC TTGGAGTGTA 576
GPIC C...CT CC. T..A..GC T..C C C..T 570
A22/M T. .C TG. T..G C. ..T T C... 600
CAL10 T. .C TG. T..G C. ..T T C... 600
L2 A.GA..T.AG A TCTG. T G..G T..T..TG CT 588
645C
S26/3 GGTGCACGCG GAGCTTTATG GGAGTGTGGT TGTGCGACTT TAGGAGCAGA GTTCCAATAC 636
GPIC G..T A C..A T 630
A22/M T A A T 660
CAL10 T A A T 660
L2 ..A..T..T. C G A A ..C C..TTC T 648
S26/3 GCTCAGTCTA ATCCTAAAAT TGAAATGTTG AATGTAGTCT CCAGCCCAGC ACAATTTGTG 696
GPIC ..G G.. C C.T A.T. .T A 690
A22/M A G G..C.C ..C..CACT. .A 720
CAL10 A G C.C ..C..CACT. .A 720
L2 A..C. .G G. C...GAA..A ..C..TC... GT.A.G TG.G...ACT 708
»> VS3 Pvul I
S26/3 GTTCACAAGC CTAGAGGATA CAAGGGAACA GCA T TTCCTTTACC TCTAACAGCT 750
GPIC A T T..A..G GGCCAAC. .C...C.G.. .T C... 750
A22/M A A. .A C.. T..A...G.T AGCTCGAAT A G... 780
CAL10 A A. .A C.. T..A...G.T AGCTCGAAT A G... 780
L2 A.CA.T A TGTA..GCA. .A. .C...C.TGA ...T.A...A 762
[ 644C«<
S26/3 GGTACTGATC AGGCAACTGA CACTAAGTCG GCTACAATTA AATACCACGA ATGGCAAGTT 810
GPIC ..A..A..GA GC..T T A..A G..T..T A.. 810
A22/M ..A..AACAG .A..T..A C..A..A T A 840
CAL10 ..A..AACAG .A..T..A C..A..A T A 840
L2 ..A..A...G GT.TG..A.G A GAT ..CT.T...G .T T C. 822
Clal
S26/3 GGTTTAGCGC TCTCTTATCG ATTGAACATG CTTGTTCCTT ACATTAGCGT AAACTGGTCA 870
GPIC T. .T A C A. .T...G.A C 870
A22/M ..CC.C..C. .G CA T A. .T...G 900
CAL10 ..CC.C..C. .G CA T A. .T...G 900
L2 A T C T... T.CAC CT A.. T..A T 882
»> VS4
S26/3 CGAGCAACTT TTGATGCTGA CGCTATCCGC ATCGCTCAAC CTAAATTAGC TGCTGCTGTG 930
GPIC A T..A T T G C. .A.G..CA.T 930
A22/M A TA T AA AT.G.AGA.T 960
CAL10 A TA T AA AT.G.AGA.T 960





































TTAAACTTGA CCACATGGAA CCCAACCCTT TTAGGAGAAG CTACAGCTTT A GAT 984
C.A. .T T..TT.A G..G TA..A. A.C 984
C.T...A.T. .T G C TC.A .C..TA GCCCAATA.. 1020
C.T...A.T. .T G A TC.A .C..TG GCCCAATA.. 1020
. .TG.TG.T TCT TA.. GCT CT. ---GC.A.G. G---AAA.C. 996
«<
ACTAGC— A ACAAATTCGC TGACTTCTTG CAAATTGCTT CGATTCAGAT CAACAAAATG 1041
...G.A---G CA AT CAG..A C A 1041
GG.G.TAAGG .TGTTC.AT. ...TG 1080
.G.G.TAAGG .TGTTC.AT. ...TG 1080
.GCGCAGAGG GTC.GC...G A..TAC.A C.T.. .CT.G..ATT G G... 1056
/Hindi 11 289C
AAGTCTAGAA AAGCTTGTGG TGTAGCTGTT GGTGCAACGT TAATCGACGC TGACAAATGG 1101
A.T C T..T 1101
1140
1140
..A T C.. .A.T..A.-A ..AA TA .TG.G..T.. A AC 1116
TCAATCACTG GTGAAGCACG CTTAATCAAT GAAAGAGCCG CTCACATGAA TGCTCAATTC 1161
..G T C T G.A.. C 1161
T 1200
T 1200
G..G.T..A. T...GA.T G...G.. ..G T G.A A 1176
STP




C.C T T.A..GTA.A ..TT.G.TA- GGCA AGTTTATCTT TGTTAATAAC 1235
> <




GTTAATAACA C.A...GTG. T..T.GG.TC GACTTCGGTC C.A.T TGCAA 1295
> <
L 612C EcoRI
CTCATCCTTT TGTAGAGCTT CAAATCTCTT TTCTAAAATC CATTCGCATA AGAATTCACT 1307
AAGCC.. 1254
AC. .C C- T 1309
AC..C.. 1293
AAAT.TT .C.TACTT.C G.TCT.C..C C.A.CTCTCT 1335
Figure 6.5. Comparison of coding and 3' flanking regions of MOMP genes of
C.psittaci strains S26/3, GPIC, A22/M and Cal10 and C.trachomatis serotype
L2. The four variable sequences (VSs) corresponding to variable domains (VDs)
in the polypeptide chain are marked by triple arrows. Gaps are indicated by
dashes (-); identical bases by dots (.); putative terminator by broken arrows.
Restriction sites are underlined; primer sequences are overlined with an arrow.
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Within the C.psittaci sequences, many base changes were
third base "wobbles" and did not result in changes in the amino
acid sequence. Across species, there were more differences but
it was interesting to note that the S26/3 MOMP gene was the
least different from L2 MOMP gene among the C.pslttaci MOMP
genes.
TABLE 6.2. Differences in nucleotides within the ORF as a
percentage of the mean of N for the two ORFs. The number of
amino acids in the ORF and the number of differences are given























17.9%(56) 12.9%(66) 12.6%(62) 33.0%(139)




To visualise the distribution of these differences,
several ungapped sequences were compared pairwise using the
COMPARE program (window = 30 and stringency =9) and displayed
by the DOTPLOT program to highlight the main regions of
similarity and differences (Figure 6.6). (As a control, the
S26/3 MOMP sequence was compared with the E.colL PhoE outer
membrane porin sequence and did not show any homology.) The
plots revealed a localisation of consecutive base changes in
four regions, first identified for C.trachomatis MOMPs and
termed variable sequences VS1 to VS4 by Stephens et al (1987),
and subsequently for C.psittaci MOMPs by Pickett et al (1988a)
and Zhang et al (1989a) while this project was in progress.
Eae.Seq ck: 1879, 1 to 1988
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Figure 6.6. DOTPLOTS of comparisons between MOMP nucleotide sequences
of A. S26/3 and A22/M; B. S26/3 and L2; C. A22/M and CallO. Panel D
is a comparison between the E.coli phoE gene and S26/3 MOMP gene. The
variable sequences are marked VS1 to VS4 and the conserved sequences
CS1 to CS5.
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These variable sequences (VSs) are marked in Figure 6.5. Within
these sequences, gaps have been introduced in the sequences to
optimise the alignments. Equally conspicuous were large
stretches of sequence identity in the 5' and 3' ends of the
C.psittaci MOMP ORFs, about 240 and 160 bp in length
respectively. In between the VS1 to VS4 were regions of
intermediate diversity in sequence. For convenience, these
regions of conservation interdigitating with the variable
sequences are termed conserved sequences CS1 to CS5.
Several of the more common restriction endonuclease sites
have been underlined. Some sites are unique to the strain but
others are conserved within C.psittaci strains. An exhaustive
restriction map of the S26/4 MOMP sequence is shown in Figure
6.7 (of restriction endonucleases commercially available up to
January 1989).
Deduced amino acid sequence
The translation of the C.psittaci S26/3 MOMP gene is
displayed in Figure 6.2 corresponding to the nucleotide
sequence. It encoded 389 amino acids with a calculated M^ of
41883 Da. Since the N-terminus of the mature MOMP began with
L(D)P(G)VGNPAEPS (Chapter 4), which corresponded to the 23rd to
the 32nd residue of the C.psittaci pre-MOMP, the initiation
codon was designated -22 and the N-terminus of the mature
protein as +1. The calculated M^ of the mature protein was
39.639 kDa, which compared favourably with the estimated 39 to
40 kDa by SDS-PAGE analysis (Chapter 3 and 4). The length of
the signal sequence and the cleavage site is identical to that
of MOMP from C.trachomatis serovar L2 (Nano et al, 1985). The
signal sequence cleavage site in the MOMPs of other strains were
assumed by their investigators to be the same as that of serovar
L2.
Alignment of the amino acid sequence of S26/3 MOMP and
those from other sources (Stephens et al, 1986; 1987; Pickett et












































(Linear) MAPPLOT of: Eae.Seq ck: 1879, 1 to: 1988
Enzyme Data: Newenz.Fil
600 BOO 1000 1200
October 25, 1989 21:51.
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Aatll AccI Af1111 AlwNI Apal Apyl Aap700 Aap71B Aval Avail AvlII Axyl
Ball Banll fibel BbvII* Bgll Bglll BspHI BapMl BaaHII BatEIl BatNI BatXI
Cfrl Cfrl3I Oral Dsal* EcoK EcoB EcoSll* Eael Eagl EcoBlI ECO0109 EeoNI
EcoRII EcoT22I Espl Fspl Bdill* Hael* Haalll Kpnl Mlul Hrol Naal Narl
Nell Ncol Ndel Nhel NotI Nrul Nail PflMI Plal PoaClM PpuHI PasI
PatI RspXI Rsrll SacI SadI Sail Sau96I Seal ScrFl Sfll saal SnaBI
Spel SphI Spll Sep! Saoll* StuI Tthllll Xcal Xhol Xaal Xaalll
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Figure 6.7. Restriction endonuclease map of S26/3 MOMP gene. Key:
Putative promoters (PI and P2), inverted repeat (IR), signal peptide
(SIG), variable sequences (VS1 to VS4), terminator (TER).
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the CLUSTAL program (Chapter 2). For optimal alignment,
further adjustments were made to the CLUSTAL output by
inspection (Figure 6.8). Corresponding closely but not exactly
to the four VSs in Figure 6.5 were four variable peptide domains
(VD1 to VD4 - boxed); similarly the conserved domains (CD1 to
CD5) corresponded to the five conserved sequences. The VD
assignments were similar but not identical to those reported for
C.trachomatis (Stephens et al, 1987) and C.psittaci (Zhang et
al, 1989a) due to the larger number of strains compared here.
It was noted that intraspecies VD boxes tended to be smaller
than those interspecies and this is particularly obvious in VD3.
General data and amino acid composition of S26/3 MOMP are
displayed with that of other chlamydial MOMPs in Table 6.3.
From Figure 6.8, it was observed that the A22/M MOMP was
identical to the CallO MOMP in polypeptide length and identical
in sequence except for changes in 10 residues which were located
in CD2 (2), VD2 (4), CD3 (1) and VD4 (3). These changes were
the result of 10 nucleotide differences out of the 12 for the
whole ORF. S26/3 MOMP on the other hand was a shorter
polypeptide with the least M^ of the MOMPs cited and was
different at 67 residue positions compared with A22/M, 55 of
which occurred in the VDs.
The M^ of the MOMPs without the signal sequences agreed
closely with SDS-PAGE estimations (Chapter 3). The signal
sequences were nearly identical within each species but differed
in 5 to 6 out of the 22 residues between the two species. These
were mainly conservative changes and did not alter the basic
structure of positively charged residues followed by hydrophobic
residues.
Although the total number of positively charged residues
in each MOMP was fairly constant, there were 10 more Asp and Glu
residues in the C.trachomatis MOMPs than those of C.psittaci
(Table 6.3). In general, the negatively charged residues were
more numerous in C.trachomatis MOMPs. The computer-predicted
isoelectric points of these MOMPs were lower than their reported
139
S26/3
.22 + + 1 - - - - - +









































TAT.N - - PS.C.A
EF-Q...K.. ATT.N - - PS.C.A.9
++ - - -+ -







P M M ■ YM ...v.. 117
P M M .YM ...v.. 117
• E ■ P R.M M • CM ...v.. 115
• E .P ...R.M M .YM ...v.. 115
-E ■ P ...R.M M .YM ...v.. 115
S26/3 TLGASNGYFK ASSAAFNLVG LIGVKG-SSI AAD QLPN VGITQGI
GPIC L. .NA I T. T.LQG.Y.. .A.S..L|..L
A22M S FSAT..T STELPM V
CAL10 FSAA... ST.LPT V
A TT..L. GN..S F.T.TQ..- GFDTANIV.. TALN.AV
C TT..L. GN..S F.T.TQ..- SFNTAKLI.. TALNEAV
B S..L. GN..S F.NNENQTK VSNGAF-V.. MSLD.SV
L2 TS..L. GN..S F.DNENHAT VS.S-ICLV.. MSLD.SV
L1 TS..L. GN..S F.DNENQ.T VKKDA--V.. MSFD.SV
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A .. S... .. .K. V F. . .LCNASE.T
C .. S... ...K. ■ V ,F. ..LCNASE.T
B .. s... ...K. ■ V., F. ..LCNA.E.T
L2 .. s... ...K. V F. ..LCNA.E.T
L1 .. s... .. .<• .V, F. ..LCNA.E.T
T A- - FPLPLTA GTDCJA
... -AN E
..A SSN I.. ..TE











G..D .S.D A 254
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S26/3 QIASIQINKM KSRKACGVAV GATLIDADKU SITGEARLIN ERAAHMNAQF RF 367
GPIC L I.. T V 367
A22M 380
CAL10 380
A .. V.L.L S..I.. .T.W Y AV.I.T...D V 374
C ..V.L.L S..I.. .T.IV Y AV.V D V 375
B ..V.L.L S..I.. .T.IV Y AV.V.T...D V 372
L2 ..V.L.L S..I.. .T.IV Y AV.V.T...D V 372
L1 ..V.L.L S..I.. .T.IV Y AV.V.T...D V 371
Figure 6.8. Comparison of the amino acid sequences of chlamydial MOMPs. The C.psittaci
S26/3 MOMP sequence is shown, aligned with those of C.psittaci strains GPIC, A22/M and Cal10
(Mn) and those of C.trachomatis serotypes A,B, C, L1 and L2. Residues identical to the
S26/3 MOMP sequence are represented by dots. To optimise alignment, gaps have been
inserted as indicated by dashes. The signal peptide is assumed to be 22 residues for MOMPs
from strains other than L2 and S26/3. The numbering begins from the first residue of the
mature MOMP. The variable domains VD1 to VD4 are marked by boxes slightly modified from the
assignment given by Zhang et aj^ (1989a). Charged residues are marked by (+) and (-).
Cysteine residues are underlined; conserved ones are marked. L1 and A MOMP sequence were
from Pickett et §! (1987) and Zhang et a^, (1989a). Other sequences are as cited in the text.
Note that there are several apparent discrepancies between the published sequences and the
sequences deposited in the databases. MOMP serovar B: Cys-33 (database) but Val-33
(Stephens et aj_, 1987); Ser-149 (database) but Gly-149 (Stephens et ai, 1987). MOMP serovar
C: Ile-80 (database) but Thr-80 (Stephens et al, 1987).
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pi of 5.3-5.5 for LGV strains and 6.9 for trachoma strains
(Batteiger et al, 1985). For C.psittaci MOMPs, the positively
charged residues outnumbered the negatively charged residues
taking into account histidine residues as positive unlike Zhang
et al (1989a) who did not. The pis of C.psittaci MOMP have not
been reported although the pi of whole C.psittaci EBs is about 5
(Vance and Hatch, 1980). These differences between species
were mainly accounted for by variation in the VDs (VD3 and VD4
in particular as arrowed in Table 6.3).
S26/3 MOMP possessed 18% charged residues which were
evenly distributed throughout the sequence, similar to other
MOMPs (16% to 20%). However, charges of one type to the
exclusion of the other were found localised in several
interesting loci. Six negatively charged residues spaced between
2 to 5 residues apart were located in a positive-charge-free
region between residues +8 to +34 (Figure 6.9 panel A - note
that 22 should be added to the amino acid number to account for
the signal sequence). Five out of the 17 Pro residues were
located within or near this region. While intervening residues
diverged across species, these Asp, Glu and Pro residues were
completely conserved. The carboxyl end of this region coincided
with a triplet of conserved Cys residues (26, 29 and 33) and
was predicted to possess a high antigenic index using the method
of Jameson and Wolf (1988) and a high /3-turn potential by both
the methods of Chou and Fasman (1978) and Garnier et al
(1978)(Figure 6.9 panels F,L,M,P). This region was termed a
cysteine- and proline-rich acidic (CAPRA) sequence. Charged
sequences exclusively rich in Asp and Glu can also be found in
the hydrophilic /3-sheet porins of E.coli, OmpF, OmpC and PhoE
(data not shown) but not in the hydrophobic a-helical
bacteriorhodopsin of Halobacterium halobium (sequence data cited
from GENBANK and EMBL databases using the UWGCG package). These
membrane proteins do not contain any cysteines.
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Figure 6.9. Outputs from the PEPPLOT, PEPTIDESTRUCTURE and
PLOTSTRUCTURE programs of the UWGCG sequence analysis package. See
text and Chapter 2 for a detailed description of the plots.
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A series of four closely spaced, positively charged
residues was found preceding VD3 in a predicted region of high
turn potential, hydrophilicity, surface probability,
flexibility and antigenic indices (residues +212 to +218)
(Figure 6.9 panels A,F,I,J,K,L,M,P - add 22 to residue number to
obtain corresponding values on the plots). (For details of these
indices, see below or Chapter 2.) This cationic sequence was
found in other C.psittaci MOMP sequences but in the
C. trachomatis MOMP, there were only two positively charged
residues (Figure 6.8). A similar positively charged region
ending with a cysteine residue, 323-NKMKSRKAC-331 was located in
the N-terminus of CD5, near the genus-specific epitope described
by Conlan et al (1988). This cysteine, lysine and
arginine-containing (CLAC) sequence was highly conserved across
species. Clusters of basic residues resembling these sequences
were also present in E.coli porins but not in bacteriorhodopsin.
Unlike bacteriorhodopsin which possesses seven hydrophobic
a-helices 20 to 25 residues long that can span the membrane, no
hydrophobic stretches of similar lengths except the putative
signal sequence could be found in the MOMP sequence despite 47%
hydrophobic residues. This type of primary sequence resembled
the E.coli porins which possess numerous hydrophilic residues
evenly distributed in the sequence without any long stretches of
hydrophobicity.
All MOMPs possessed 7 Cys residues that were conserved in
location and context throughout the genus. In addition,
C.trachomatis MOMPs had 1 or 2 more. Although not all of these
residues may be involved in disulphide cross-linking, some may
participate in the intra- and inter-molecular linkages that have
been suggested previously (Hatch et al, 1984; Bavoil et al,
1984), possibly those located in the CAPRA and CLAC sequences.
An exhaustive search (PROSRCH and PATSRCH) of the current major
databases of protein sequences for CAPRA and CLAC-like sequences
did not pick out any sequences of significant homology other
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than those of other MOMPs. Local regions of the CAPRA sequence,
for example, at the cysteine residues, produced homology with
human, murine and Drosophila laminin, E.coli alanyl-tRNA
synthetase, sheep microfibrillar keratin, yeast methionyl-tRNA
synthetase but the significance of these similarities was low.
Table 6.3 shows that the composition of MOMPs with respect
to certain amino acids were similar whereas some displayed
interspecies differences (marked with x) or intraspecies
differences (marked with square brackets). In every VD of all
the MOMPs examined, there was at least one conserved Pro residue
despite nearly complete variation in other surrounding residues.
Table 6.3. Molecular mass of MOMPs, amino acid composition.
C .psittaci MOMPs C.trachomatis MOMPs
S26/3 GPIC A22/M CAL10 C B L2
PreMOMP 41883 41946 43277 43232 42833 42532 42550
LENGTH 389 389 402 402 397 394 394
CHARGE +5 +4 +4 +3 -3 -4 -5
AVE 107.7 107.8 107.7 107.5 107.9 107.9 108 .0
SIG 2263 2293 2263 2263 2293 2293 2293
CHARGE +3 +3 +3 +3 +3 +3 +3
MOMP 39639 39672 41032 40987 40559 40257 40275
LENGTH 367 367 380 380 375 372 372
CHARGE +2 +1 +1 0 -6 -7 -8
Pi 6.50 6.14 6.15 5.78 4.82 4.76 4.69
CHARGED RESIDUES
SIG 3-0 3-0 3-0 3-0 3-0 3-0 3-0
CD1 4-9 4-9 4-9 4-9 4-9 4-9 3-9
CD2 4-4 4-4 4-4 4-5 4-4 4-4 4-4
CD3 6-5 6-5 6-5 6-5 5-5 5-6 5-6
CD4 7-4 7-4 7-4 7-4 7-5 7-5 7-5
CD5 9-4 9-4 9-4 9-4 9-5 9-5 9-5
CHARGE 33-26 33-26 33-26 33-27 32-30 32-31 31-31
+7 +7 +7 +6 +2 +1 0
VD1 2-1 2-2 1-1 1-1 1-3 2-2 2-2
VD2 1-1 0-1 0-1 0-1 2-1 1-2 2-4
VD3 0-1 0-1 0-1 0-1 0-2 1-3 1-3 <-
VD4 1-3 1-2 2-3 2-3 1-5 1-5 1-4 <-
CHARGE -2 -3 -3 -3 -5 -5 -5
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C.psittaci MOMPs C. trachomatis MOMPs
S26/3 GPIC A22/M CAL10 C B L2
pre-MOMP
A Ala 54 51 47 50 49 47 48
G Gly 30 31 32 31 28 30 30
I He 22 24 23 25 X 18 15 14
L Leu 35 38 34 33 33 32 31
V Val 21 17 20 19 X 28 26 26
M Met 7 7 8 8 X 10 12 12
P Pro 17 16 [ 19 19 ] 16 15 15
F Phe 18 t 14 ] 18 18 19 19 19
W Trp 10 10 10 10 X 7 7 7
N Asn 19 22 [ 24 24 ] 22 20 18
Q Gin 13 14 14 13 12 13 14
C Cys 7 7 7 7 X 8 9 9
D Asp 21 20 [ 18 19 ] 22 24 26
E Glu 11 12 14 14 X 17 17 16
H His 4 4 4 4 3 3 4
K Lys 20 19 18 18 21 21 20
R Arg 13 13 14 14 12 13 13
S Ser 25 24 [ 35 35 ] 27 28 28
T Thr 30 33 32 30 33 32 32
Y Tyr 12 13 11 11 12 11 12
AG 84 82 79 81 77 77 78
ST 55 57 67 65 60 60 60
DE 32 32 32 33 39 41 42
HKR 37 36 36 36 36 37 37
%charged (17.7%) (17.5%) (16.9%) (17.2%) (18.9%) (19.8%) (20.i
NQ 32 36 38 37 34 33 32
DEHKR 69 68 68 69 75 78 79
ILMV 85 86 85 85 89 85 83
FWY 28 24 28 28 26 26 26
Note: AVE = average M of each residue
SIG = putative signal peptide of 22 amino acid long
LENGTH = number of amino acids
preMOMP= putative precursor of MOMP before cleavage of SIG.
CHARGE = summation of the total number of residues with
positively charged side chains (H,K and R) and
negative charged side chains (D and E).
pi — predicted isoelectric point
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Although there is no evidence of host glycosylation of
chlamydial proteins, several potential eukaryotic glycosylation
sites having the sequence Asn-X-Thr or Asn-X-Ser were present in
the MOMP sequences. A weak glycosylation site (Asn-Pro-Thr or
Ser) was present in MOMPs of both species; three strong sites
were conserved in the C.psittaci MOMPs whereas only one was
conserved in C.trachomatis MOMPs. These are displayed in Figure
6.9 panel S for S26/3 MOMP.
The codon usage of S26/3 MOMP was compared with that of
other MOMPs (Zhang et al, 1989a; Pickett et al, 1988a; Stephens
et al, 1986) and with other outer membrane proteins of E.coli,
OmpF, OmpC and PhoE porins (EMBL database) and displayed in
Table 6.4. The codon usage for S26/M MOMP was not random but
did not display preferences as distinctly as those of E.coli
OMPs. Several codons corresponding to the major isoaccepting
species of tRNA in E.coli were not used in the gene eg. CTG for
Leu, CCG for Pro.
Secondary structure prediction of S26/3 MOM?
and other analyses based on primary structure
The MOMP amino acid sequences were analysed by a variety
of tests for secondary structure and the results are displayed
in Figure 6.9. As a guide to interpretation and to assess its
predictive value, the secondary structure prediction was carried
out firstly for the the matrix protein of E.coli, OmpF, a major
outer membrane porin with two-thirds /3-sheet structure
(Inokuchi et al, 1982; Kleffel et al, 1985), some of which form
intermolecular aqueous channels (Schindler and Rosenbusch, 1984;
Engel et al, 1985) and secondly, for bacteriorhodopsin from
Halobacterium halobium, a hydrophobic transmembrane protein
known to contain seven transmembrane helices (Henderson and
Unwin, 1975). The two conventional algorithms (Chou and
Fasman, 1978; Gamier et al, 1978) predicted a high degree of
^-structure in OmpF porin as expected. Several helical regions
were also predicted. However, the prediction for
bacteriorhodopsin was generally ambiguous. (Sequence data were
obtained directly from the EMBL database.)
Chapter 6 MOMP Sequence Analysis 148
For example, bacteriorhodopsin sequences (data not shown)
known to be transmembrane helices were not predicted accurately
if at all by the C-F (Chou and Fasman, 1978) or GOR (Gamier et
al, 1978) algorithms. They were identified by the GES (Engelman
et al, 1986) and hydropathy (Kyte and Doolittle, 1982) plots
strikingly well, which confirmed a previous report (Engelman et
al, 1980). The surface probability (Emini et al, 1985),
flexibility (Karplus and Schulz, 1985) and hydrophilicity (Hopp
and Woods, 1981) plots accurately predicted those regions which
projected into either the internal or external surface of the
membrane. The correspondence of the antigenic index to such
regions was striking, but did not distinguish between the
internal or external surface. In the C-F and GOR predictions
the helices showed up as random coil, probably caused by
collisions of simultaneously predicted a-helix and
/3-sheet.
Consequently, these data for MOMP were interpreted with
caution bearing in mind the predictive limitations and were used
in combination with other analyses also displayed in the figure.
The signal peptide was predicted to be hydrophobic and helical,
carrying negatively charged lysines (-21, -20 and -17) at the
N-terminus. Twenty residues at the C-terminus were also
predicted by both C-F and GOR algorithms to be helical. No
other continuous stretches of hydrophobic residues long enough
to span a membrane in an helical structure (20-25 residues)
could be detected in the various hydropathy plots of the MOMP
sequence in contrast to those detected for bacteriorhodopsin.
Instead short stretches of a-helices generally less than 20
residues were predicted throughout the sequence. These helices
tended to be spaced about 40 to 60 residues apart. Overall,
more /3-sheet than a-helix structure was predicted as has
been previously reported (Baehr et al, 1988).
Surface probability, flexibility and hydrophilicity plots
tended to fall into a trough over VD1 and VD3 whereas flanking
sequences were sharp peaks. Most residues in these VDs were
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hydrophobic and comparison with other MOMPs showed that despite
substantial sequence variation, the hydrophobic character of
these sites was retained. Both VDs possessed f3 - turn
potential.
In contrast, VD2 and VD4 contained relatively more
hydrophilic residues; the surface probability, flexibility and
antigenicity indices were high in these regions. Several peaks
of /3-turn potential occurred in these segments. This pattern
was present in L2 MOMP which agreed well with epitope mapping
data identifying these regions as highly antigenic sites
(Stephens et al, 1988b; Baehr et al, 1988; Conlan et al, 1988).
The CAPRA and CLAC sequences previously mentioned were
predicted to be regions of £i-turns sandwiched by a-helix or
f3 - sheet structure. These two regions possessed very low
hydrophobic moment as were the corresponding sequences in A22/M
and L2 MOMP. (VD1 was also another region of strikingly low
hydrophobic moment.) CAPRA sequences possessed the strongest
jS-turn potential in S26/3 MOMP as well as A22/M and L2 MOMPs.
A program for joint prediction of secondary structure
(Sawyer et al, 1986) was recently made available (courtesy of Dr
Lindsay Sawyer) and the S26/3 peptide sequence was analysed.
Preliminary results were not in conflict with any of the
interpretations made (data not shown). Conflicting structural
predictions produced by different programs made any useful
deductions about the secondary structure of MOMP difficult.
T-cell epitope prediction
A computer program written by D.Thomson (University of
Edinburgh - unpublished) was used to detect motifs commonly
found in known T-cell epitopes (Rothbard and Taylor, 1988).
Several such motifs were clustered in the following regions.
a. 29-CSTWCDIASIRAGYYGDYVFDRVLKVDVNK-58 which contains segments
with high antigenic index and high /3-turn potential;
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b. 122-YFKASSAAFNLVGLIGVKGSSIAADQLPNV-151 which possesses a high
antigenic index at the N-terminus and included the whole of VD2
at the C-terminus; and
c. 292 -TTWNPTLLGEATALDTSNKFADFLQIASIQ-321 which is part of VD4.
Other tetrameric or pentameric 'Rothbardian' motifs were found
localised in other segments of the sequence. An independent
computer-assisted search for T-cell epitopes was carried out
using the method of DeLisi and Berzofsky (1985) as adapted by
D.Thomson (unpublished data). Amphipathic sequences longer than
four residues are listed, several of which also contained
'Rothbardian' tetramers or pentamers.
3-VGNPAEP-9
15-GTMWEGASGDPCDPCS- 30 in the CAPRA sequence
43-YGDYVFDRV-51 in a.
93-AEWFTN-98
154-TQGIV-159 in C. (see below)
295-NPTLLGE-301 in c.
306-DTSNKFADF-319 in D and in c.
353-LINER-357
The hydrophobic moment mentioned in the preceding section
is a marker of periodicity in hydrophobicity of a protein
sequence (Eisenberg et al, 1984). Amphipathic a-helices or
/3-sheets possess a periodicity in their hydrophobicity of about
3.6 or 2.3 residues respectively. The hydrophobic moment plots
displayed in Figure 6.9 are profiles of the moment at 100° for
a-helices and 160° to 180° for /?-sheets. T-cell epitopes
tend to be amphipathic helices (DeLisi and Berzofsky, 1985) ; a
scan of the helix hydrophobic moment profile revealed large
peaks at
A. 41-GYYGDYVFDRV-51 in a. (see above)
B. 105-NIWDRFDIFC-114
C. 156-GIVEFYT-162
D. 308 -SNKFADFLQ-316 in c.
The first two are in highly conserved regions CD1 and CD2
while the second two are located at the C-termini of the
putative antigenic sites, VD2 and VD4. These are also present
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in the corresponding sites in L2 MOMP despite differences in
sequence. The first and the fourth are contained in the sites
predicted above as containing many 'Rothbardian' motifs. Both
the second and the third contain several such motifs. All four
corresponding sites were present in A22/M MOMP. L2 MOMP
possessed several more regions with large hydrophobic moment
peaks.
DISCUSSION
Serology, peptide mapping and sequence data of MOMP has
shown it to be the site of antigenic variation for C.trachomatis
(see discussion of previous chapters). Data in preceding
chapters showed that MOMP is likely to carry immunoprotective
epitopes. This dual involvement of MOMP in antigenic variation
and immunity has prompted the cloning and sequencing of its
encoding gene from the OEA strain.
In this chapter, the structure of the MOMP gene has been
elucidated as a prelude to gene expression. The sequence data of
OEA C.psittaci MOMP has been presented together with that of
other chlamydial MOMP to demonstrate inter-species and
intra-species variation. Comparison was also made with
well-studied outer membrane proteins of E.coli and with the
paradigmatic bacteriorhodopsin of Halobacterium. Techniques in
computer-assisted analysis of DNA and protein sequence data were
used to make observations and inferences about higher level
structure in relation to known functions and immunological
effects of MOMP.
Resolving the identity of OEA MOMPs
The species C.psittaci is a diverse grouping within which
strains have been defined by their origin of isolation and
biological properties only until recently. Techniques such as
restriction endonuclease analysis (REA)(McClenaghan et al, 1984;
Timms et al, 1988), micro-immunofluorescence (MIF)
(Perez-Martinez and Storz, 1985), monoclonal antibodies
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(DeLong and Magee, 1986; Fukushi et al, 1987) and
immunoblotting (Fukushi and Hirai, 1988) have been used to show
variation at specific loci. Despite demonstrably large
differences among strains of C.psittaci, strains that cause OEA
when analysed by REA (McClenaghan et al 1984) and SDS-PAGE
profiling (A.J.Herring, in preparation) are virtually identical.
Some evidence for biological variation has been adduced (Russo
et al, 1979; Aitken et al, 1981; Johnson and Clarkson, 1986)
but SDS-PAGE and peptide mapping (Chapter 4) analyses on MOMP
from several OEA strains do not show clear evidence for the loci
of variation (if any) to reside within MOMP.
Given that A22/M as reported by Pickett et al (1988a) is
purportedly an ovine abortion isolate, the degree of variation
found between S26/3 and A22/M MOMPs was surprising. From the
sequence data and DOTPLOT comparisons, A22/M MOMP resembles
that of the meningopneumonitis strain CallO far more closely
than it does S26/3 MOMP. S26/3 MOMP in turn resembles that of
the other strain of mammalian origin, GPIC. Since the CallO
strain is avian in type as judged by its origin from a case of
presumptive ornithosis (Francis and Magill, 1938), by its REA
profile (McClenaghan et al, 1984) and its DNA reassociation
properties (Cox et al, 1988), the A22/M strain could be of
avian origin. Moreover, genomic REA profiles and Southern
blotting with a MOMP gene probe showed A22/M to be virtually
identical to CallO and avian strains; similarly, S26/3 was
identical to other OEA strains (A.J.Herring and S.Baxter,
personal communication; Herring et al, 1989). The comparison
of A22/M and S26/3 MOMP sequences is thus an inter-type
comparison rather than an inter-strain comparison.
The history of the A22/M strain is not clear but it should
have been identical to A22, which is the original ovine
abortion strain isolated at the Moredun Institute (Stamp et
al, 1950); the "M" stands for Moredun (I.Clarke and A.J.Herring,
personal communication). In contrast, the S26/3 MOMP gene was
isolated from the same preparation of chlamydial organisms as
that used in a vaccination-challenge experiment (Anderson et al,
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submitted). Since the A22 isolate has had a very long passage
history, one obvious explanation is that at some point an
accidental substitution with an avian isolate has occurred,
probably after it had left the institute.
As this thesis was being prepared, further evidence
indicated that A22/M is unlikely to be the A22 OEA strain and
that the S26/3 sequence is unequivocally from an OEA strain.
Using primers based on the DNA sequence of S26/3 MOMP CDs
(Figure 6.ID), amplification of MOMP genes by the polymerase
chain reaction (Saiki et al, 1985), particularly from field
isolates of OEA strains, followed by DNA sequencing and/or REA
has shown that the S26/3 sequence is identical to that of other
strains isolated from cases of OEA, including the A22 strain
(S.Baxter, PhD thesis in preparation). Thus, while MOMP may
be the loci of inter-type variation in C.psittaci as shown by
the comparisons with CallO, A22/M and GPIC, it does not appear
to be a loci of primary structure variation in the OEA isolates
tested so far. This conclusion agrees with the data on limited
proteolysis of MOMP described in Chapter 4 although the
question of post-translational modification remains to be
resolved.
Promoter Region
Based on sequence data and Northern blot analysis, it has
been shown that the C.trachomatis MOMP gene is monocistronic,
possessing promoter sequences upstream of the ORF and
termination signals immediately downstream (Stephens et al,
1986) . It was subsequently demonstrated that the L2 MOMP gene
(omplL2) is differentially transcribed from two tandemly
arranged promoters, a shorter transcript (PI) being
constitutively synthesised and the longer (P2) under regulatory
control (Stephens et al, 1988a). Since the regulatory sequences
of S26/3 MOMP are highly conserved with C.trachomatis sequences
and possess identical PI -35 and -10 regions and IR sequences,
with very similar P2 and terminator sequences, it is likely
that S26/3 MOMP gene is also monocistronic and differentially
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transcribed from two tandem promoters. However, whether
this is the case needs to be formally demonstrated with
C.psittaci MOMP.
Although the C.psittaci MOMPs presented in Figure 6.4 and
6.5 are from diverse sources, they were virtually identical as
much as 200 bp upstream of the start codon despite clear
differences in the ORF, particularly in the VSs. Inter-species
comparison in this region showed 75% identical residues after
alignment, much higher than the corresponding degree of
conservation within the coding region between the two species .
Such a striking degree of conservation suggests that either
these strains are more related than previously thought
(Kingsbury and Weiss, 1968), or that there is an extremely
strong selection pressure on this non-coding region as a result
of its putative promoter and other regulatory functions, or
both. An example where highly conserved upstream sequences has
been linked to transcriptional regulation is the phoE promoter
of Enterohacteriaceae (van der Ley et al, 1987a) but the degree
of conservation is not as high as that in the MOMP promoters.
Mechanisms of transcriptional regulation in prokaryotes
involve RNA polymerase modification, its association with sigma
factors, repressors and activators, and the association of the
transcription apparatus with specific nucleotide sequences (von
Hippel et al, 1984). For instance, the owpR product is an
osmolarity-dependent activator of both OmpF and OmpC porin
expression in E.coli (Hall and Silhavy, 1981 - review). Both
the genes encoding these major outer membrane porin possess a
highly conserved sequence in the promoter that has been
subsequently shown to be within the binding site of OmpR (Mizuno
et al, 1983; Mizuno and Mizushima, 1986). Similarly the
phoE, phok, phoB, and pst genes of Enterobacteriaceae are
thought to be regulated by the products of the pho regulon via
upstream elements called pho boxes, originally deduced by
sequence comparison of their respective promoters (Tommassen et
al, 1987).
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Comparison of the S26/3 MOMP promoter with C.trachomatis
MOMP promoters revealed that while sequences upstream of the
promoter-IR motif had diverged, there were many identical
sequences in the motif, including the perfect IR, the cognate
elements of PI and the ribosome-binding site. In extending the
suggestion of Pickett et al (1988a) that these conserved regions
might function in regulation and expression of the gene, it is
proposed that a search for chlamydial proteins that bind at
these sites might uncover trans-acting regulatory factors of
MOMP gene transcription. It is also interesting to note that
another highly transcribed gene, the rRNA cistron of
C. trachomatis also possesses tandem promoters (Engel and Ganem,
1987) but they bear little homology with either C.trachomatis or
C.psittaci MOMP promoters. The suggestion by Engel and Ganem
(1987) that chlamydial transcription signals are significantly
different from all previously described prokaryotic promoters,
if true, also requires the proposition that chlamydial RNA
polymerases and accessory factors differ, at least in the
critical DNA binding sites.
The sequence and the spacing of the -10 and -35 promoter
elements are critically important for optimal binding of RNA
polymerase holoenzyme (Esigma^) of E.coli (Hawley and McClure,
1983), particularly where highly transcribed genes are involved.
Generally, conformity to the -10 (TATAAT) and -35 (TTGACA)
consensus sequences and their spacing (17+1) results in optimal
expression in E.coli. C.trachomatis MOMP promoters appear to
function poorly in E.coli and this has been attributed to the
lack of sequence homology between the promoters of C. trachomatis
MOMP and the E.coli consensus (Stephens et al, 1988a). The
putative C.psittaci promoters particularly PI possess a longer
spacing between the promoter elements in addition to the lack of
homology in sequence to that of E.coli. The obvious implication
for the development of recombinant S26/3 MOMP is that the coding
gene should be attached to a strong E.coli promoter rather than
retain the natural promoter.
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It has been shown for Bacillus subtilis (Rather et al,
1986) and for E.coli (Cowing et al, 1985) that the utilisation
of different sigma factors by the RNA polymerase core enzyme (E)
occurs with differences in promoter sequence specificity.
McClure (1985) proposed that if "consensus is best" for
transcription initiation in prokaryotes, then the data in the
literature suggest that poor homologies at the -35 region might
indicate control by dissociable activators (or repressors) while
those at the -10 region might suggest the presence of additional
sigma subunits. The possibility that C.trachomatis might use
different sigma subunit(s) from E.coli has been explored by
Stephens et al (1988a). The longer spacing between the -35 and
-10 of the C.psittaci promoters compared to that of
C. trachomatis suggests that if sigma subunits are involved, they
are likely to be different between the two chlamydial species.
Efforts to test these speculations will be hampered by the
absence of a transformation system for Chlamydia spp. despite
many studies of the chlamydial plasmid (Joseph et al, 1986;
Sriprakash and MacAvoy, 1987; McClenaghan et al, 1988; Hatt et
al, 1938). In addition, there have been reports of
chlamydia-specific phage (Harshbarger et al, 1977; Richmond et
al, 1982; Bevan and Labram, 1983) but its development as an
agent of transfection has yet to be demonstrated.
Coding Region
Prokaryotic outer membrane proteins have signal sequences
at their N-termini which are cleaved off as they mediate
transport to the surface location (reviewed by Perlman and
Halvorson, 1983). Such sequences of outer membrane porins of
E.coli are very similar in length (20 residues) and structure:
positively charged residues followed by a hydrophobic core and a
post-translational cleavage recognition site, Leu-X-Ala
(Oliver, 1985 - review). In addition to the positively charged
N-terminus and the hydrophobic core (n-region and h-region
respectively), von Heijne (1985) also describes the c-region of
the signal sequence, a region of more polar character which is
at the C-terminus.
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The N-terminus of the C.trachomatis L2 pre-MOMP conforms
to these requirements and the N-terminal residue Leu of the
mature MOMP begins immediately after the consensus site,
Leu-Gln-Ala (Nano et al, 1985; Stephens et al, 1986). Protein
microsequencing of the mature C.psittaci S26/3 MOMP showed that
the N-terminus is also identical to that of C.trachomatis L2
(Chapter 4). Although MOMPs from other strains have not been
sequenced, it is likely that the processing site is identical to
that of C. trachomatis L2 or C.psittaci S26/3 because of the high
degree of conservation, particular at the proposed cleavage
site. The three Lys residues and the consensus site were
identical in all these chlamydial MOMPs. Substitutions were
conservative and maintained the overall hydrophobic character of
the h-region.
It is an established observation that heterogeneity in
MOMP sizes exists (see Chapter 1). The sequence comparisons made
here and that of others (Stephens et al, 1987; Pickett et al,
1987 and 1988a; Yuan et al, 1989; Zhang et al, 1989a) have shown
that such size differences are due to differences in the length
of the peptide sequence at these variable domains. However,
estimations of M^ from SDS-PAGE do not always agree closely with
calculated values prompting speculations of post-translational
modification.
There are eukaryotic signals for glycosylation within the
MOMP sequence but the evidence for glycosylation of MOMP has so
far been ambiguous (Hatch et al, 1981; Caldwell et al, 1981;
Carlson et al, 1986). Hatch et al (1981) demonstrated the
presence of glycosyl moieties on MOMP using the sensitive
periodic acid-dansyl hydrazine (PAD) stain where Caldwell et al
(1981) failed with the periodic acid-Schiff (PAS) stain. Carlson
et al (1986) have shown that MOMP and other chlamydial proteins
bound specific lectins in a ligand blotting study. The lectin
specificities of these proteins were consistent with O-linked
oligosaccharide-containing glycoproteins and these investigators
suggested that chlamydial glycosylation is not derived from host
cell N-linked lipid pathways.
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The composition of the VDs from the sequence analyses
appeared to vary significantly thus influencing hydrophilicity
and antigenicity . Within these VDs are often found regions of
high turn potential and high hydrophilicity indices suggesting
that these are regions which are exposed on the surface of the
outer membrane. In studies with C.trachomatis MOMP using
monoclonal antibodies and recombinant proteins (Stephens et al,
1988b; Baehr et al, 1988) or solid-phase peptides (Conlan et al,
1988) , VD2 and VD4 have been found to be the loci of a complex
hierarchy of serovar-, subspecies-, species- and genus-
specific epitopes. Su et al (1988) have also found trypsin
cleavage sites located in two VDs showing the accessibility of
such domains. For trachoma serovar B, they have correlated
loss of infectivity to trypsin cleavage at VD2. Visual
inspection of the S26/3 sequence showed potential sites for
trypsin or chymotrypsin cleavage in VD2. Further investigations
on the effect of protease treatment of S26/3 EBs may reveal
whether an analogous situation occurs for C.psittaci
infectivity.
Chlamydial MOMP is a structural component and functions as
a porin (Bavoil et al, 1984). It is covalently linked through
disulphide bridging to itself and to other outer membrane
proteins (Bavoil et al, 1984; Hatch et al, 1984; Newhall and
Jones, 1983) and that redox control of these bonds affect
differentiation of EB to RB (Hackstadt et al, 1985) and regulate
porin function (Bavoil et al, 1984). Comparison of the
C.psittaci with the C.trachomatis MOMP sequences in this chapter
and by Zhang et al (1989a) revealed five highly conserved
portions of the MOMP sequence designated constant domains 1 to 5
(CD1 to CD5). It is likely that the biological functions common
to all chlamydial MOMPs may be located in these regions. The 7
conserved cysteine residues in the CDs of C.psittaci and
C.trachomatis MOMPs occur at the same location in a virtually
identical context between species. Thus while the variable
regions, thought to be the surface-exposed stretches, diverged
at the primary sequence to give rise to the observed antigenic
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variation, the constant regions may have been preserved to
maintain the secondary, tertiary or quaternary structures
necessary for the retention of these functions.
The data in the literature and in Chapter 4 suggests that
MOMP possesses a hierarchy of disulphide bridges that mediate
inter-oligomeric, inter-monomeric and intra-molecular linkages.
The presence of at least seven cysteine residues provides MOMP
with the capacity to form such linkages: at least one thiol
group to form links from one oligomer complex to another either
directly or with via other CRPs, at least two to form
intra-complex links between monomers with two pairs left for
intra-molecular stabilisation. The highly conserved context in
which the cysteine residues occur suggests that it may be
possible to reconstitute hybrid oligomers made of MOMPs from
different strains.
The aggregation of denatured and reduced MOMP to form
putative dimers, trimers and higher order oligomers under
partially renaturing and non-reducing conditions was described
in Chapter 4. The striking features of CAPRA and CLAC sequences
described in this chapter suggest a possible explanation and a
testable hypothesis for this observation. These oppositely
charged sequences may fold into stable secondary structures that
facilitate close interaction of MOMP monomers, thereby bringing
the thiol residues into close proximity for disulphide bonds to
form.
For example, it is speculated that two cysteine residues
at the end of the CAPRA sequence may cross-link with each other
to stabilise a /?- turn, leaving one free cysteine to project
out from a negatively charged domain. Alternatively, if at
least part of the CAPRA sequence can form a helix, it is
possible to draw a model in which all three Cys residues occur
on the same side and all the negatively charged Asp residues lie
on another to form a negatively charged cysteine "barrel". The
CLAC sequence, not necessarily from the same polypeptide chain,
with its positively charged side chains, may form stable ion
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pairs and a disulphide linkage with this moiety. Excess anionic
groups on the CAPRA sequence may also be involved in the sites
on the surface of EBs and RBs which bind polycationic ferritin
molecules (Schiefer et al, 1982). Computer modelling of these
sequences should reveal the thermodynamic and steric possibility
of the speculated structures.
However, in the absence of experimental data, it would be
premature to form firm inferences about the secondary structure
of MOMP based on the computer predictions. It is generally
accepted by workers in this field that VDs are surface-exposed,
immunoaccessible and protease-accessible. The preliminary model
of the way MOMP folds in the outer membrane as proposed by Baehr
et al (1988) might be too simplistic in view of the complexity
of the various parameter profiles. If the knob-like structures
observed in the EM pictures of the outer membrane preparations
(Chapter 4) are indeed the side elevations of MOMP aggregates,
then these knobs may be globular MOMP domains on the exterior
with contiguous segments of the polypeptide chain extending into
the CM as anchor points and as channels. OmpF porin has already
been shown to exist as a triple channel trimer at the external
surface which merges into a single channel at the periplasmic
face (Engel et al, 1985). Perhaps certain domains of MOMP may
form a similar structure.
It is clear that MOMP does not possess the all helical
structure of bacteriorhodopsin but it is not possible to rule
out the presence of a-helices. The amphipathicity
determinations and hydrophobic moments suggest that certain
regions may fold into amphipathic helices at the surface of the
polypeptide, either lining the putative channels or exposed to
the exterior or the periplasmic space.
It is also clear that MOMP resembles E.coli porins in its
parameter profiles as well as amino acid composition and charge
distribution. This suggests that a large part of MOMP might be
(3- sheet structure. Circular dichroism analyses of outer
membrane preparations such as those performed on OmpF by Kleffel
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et al (1985) or^reconstituted MOMP may provide some answers
here. In the absence of transformation procedures for
Chlamydia spp., a potential alternative for testing the porin
function of MOMP may be to contrive porin-MOMP hybrids to
determine how far MOMP domains can substitute for channel
forming domains of porin. This has been successfully performed
for OmpF, OmpC and PhoE (van der Ley et al, 1987b). In this
respect, informed secondary structure predictions may assist
in the selection of domains for testing. In the same manner,
OmpA-MOMP hybrids may assist in assessing the basic molecular
requirements for a structural function. Sites where the two
cysteine residues of OmpA occur may be substituted for MOMP
domains carrying cysteine residues.
Codon Usage
As proposed by Crick (1966) in his "wobble hypothesis", a
single tRNA can usually respond to multiple codons. Despite
this degeneracy in the genetic code, codon choices,
particularly for some amino acids, are highly biased and the
choice of synonymous codons varies with the type of organism
(the "genome hypothesis" of Grantham, 1980). Such an
organism-specific codon preference is related to the population
profile of the isoaccepting tRNAs for each organism, as has
been demonstrated for E.coli and yeast (reviewed by Ikemura,
1985)(isoaccepting tRNAs are tRNAs that are charged with the
same amino acid but usually respond to different codons for that
amino acid). The correlation between the usage frequency of a
particular codon with the abundance of their respective tRNAs is
especially evident for highly expressed genes, for example,
E.coli RNA polymerase and major outer membrane proteins, yeast
enolase and histone genes. Although the choice between
synonymous codons does not affect the nature of the protein
synthesised, it will influence the translation efficiency of
mRNAs transcribed from these genes (Ikemura, 1981) . As shown in
Table 6.4, about half of the optimal codons of E.coli do not
correspond to the frequently used codons of S26/3 MOMP. It is
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possible that attempts at over-expression of MOMP in E.coli may
be limited at the level of translation as specific tRNA
populations become depleted.
TABLE 6.4. Codon usages.
AmAcid Codon S G A Ca L2 Ec optir
Gly GGG 2 7 4 4 2 0
Gly GGA 10 8 10 10 15 0
Gly GGT 13* 8 11 10 7 29 E
Gly GGC 5 8 7 7 6 19 E H
Glu GAG 2 4 4 3 8 0 H
Glu GAA 9* 8 10 11 8 11 E
Asp GAT 15* 14 12 13 20 9
Asp GAC 6 6 6 6 6 23 H
Val GTG 3 1 4 3 6 2 E H
Val GTA 7 7 7 7 6 9 E
Val GTT 10* 7 7 7 12 12 E
Val GTC 1 2 2 2 2 2
Ala GCG 3 4 0 0 1 3 E
Ala GCA 17 13 15 17 15 8 E
Ala GCT 30* 28 26 27 28 18 E
Ala GCC 4 6 6 6 4 0 H
Arg AGG 0 1 1 1 0 0 h
Arg AGA 5* 6 7 7 4 0 H
Ser AGT 3 1 3 4 6 1
Ser AGC 4 5 7 7 4 2 H
Lys AAG 4 4 3 3 7 0 H
Lys AAA 16* 15 15 15 13 17 E
Asn AAT 10* 8 13 13 12 0
Asn AAC 9 14 11 11 6 32 E H
Met ATG 7 7 8 8 12 4
He ATA 1 2 2 3 0 0
lie ATT 7 12 13 13 9 0
lie ATC 14* 10 8 9 5 10 E H
Thr ACG 3 2 4 5 1 0
Thr ACA 10 12 8 8 13 0
Thr ACT 12* 15 13 12 14 12 E
Thr ACC 5 4 7 5 4 12 E H
Trp TGG 10 10 10 10 7 4
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AmAcid Codon S G A Ca L2 Ec optima
End TGA 0 0 0 0 0 0
Cys TGT 4* 4 4 4 5 0
Cys TGC 3 3 3 3 4 0 H
End TAG 0 0 0 0 0 0
End TAA 1 1 1 1 1 1
Tyr TAT 3 10 4 4 4 5
Tyr TAC 9* 3 7 7 8 24 E H
Leu TTG 9 4 7 7 10 0
Leu TTA 17* 20 14 14 8 1
Phe TTT 6 5 9 9 8 2
Phe TTC 12* 9 9 9 11 17 E H
Ser TCG 3 3 5 5 1 0
Ser TCA 3 2 11 10 3 0
Ser TCT 7* 9 6 6 9 6
Ser TCC 5 4 3 3 5 8 h
Arg CGG 0 0 0 0 0 0
Arg CGA 2 0 0 0 2 0
Arg CGT 1 2 2 2 5 12 E
Arg CGC 5* 4 4 4 2 1 E
Gin CAG 4 3 3 3 3 20 E H
Gin CAA 9* 11 11 10 11 1
His CAT 0 3 2 2 3 0
His CAC 4* 1 2 2 1 1 H
Leu CTG 0 1 1 1 3 24 E H
Leu CTA 1 2 3 2 1 0
Leu CTT 3 7 5 5 5 1
Leu CTC 5 4 4 4 4 1 h
Pro CCG 0 0 1 1 1 1 E
Pro CCA 4 6 8 8 4 3 e
Pro CCT 11* 10 9 9 9 0 h
Pro CCC 2 0 1 1 1 0 H
Note:
S = S26/3 MOMP
G = GPIC MOMP (Zhang et al, 1989a)
A = A22/M MOMP (Pickett et al, 1988b)
Ca= CallO MOMP (Zhang et al, 1989a)
L2= C. trachomatis L2 MOMP (Stephens et al, 1986)
Ec= OmpC major outer membrane porin of E.coli (Mizuno et al, 1983)
* = preferred codons in S26/3 MOMP
E = optimal codons and the major tRNA species for E.coli (Ikemura, 1985
H/h = Most and second most preferred codon in human genes (Ikemura, 1985)
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For highly expressed genes, similarities in codon usage
in different unicellular organisms are thought to reflect
similarities in the composition of the tRNA population and such
similarities have been suggested as taxonomic markers (Ikemura,
1985). Table 6.4 shows that MOMP codon usages are similar
within the genus but different from a typical E.coli major outer
membrane porin gene, ompC. The degree of bias in the MOMP codon
usage is not as pronounced as that of OmpC; less than 10 out of
the 59 synonymous codons were used only once or not at all
compared to more than half in OmpC. Since there is no evidence
that chlamydial reticulate bodies utilise host tRNAs,
correlation between the codon preferences in the chlamydial
MOMPs and that of eukaryotes (as typified by human genes) was
not expected. Indeed, Table 6.4 shows that there is little
correlation in the preferences of MOMP genes from the
representative avian, mammalian or human chlamydial strains with
that of human genes.
Suitability of the MOMP gene for PCR
Although C.psittaci and C.trachomatis share some
characteristics such as genus-specific epitopes (Dhir et al,
1972; Caldwell and Hitchcock, 1984), certain rRNA gene
sequences (Palmer et al, 1986) and a unique developmental cycle
(Higashi, 1965), they share only 10% or less DNA homology
(Kingsbury and Weiss, 1968; Cox et al, 1988). Yet within the
MOMP coding sequences, the overall inter-species homology is
high. This accounts for the finding that L2 MOMP probes can
hybridise to sequences from other chlamydial strains (Stephens
et al, 1985) and was used in the cloning of the S26/3 MOMP gene
(Herring et al, 1989). Within the VDs the homology declines to
the overall percentage but in the conserved domains, it rises
to greater than 90% between species, particularly at the termini
of the gene.
The sequence conservation at the termini of the MOMP gene
clearly makes it an ideal target for amplification by the
polymerase chain reaction (PCR) (Saiki et al, 1985). PCR
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primers (amplimers) 288C and 289C have been successfully used to
amplify DNA of S26/3 and A22 MOMPs. Preliminary results have
shown that it is possible to amplify the MOMP sequences from a
wide range of C.psittaci strains using the appropriate amplimers
(Figure 6.1) (S.Baxter and A.J.Herring, personal
communication). Some of these PCR-amplified sequences have been
easily cloned and sequenced (S. Baxter, personal
communication). Restriction sites specific to each strain which
are generated by differences within the VSs or by silent changes
in the CDs imply that restriction endonuclease profiling may be
used as a rapid method for typing strains. Thus the development
of a generally applicable PCR-based test for use with clinical
samples which can both detect and type C.psittaci infections
seems imminent.
The next chapter describes how the PCR technique was used
to amplify a precise MOMP gene fragment for insertion into an
expression vector.
CHAPTER 7
EXPRESSION OF RECOMBINANT MOMP
INTRODUCTION
Allan et al (1984) were the first to report the expression
of the complete MOMP gene of C. trachomatis (serovar LI) in
E.coli using a bacteriophage vector, \ 1059. They showed that
the recombinant produced a doublet of polypeptides (about 40
kDa) similar to purified MOMP by serological and by proteolytic
analysis. Using a \ gtll /3-galactosidase fusion vector,
Stephens et al (1985, 1988b), Baehr et al (1988) and Carlson et
al (1989) have expressed fragments of the MOMP gene from
serovars L2 and L3 of C.trachomatis. The N-terminus of
/?-galactosidase, however, constituted a major portion of the
recombinant protein using this expression system. More recent
attempts to express the MOMP gene from its own promoter
either in vivo using another \ system (\ L47.1) or by in vitro
transcription/translation have failed (M.A.Pickett, M.E.Ward and
I.N.Clarke, unpublished data). Pickett et al (1988b) have
subsequently succeeded by using plasmid vectors of the pUC
series (Vieira and Messing, 1982; Yanisch-Perron et al, 1985).
They reported high level expression of C.trachomatis LI MOMP
fragments of M 33, 26 and 13 kDa attached to short peptides
from the N-terminus of the /3-galactosidase. These fragments
form an N-terminal deletion series progressively omitting MOMP
antigenic sites. Expression is regulated by the lac promoter
and is achieved via induction with isopropyl /3-D-thiogalactoside
(IPTG). As far as the author is aware at the time of the work
described in this chapter, there have been no reports on the
expression of MOMP genes from C.psittaci although there have
been reports of sequence data on the MOMP gene from the putative
abortion strain, A22/M (Pickett et al, 1988a), the GPIC strain
1 and the meningopneumonitis strain CallO (Zhang et al, 1989a).
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From the analysis of the structure of the S26/3 MOMP gene
in the preceding chapter, several important observations
pertinent to the design of a MOMP expression construct were
made. Firstly, the MOMP promoter is significantly different from
the E.coli promoter consensus sequence and is unlikely to be a
good substrate for E.coli RNA polymerase. This observation may
explain why Pickett et al could not obtain expression using the
LI MOMP gene promoter, which is also quite different from the
E.coli consensus. Thus expression vectors containing strong
E.coli promoters were chosen. Several strong promoters are
known to be used successfully for the expression of foreign
genes, for example, the lac, trp, \ P and P promoters or theK .L
synthetic tac promoter (Marston, 1987 and references therein).
It has been suggested that chlamydial outer membrane
protein (OMP) genes may be unstable in plasmid vectors and that
cloning in M13 vectors may overcome instability (Clarke and
Lambden, 1988). An M13 vector carrying a tac promoter (Larder
et al, 1987) was readily available and this was used as the
initial expression vector in this study. This vector, M13
mptacl8, was derived from M13 mpl8 (Yanisch-Perron et al, 1985)
and carried in place of its lac promoter sequence, the tac
promoter, a Shine-Dalgarno ribosome binding sequence and an ATG
start codon followed by a multiple cloning site (MCS).
A second observation concerning the construction of a
recombinant expressing MOMP was that there were no convenient
restriction sites at the 5' end for manipulating the MOMP gene
into a vector. Several alternatives were available for
circumventing this problem. One method would be to make a
library of unidirectional nested deletions from the 5' end of
the MOMP SstI insert. The option of creating a 5' nested
deletion was particularly attractive because it was envisaged
that recombinants expressing progressively shorter polypeptides
would be useful for analysing the relative importance of the
variable domains. However, initial attempts to use this
technique for creating a set of 3' nested deletions to
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These attempts relied on reagents purchased from different
manufacturers and the procedure required more experiments to
optimise conditions. Alternatively, commercially available kits
for this technique may be purchased.
Thirdly, a leader peptide sequence similar to that of
C.trachomatis MOMP sequences was also present in S26/3 MOMP
gene, as is expected for an OMP. This signal sequence is
thought to direct the export of MOMP to the outer membrane.
Since MOMP is a major structural protein with porin functions,
expression and export to the E.coli outer membrane may have
adverse effects on the growth of the host. Moreover, the signal
peptide cleavage apparatus of E.coli may not recognise and
cleave the MOMP leader sequence at the correct site. Based on
these considerations, the cloning of the sequence coding for
the processed MOMP was attempted instead.
EXPERIMENTAL STRATEGY
The strategy adopted was to design an oligonucleotide
based on the elucidated S26/3 MOMP sequence (Chapter 6) for
priming DNA polymerisation of the desired MOMP coding sequence.
The oligonucleotide sequence chosen was 288C (Figure 6.1). It
was used as a primer to initiate DNA polymerisation from the
site corresponding to the N-terminus of the mature MOMP towards
the 3' end of the gene (Figure 7.1). The template (C2/2) used
was the anti-sense strand of the MOMP gene cloned into the M13
ssDNA plus strand (courtesy of Dr A.J.Herring and Sue Dunbar).
This clone, C2/2, was produced by recloning the SstI dsDNA
insert from Al/4, the original recombinant carrying the 2.6kb
insert containing the MOMP gene (Chapter 6), into M13 mpl8 and
selecting for a recombinant containing the insert in the
opposite orientation.
The experiment was carried out as outlined in Figure 7.1
but no positive recombinants could be isolated. One speculation
was that the SI nuclease digestion was not optimised for blunt
end formation. Alternatively, the generation of many small
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Figure 7.2 Construction of MOMP expression vector,
H11, using the polymerase chain reaction (PCR).
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The polymerase chain reaction (PCR) method of Saiki et al
(1985) was tried next. Oligonucleotide 288C was used together
with another oligonucleotide 612C to amplify the coding sequence
plus the 3' terminator from the replicative form of the original
MOMP clone, Al/4. The location of primer 612C was selected such
that it would prime into the MOMP gene terminator towards the
coding region (Figure 6.1). The primer was designed to end at a
well-characterised restriction site, tfindlll, to ensure that it
would act as a substrate for Taq polymerase, the thermostable
DNA polymerase from the thermophile, Thermus aquaticus. To
force cloning in the right orientation, a PstI site was also
designed into the primer 612C. The strategy as summarised in
Figure 7.2 and described in the Results section, was carried
out according to standard procedures as detailed in Maniatis et
al (1982) and in Chapter 2. This strategy was successfully used
to make an expression construct carrying the sequence
information for directing the synthesis of the mature MOMP.
Once the desired MOMP sequence was stably cloned, the
insert could be conveniently manipulated into other specialised
expression vectors to optimise expression. Restriction sites of
the multiple cloning site (MCS) of M13 mptacl8 upstream from the
5' end of the cloned MOMP gene facilitated this manipulation.
Plasmid vector pUC8 (Yanisch-Perron et al, 1985) was used to
express the complete processed MOMP and various truncated MOMP
constructs. The N-terminus of these recombinant MOMPs (rMOMPs)
were attached to several amino acid residues of the
/?-galactosidase N-terminus. Protein A-fusion vectors, pRIT5
and pRIT2T (purchased from Pharmacia) were also used to express
these MOMP inserts. Details of the procedure will be described
in the Results section (Figure 7.4 and 7.5).
The fusion vector pRIT5 (6.9kb) contains nucleotides 1 to
1103 of the staphylococcal Protein A gene which includes the
Protein A promoter and terminator, the signal sequence and the
coding sequence for a truncated form of the staphylococcal
Protein A bearing the IgG-binding domains (Uhlen et al, 1984a;
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Uhlen et al, 1984b; Nilsson et al, 1985). It is derived from
the shuttle vector pSPA16 (Uhlen et al, 1984a), pEMBL9 (Dente
et al, 1983) and the staphylococcal plasmid pC194 (Iordanescu,
1975). The E.coli and Staphylococcus aureus origins of
replication together with the /3-lactamase (ampicillin
resistance) and chloramphenicol acetyltransferase
(chloramphenicol resistance) genes are included for optimal
replication and for selection in both E.coli and S.aureus. Five
unique restriction sites, also present in pUC8, are located
within the (MCS), downstream from the Protein A sequence:
FcoRI, Smal, SamHI, Sal I and Pstl. Recombinant fusion
polypeptides expressed from the Protein A promoter are directed
to the periplasmic space in Gram-negative hosts or exported into
the medium in Gram-positive hosts.
pRIT2T (4.25 kb) contains the thermoinducible \ PK.
promoter and the first 12 codons of a \ cro/lacZ gene fused to a
truncated form of the staphylococcal Protein A gene (nucleotides
385-1103) which codes for the IgG binding domains. Both the
Protein A promoter and signal sequence have been removed. The
3' terminal region of the Protein A gene, nucleotides 1550-1920
and approximately 300 additional nucleotides from the non-coding
region, are fused downstream of the MCS and provide
transcription termination signals. The translation termination
signals may be provided by the cloned DNA fragment but are also
present in two reading frames immediately downstream of the MCS.
The pBR322 origin of replication and the /3-lactamase gene are
present for replication and selection in E.coli. Strain N99cl+
is used for the initial isolation of recombinant clones. It
contains the wild type \ repressor which allows growth at 37 °C.
Suitable host E.coli strains for controlled expression include
strain N4830-1 which has a temperature-sensitive \ cI857
repressor. When the temperature is shifted from 30°C to 42°C,
the repressor is inactivated and the \ P promoter is
derepressed, thus initiating expression of the fusion protein.
Since no signal sequence is present, the fusion protein is not
exported and remains in the cytoplasm.
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Figure 7.3. Cloning in M13 mptacl8: analysis by agarose g
electrophoresis. Panel A. PCR amplification of Al/4 (lane 2),
(lane 3) and Hll (lane 4). Nucleic acid standards (lane 1) are fron
lambda Hindlll digest: 23, 9.4, 6.6, 4.4, 2.3, 2.0 and 0.6 kbp (ft
the top). Panel B. Mobility of ssDNA from selected plaques. >
mptacl8 (lane 1). Clones H2 to H9 (lanes 2 to 9). H9 did not grow,
and Hll (lanes 10 and 11) possessed slightly lower mobilities. Panel
Retardation assay of C2/2 ssDNA with H2 to H8, H10 and Hll ssDNA (lai
1 to 9). Retardation assay of A7/9 ssDNA with Hll ssDNA (lane 10) e
with C2/2 ssDNA (lane 11).
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Successfully isolated recombinants were cultured in larger
quantities for SDS-PAGE and immunoblotting analyses of total
cell lysate. Recombinants producing detectable amounts of
fusion MOMPs were further characterised for optimal conditions
of expression and the cellular location of accumulated rMOMPs.
Procedures were developed to isolate rMOMPs in quantities
sufficient for immunisation experiments in the future.
RESULTS
Cloning in M13 mptacl8
The M13 recombinant carrying the SstI MOMP insert, Al/4,
was used as a template for the polymerase chain reaction (PCR).
Typically, 10ng of the ssDNA vector was sufficient to generate
1000 ng or more of the insert material (1.3 kb) after 30 cycles
of amplification using 50 pmol of each primer (Figure 7.3A -
lane 2). To remove any potential 'ghost' bands (none detected by
agarose gel electrophoresis (AGE) and ethidium bromide staining)
and excess primers, preparative AGE was carried out and the 1.3
kb band excised. The insert was isolated by GENECLEAN (BiolOl,
USA), phosphorylated with T4 polynucleotide kinase and cleaved
with PstI to generate the downstream sticky end. The elaborated
insert was ligated into M13 mptacl8 vector cut with Smal and
PstI. This construct was transformed into competent E.coli
JM101 cells and plated out in top agar containing IPTG and Xgal.
Initial attempts to obtain an M13 mptacl8 recombinant
using IPTG and Xgal in the plating agar were not successful.
Transfection efficiency of E.coli JM101 cells was low.
Subsequently, IPTG and Xgal were omitted from the plating agar.
Selected plaques were picked and cultured for the preparation of
infectious phage, ssDNA and dsDNA. Single stranded DNA was
analysed by AGE and gel retardation assay for the MOMP gene
insert (Figure 7.3 panels B and C). Clone Hll was identified as
a recombinant with a ssDNA electrophoretic mobility in agarose
gel between that of Al/4 and the parent vector. In a gel
retardation assay, Hll was retarded by C2/2 and not by A7/9
(similar to Al/4 but lacking the iscoRI-Sstl fragment at the 3'
end of the SstI MOMP insert - see Figure 6.1) indicating that it
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was inserted in the correct orientation (Figure 7.3C lanes 9 and
10). Confirmation of the presence of the required insert was
carried out by using primers 288C and 612C in the PCR
amplification of Hll in comparison with Al/4 and a negative
(H10) control (Figure 7.3A lanes 3 and 4). DNA sequencing using
the 645C and 845C primers confirmed the orientation and showed
that the ligation of the insert into the vector sequence
carrying the promoter signal was in frame:
< Vector | Insert >
FcoRI SacI (Smal)Primer 288C
- Kpnl ---
ATG AAT TCG AGC TCG GTA CCC TTG CCT GTA GGG AAC CCA
Induction of the M13 mptacl8 recombinant, Hll
11 12
Infectious phage Hll at titres of 5x10 to 5x10 plaque
forming units per ml were obtained from culture supernatants.
This was used to infect TG-1 cells at a multiplicity of
infection of 100:1, 50:1, 10:1 and 1:1. Infected cells were
grown to logarithmic phase and then incubated overnight with and
without IPTG (final concentration 0.5 mM). Cells were harvested
by low speed centrifugation (6500g 5 minutes) and resuspended in
sample buffer for SDS-PAGE and immunoblot analysis. Initial
results did not show expression of MOMP gene product in
detectable quantities (data not shown). Consequently, the MOMP
gene was subcloned into plasmid expression vectors.
Cloning in plasmid expression vectors: pUC8, pRIT5 and pRIT2T
Constructs according to the strategy outlined in Figures
7.4 and 7.5 were made. Briefly, pUC8 was linearised with EcoRI
and treated with calf intestinal phosphatase to inhibit
recircularisation. Hll was cut with FcoRI and the 1.3kb insert
was isolated by preparative agarose gel electrophoresis and
purified by the GENECLEAN reagent. Treated vector and insert
were mixed in 3:1 molar ratio and ligated to give plasmid pD
that should code for the whole mature MOMP attached to several
p EcoRI Mspl BamHI
130
i i i
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Figure 7.4 Construction of pUC8 recombinants, pD, pE and pC
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residues of /?-galactosidase and of the MCS (Figure 7.4).
Similarly, FcoRI-restricted and phosphatased pRIT5 and pRIT2T
vectors were ligated with the 1.3kb insert to give plasmids pB
and pG respectively (Figure 7.5). Recombinant plasmid pC was
produced by cloning the 0.9kb BamHI-PstI fragment from Hll into
pUC8 vector cut with BamHI and Pstl. This Bamill-Pstl fragment
was also ligated into the compatible sites of pRIT5 and pRIT2T
to produce pA and pF respectively.
The construction of pE involved ligating the MspI-PstI
fragment from Hll into pUC8 vector cleaved with AccI and Pstl
(Figure 7.3). Restriction endonucleases AccI and MspI produce
sticky ends which are compatible. pRIT5 and pRIT2T do not
possess MspI compatible sites but carry a blunt end Smal
restriction site. pE also carries a Smal site a few bases
upstream of the Mspl/Accl insertion site. Consequently, pE and
the pRIT vectors were restricted with Smal and Pstl and the
relevant fragments isolated by preparative agarose gel
electrophoresis and recovered with GENECLEAN. Vector and insert
were ligated and produced hybrid sequences of protein A and MOMP
genes in the correct reading frame within plasmids pH and pi
respectively (Figure 7.4).
The DNA ligations were transformed into competent E.coli
strains using standard procedures (Chapter 2). Recombinants
based on pUC8 were selected by the loss of /3-galactosidase
activity on IPTG-Xgal agar plates; those based on the pRIT
vectors were selected for antibiotic resistance on ampicillin
agar plates. The recombinant plasmids were isolated by the
modified alkaline-SDS method (Chapter 2) and characterised by
restriction endonuclease analyses to determine the presence and
orientation of the MOMP inserts. Putative positive clones were
further characterised by the detection of rMOMPs using SDS-PAGE
and immunoblotting. The results are summarised in Table 7.1
and in the next two sections. Recombinant clones, pD5 and pC2,
were found to produce rMOMPs. Further analyses concentrated on
these two clones to optimise methods for purification.
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Figure 7.5 Construction of pRIT5 recombinants, pA, pB and pH
and pRIT2T recombinants, pF, pG and pi.
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Induction of expression in the pUC8 system
pD, pE, and pC were grown to OD-qo r^c^1 medium
(L-broth) containing 50 mg/ml ampicillin before induction with
0.1 mM IPTG for 1 hr. Total cell lysates were found to contain
extra polypeptide bands at 40kDa, 31kDa and 27kDa respectively
(Figure 7.6AB - solid arrowhead). In addition, the profile of
pE also possessed a 50kDa band (asterisked). Immunoblotting
showed that the 40kDa and 27kDa polypeptides were cross-reactive
with anti-MOMP polyclonal antibodies (Figure 7.6C). No clear
reaction was observed with the 31kDa or the 50kDa polypeptide.
Recombinant E.coli carrying plasmids pD and pC were
considered the most promising clones and were selected for
further characterisation. Phase contrast light microscopy of
both recombinants showed the presence of inclusion bodies as
large refractile ovoid aggregates located at the poles of E.coli
cells. Occasionally, these were found in the central region of
the rod, resulting in a bent-shaped rod. In mature cultures,
recombinant bacteria were observed to be filamentous and more
pleiomorphic, possessing large inclusion bodies at irregular
intervals along the length of each filament.
An initial experiment was performed to determine the
kinetics of expression. Results showed that rMOMP was expressed
in pD without induction with IPTG (ImM in L-broth). Yields were
not significantly better with IPTG induction. pC also produced
some rMOMP without induction but more was produced on induction
for 2h or 16h (overnight). These recombinant bacteria containing
rMOMP were subsequently used in the next experiment to determine
methods for purifying the rMOMPs (Figure 7.7).
Sonication for 5 minutes in a bath sonicator was
sufficient for lysis and release of rMOMP inclusions (Figure
7.1k). However, many E.coli components co-sedimented with the
rMOMPs at high speed centrifugation (13,000g for 10 minutes).
Low speed centrifugation (6500g 3 to 10 minutes) was also able
to sediment all rMOMPs from the supernatant containing soluble
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Figure 7.6 SDS-PAGE and immunoblot profiles of pUC8 recombinants.
Partially blotted (Panel A) and unblotted (Panel B) gel stained with
Coomassie Blue; autoradiogram of immunoblotted gel replica (Panel C).
Total cell lysates of chlamydial EBs (lane 1), and recombinant bacteria
carrying plasmids pD (lane 2), pE (lane 3), pC (lane 4) and pUC8 (lane
5) induced with IPTG. The M standards are marked in kDa. (Trypsinogen,
24kDa, was not used in the M estimations of rMOMPs because it was an
r
outlier in the calibration curve. Subsequent gels using other
standards confirmed the M of pC rMOMP as 26 to 27kDa.) A polyclonal
serum with predominantly anti-MOMP specificity (lane 1) was used for
the immunoblot analysis.
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Figure 7.7. Purification of rMOMP inclusion bodies from recombinant
E.coli carrying plasmids pD and pC: SDS-PAGE analyses of various
treatments. Panel A. Total cell lysates from clones pD and pC (lanes 3
and 7 respectively). These recombinant bacteria were sonicated (5
minutes in bath sonicator) and centrifuged (13,000g at 20°C for 10
minutes) to produce a pellet (lanes 4 and 8 respectively) and a
supernatant (lanes 5 and 9 respectively). M standards (lanes 2 and 6)
are 116, 93, 77, 67, 45, 30, 17 and 12kDa from the top.
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Panel B. The respective post-sonication pellets (Panel A lanes 4 and 8)
were resuspended and sampled for SDS-PAGE (lanes 2 and 6). In lanes 3
and 7, corresponding samples were not treated with 2-ME or boiled.
The resuspendates were centrifuged (6,500g at 20°C for 8 minutes) to
yield pellets (lanes 4 and 8) and supernatants (lanes 5 and 9). M
standards in lane 1 are the same as that in Panel A.
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Panel C. The post-sonication pellet (lane 2) as described for Panele-
and B was resuspended in PBE and centrifuged (6,500g for 3 minutes)
produce PBE I supernatant (lane 3) and pellet (lane 4). This was!
pellet was resuspended in PBE-1% Sarkosyl (PBES) and re-centrifuged
yield the PBES supernatant (lane 5) and pellet (lane 6). This pell"
was then resuspended in PBE-1M urea (PBEU) and similarly centrifuged
give the PBEU supernatant (lane 7) and pellet (lane 8). Finally t
PBEU pellet was resuspended in PBE and re-centrifuged to give the I—
II supernatant (lane 9) and pellet (lane 10).
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intracellular proteins (Figure 7.7B). Other contaminants,
presumably outer membrane components of E.coli and other cell
debris, which co-sedimented with the rMOMP inclusion bodies
could be washed off by resuspension in lOmM sodium phosphate
buffer pH7.4 containing 1 mM EDTA (PBE) followed by
re-centrifugation. Sequential washes with PBE, with PBE
containing 1% Sarkosyl and with PBE containing 1M urea were able
to reduce the level of background contamination (Figure 7.7C).
Alternatively, recombinant bacteria were treated with
lysozyme (1 mg/ml) in a Tris buffer (50mM pH 8.0) containing
lOOmM NaCl and ImM EDTA for 20 minutes at room temperature.
Spheroplasts thus formed were collected by low speed
centrifugation. Brief sonication (3x30seconds) of
lysozyme-treated bacteria was sufficient to release inclusion
bodies but this did not improve the quality of crude rMOMP
precipitate and introduced lysozyme as an additional protein
contaminant (data not shown).
It was also noted that the SDS-PAGE profiles of crude
rMOMP inclusion bodies resuspended in sample buffer with the
omission of reducing agent, 2-mercaptoethanol, and the boiling
step (Figure 7.7B lanes 3 and 7), were slightly different from
that of reduced and boiled material (Figure 7.7B lanes 2 and 6).
Several bands present in the profile of the reduced and boiled
sample were absent in that of unreduced and unboiled sample.
Instead, bands of significantly lower mobility appeared in the
latter. Unreduced and unboiled rMOMP, however, only migrated
slightly ahead of the reduced and boiled rMOMP.
Induction of expression in the pRIT5 system
Selected clones carrying the desired recombinant plasmid
grew to early stationary phase ^^600nm a^out 1) ri-ch medium
(L-broth) containing 50jlig/ml ampicillin in 4-5 h. Cells were
harvested and periplasmic proteins obtained by osmotic shock
treatment (see Chapter 2; manufacturer's instructions). The
periplasmic lysate was analysed by SDS-PAGE and immunoblotting
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Figure 7.8. Immunoblot analyses of Protein A fusion products
synthesised by recombinant clones pA and pB. Panel A is an
autoradiogram of a blot probed only with radio-iodinated rabbit
anti-sheep F(ab). antibodies. Panel B is an autoradiogram of the same
blot probed with polyclonal serum with strong anti-MOMP specificity
followed by radio-iodinated anti-sheep F(ab)2 antibodies. Key: Native
Protein A (lane 1), periplasmic fractions of pRIT5 (lane 2), pA4 (lane
3) and pB15 (lane 4), remaining cell pellet of the corresponding clones
(lanes 5 to 7 respectively). The standards are marked in kDa.
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(Figure 7.8). The SDS-PAGE profiles were very complex and
recombinant polypeptides could not be distinguished from host
cell components when compared with the control cells carrying
the parent plasmid, pRIT5 (data not shown). The recombinant
polypeptides were identified by immunoblotting using
radio-iodinated rabbit immunoglobulins.
Native Protein A (Sigma) from S.aureus strain Cowan I
migrated as several bands with the predominant band having an
apparent M of about 52 kDa (Figure 7.8 lanes 1). Truncated
Protein A expressed by the parent plasmid pRIT5 was associated
with the periplasmic fraction and produced a dominant
IgG-reactive band at approximately 29 kDa flanked by two minor
bands at 30 kDa and 27.5 kDa. Bands similar in mobility to the
triplet were also found in the periplasmic profiles of both pA
and pB. In addition, the profile of pA included a 32kDa band
and two other fainter bands at 53.5 kDa and 23 kDa (Figure 7.8
triangles). The two faint bands became slightly darker when the
blots were re-probed with anti-MOMP antibodies (Figure 7.8B
triangles). Additional bands in the profile of pB, however,
were all weak and some also became darker upon re-probing with
anti-MOMP antibodies (33kDa and 23kDa) . Faint reactive bands,
particularly those in the cell pellets, may represent
non-specific reactions as a result of prolonged exposure to
sheep anti-MOMP antibodies (lanes 5-7).
DISCUSSION
This chapter describes several approaches used to express
the MOMP gene from C.psittaci OEA strain S26/3. One viral
expression vector, M13 mptacl8, and three different plasmid
vectors, pUC8, pRIT5 and pRIT2T, were used. Of the ten
different expression constructs made, several which expressed
rMOMPs were chosen for further characterisation. One construct
(plasmid pD) codes for the complete mature MOMP fused at the
N-terminus to a short sequence (11 amino acids) of
/3-galactosidase and the multiple cloning site. It is the
second report, after Allan et al (1984), of the expression of a
complete mature chlamydial MOMP, and the first for C.psittaci.
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A truncated form of MOMP from plasmid pC was also successfully
produced. Amino acid residues 1 to 139 containing CD1, VD1, CD2
and a few residues of VD2 were deleted from this recombinant
polypeptide. These rMOMPs should be useful for future
investigations into the immunoprotective role of MOMP in ovine
enzootic abortion.
Cloning in expression vector M13 mptacl8
The first attempt at expression in E.coli using the M13
mptacl8 construct, Hll, was not successful. Despite attempts
to vary several parameters including the multiplicity of
infection, the duration of induction and the concentration of
the inducer, no expression was detected either by SDS-PAGE or
immunoblotting (data not shown). Nevertheless this attempt
resulted in the cloning of the MOMP gene insert into a multiple
cloning site with useful restriction sites flanking the desired
sequence. This sequence was thus easily manipulated into the
three plasmid expression vectors.
Expression of rMOMP using the pUC8 system
The characteristics of rMOMPs derived from the pUC8 system
for expressing "fusion" recombinants with a short segment of
/3-galactosidase sequence are given in Figure 7.4 and Table 7.1.
Both pD and pC expressed rMOMPs with M^ estimated in SDS-PAGE
gels, 40.3 and 26.7 kDa, which agreed very well with the
predicted values, 40.8 and 25.7 kDa, respectively. Both
rMOMPs cross-reacted in the immunoblot test with anti-MOMP
polyclonal antibodies showing that at least some antigenic
determinants have been reproduced. These determinants detected
by immunoblotting are probably linear, denaturation-resistant
and/or "renaturable" epitopes.
Owing to the lack of anti-MOMP monoclonal antibodies that
are directed to conformational epitopes, it was not possible to
determine if the rMOMPs coded for by pD and pC had refolded into
similar tertiary structures as the native MOMP. Initial
characterisation of the rMOMPs showed that in an unreduced
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state, the rMOMPs migrated in SDS-PAGE gels in a monomeric
form. This indicated that most recombinant polypeptides were
not cross-linked with each other, unlike MOMPs in the outer
membrane of EBs (Bavoil et al, 1984; Hatch et al, 1984). The
slightly higher mobility of unreduced rMOMPs compared to reduced
rMOMPs is indicative of a tighter conformation, suggesting the
possibility that intra-chain disulphide bonds may have formed
despite the lack of inter-chain bonding. Whether these
disulphide linkages are randomly paired or similar to that in
the native MOMP is not known. It may be possible, without
elucidating the disulphide linkage pattern of either the native
or recombinant MOMP, to obtain an idea of how similar these
linkages are by performing comparative limited proteolysis on
the unreduced purified polypeptides, and by analysing the
fragments under non-reducing and reducing conditions with
SDS-PAGE or liquid chromatography.
Bavoil et al (1984) have shown that MOMP from
C.trachomatis serotype L2 can be purified in a form which allows
its putative porin-like activity to be demonstrated in vitro. If
the proteolytic patterns of rMOMP and native MOMP are similar,
it may be possible to reconstitute rMOMPs into artificial
membranes, perhaps with the inclusion of chlamydial LPS to mimic
the native situation as far as possible. Such a model will be
useful for studying the relationship of structural domains of
MOMP with functions such as permeability and structural
rigidity, the interaction of MOMP with other outer membrane
components, as well as its folding pattern in the membrane and
possibly its high resolution structure.
With regard to the ultimate objective of determining
whether MOMP is an immunoprotective antigen in OEA, the initial
results showed that rMOMP polypeptides can be produced for
vaccine testing in far larger quantities and with considerable
ease compared to isolating MOMP from cell-cultured chlamydiae.
For example, typical yields of chlamydial organisms from six 25
ml Falcon flask monolayers range from 0.5 to 2 mg protein. Since
each EB contains an estimated 10-20% MOMP by mass, about 200 /ig
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to 400 /ig of MOMP can be purified from six monolayers at maximum
efficiency. The procedure typically requires 1 day for seeding
the inoculum, 3 days for IDU treatment, 4-7 days for the
chlamydial culture to mature, 1 day for harvesting and
purification, 1 day for detergent extraction, a total of 10 to
13 days. In contrast, an 0D^_.„ 0.4 culture of recombinantJ 600nm
E.coli yields up to 4000 /ig per 150 ml of rMOMP without optimis¬
ation. It takes 1 day for the overnight culture and 1 day for
the induction and the isolation of rMOMP inclusion bodies using
half the number of centrifugation steps and having no require¬
ment for ultracentrifuges.
Presently, rMOMPs from plasmid pD and pC are being
produced in milligram quantities for immunogenicity tests. If
antibodies that cross-react with native MOMP can be elicited,
these rMOMPs will be tested as potential recombinant subunit
vaccines in sheep. Both the complete rMOMP and the truncated
rMOMP when tested will also permit an assessment of the relative
importance of the N-terminus and C-terminus domains of MOMP in
immunoprotection.
It is not understood why the rMOMP of pE failed to react
with anti-MOMP antibodies. It is unlikely that an out-of-frame
ligation resulting from an illegitimate annealing of the AccI
and Mspl sticky ends could have produced the observed 31 kDa
rMOMP, a size close to the predicted 34 kDa, because stop codons
were present near the ligation site in the other two reading
frames. The origin of the additional band around 50kDa is not
known. Until DNA sequencing of the joint using primer 844C is
carried out, it would be premature to speculate about the
explanation for these observations. It should be noted that
pUC8 carries the fi- lactamase gene which codes for
pre-/3-lactamase of approximately 30 kDa in SDS-PAGE gels.
Expression of rMOMP using the pRIT system
The size of native Protein A has been estimated to be 42
kDa by gel filtration and 56 kDa by disc electrophoresis in
polyacrylamide gels containing 0.1% SDS (Bjork et al, 1972;
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Movitz et al, 1979). From the sequence data of Protein A (Uhlen
et al, 1984b and erratum), the mature protein contained 488
amino acids (and 36 amino acids as the signal sequence) giving a
calculated of 53,697 Da. SDS-PAGE estimates by Uhlen et al
(1984a) were in the range of 52 to 53 kDa. The result of 52 kDa
in this study agreed well with the electrophoretic results. It
is not known what the higher IgG-reactive bands in the
Protein A track in Figure 7.8 might be. Heterogeneity in
Protein A has been observed before (Uhlen et al, 1984a) but the
size variation is less than 10 kDa.
The recombinant E.coli HB101 cells carrying pRIT5, pA and
pB produced IgG-reactive bands in the periplasmic fraction and
not in the spheroplasts showing that the polypeptide chains of
the C-terminus truncated Protein A (tProtein A) and its fusion
products have been recognised as substrates for translocation by
the E.coli secretory apparatus. The signal sequence of 36 amino
acids (4 kDa), or similar size fragments, are probably cleaved
off in the process because the sizes of the tProtein A bands
produced by pRITS corresponded to the expected range (Table
7.1 and 7.2). Although alternative cleavage sites of the signal
sequence may have produced the triplet of tProtein A, Uhlen et
al (1984a) have suggested proteolytic degradation as a likely
explanation. While homogeneous species of full length tProtein A
are secreted directly into the medium by Gram-positive
staphylococcal strains, sequestration of such polypeptides in
the periplasmic space of E.coli may have resulted in exposure to
the action of periplasmic or membrane-bound proteases. Signal
peptides released into the periplasmic space by signal peptidase
in the process of translocation are known to be rapidly degraded
presumably by enzymes such as Protease IV, a membrane-bound
signal peptide peptidase (Novak and Dev, 1988 and references
therein). Recombinant polypeptides may be substrates for such
proteases.
The expected size of the fusion product from construct pA
was calculated to be 55.9 kDa (Table 7.2) which may be
represented by a weak band at 53.5 kDa on the blot profile.
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other bands at 32.5 and 23 kDa could be degradation products of
this putative fusion protein. However, the amount of fusion or
degradation products detected by SDS-PAGE or blotting was very low
compared to the bands at 30, 29 and 27.5 kDa. These appeared to
co-migrate with the tProtein A bands produced by the parent
plasmid pRIT5. The possibility that this pA E.coli preparation
may have been contaminated by clones bearing the parent plasmid
was thought to be unlikely because the original clone had been
re-streaked several times to ensure that a pure clone was
obtained. Further work is necessary to characterise these bands
which were also present in the pB recombinant.
It was not known why recombinants isolated from the pB
constructs were found to carry only inserts in the wrong
orientation when characterised by REA. Several had triple
inserts but none had the insert in the right orientation despite
screening nearly 60 colonies. These triple inserts were
arranged in the following orientation, wrong-right-wrong, and
resulted in a stop codon in the tProtein A reading frame as
shown in Table 7.2. The expected size of this recombinant
polypeptide is 31.5 kDa and may be represented on the blot by
the 33 kDa band not present in the pRIT5 lane (Figure 7.8).
The difficulty in characterising these recombinant
products was due to the lack of suitable probes which can
distinguish the presence of MOMP epitopes on putative fusion or
degradation products from the IgG-binding domains of Protein A.
Consequently, the construct pF, although successfully
isolated, was not re-transformed into E.coli N4830-1 cells for
the production of fusion polypeptides. Isolation of construct
pG was not attempted again after the initial failure to obtain
insert in the correct orientation (Table 7.1). Ligated plasmids
pH and pi were also not transformed into E.coli HB101 and N99cl+
cells respectively for the same reason.
Errors in the polymerase chain reaction
The polymerase chain reaction uses the Taq polymerase
which, unlike E.coli DNA polymerase I, does not possess a
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"proof-reading" 3'->5' exonuclease activity. Consequently, the
fidelity of replication is lower. Typical estimates of the
error rate range from 1 nucleotide per 800 bases (Dunning et al,
1988) to 1 per 2500 (Larrick et al, 1989). It is therefore
essential to sequence the coding region of the rMOMP plasmid
constructs to determine if the MOMP sequences have been
accurately replicated. In addition, the limited proteolytic
peptide profiles of the rMOMPs in comparison with that of the
native MOMP should provide some indication as to the degree
these rMOMPs have been properly transcribed and translated. (As
this thesis was being prepared, chymotryptic profiles of pD and
pC rMOMPs were obtained, showing an identical set or a subset of
bands to that of MOMP respectively.)
Potential application of the strategy to express other MOMPs
The experimental strategy, as exemplified by the
construction of Hll, demonstrated that MOMP sequence can be
amplified very conveniently and very quickly in quantity by PCR
for insertion into expression vectors. In that process, the
appropriate restriction sites (in the case of Hll, the PstI
site) can be engineered into the insert to facilitate subsequent
manipulation. Useful cloning sites can be tagged on by cloning
into the appropriate MCS of the plasmid vector (in the case of
pH and pi, relying on the MCS restriction site Smal of pE).
The success of the PCR in amplifying various MOMP
sequences for DNA sequencing (as discussed in Chapter 6) and for
expression (as described in this chapter) suggests that rMOMP
constructs derived from other strains of C.psittaci and
C.trachomatis can be readily made by a similar procedure. The
MOMP primers, 288C and 289C, have been used for the
amplification of MOMP sequences from nearly all C.psittaci
strains available in the institute (S.Baxter, personal
communication). Primer 612C was also successfully used for
C.psittaci strains, S26/3, A22 and CallO.
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From the comparison of various MOMP nucleotide sequences
displayed in Figure 6.5, it is likely that universal chlamydial
MOMP primers can be designed for PCR amplification of the MOMP
coding sequence of C.psittaci and C.trachomatis strains (see
Figure 8.1; Dutilh et al, 1989; Griffais and Thibon et al,
1989). Amplified sequences will contain the variable regions
characteristic of each strain which may be differentiated by
REA.
Signal sequence and recombinant MOMPs
Measures were taken as part of the overall strategy to
avoid the expression of the signal peptide so that the
recombinant MOMP product will not be a substrate for the
secretory apparatus of E.coli. It was thought that this may
circumvent any toxic effect related to the possible insertion of
rMOMPs into the outer membrane.
For secreted polypeptides in general, the signal sequence
binds the signal recognition protein (SRP) resulting in a
translational block at the ribosome until the complex binds the
'docking protein' which in turn catalyses the release of the
SRP-induced block (Walter et al, 1981). Removal of the signal
sequence may thus preclude any negative feedback mechanisms on
expression caused by saturation of the secretory system of host
E.coli. It may also result in the accumulation of recombinant
polypeptides within cytoplasmic inclusion bodies which may
facilitate subsequent purification.
Although the rMOMP constructs of the pUC8-based system do
not possess E.coli signal sequences, the additional N-terminus
residues partially originated from the N-terminus of
/3-galactosidase and partially corresponded to the MCS (Figure
7.4). These residues, MTMITNSSSVP, MTMITNSRGSV and MTMITNSR
(of pD, pE and pC respectively), however, do not possess even
the minimal structures for translocation across membranes
(Perlman and Halvorson, 1983; von Heijne, 1985) and,
therefore, were not expected to bind SRP. Indeed the data for
pD and pC confirmed that they were not exported.
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Purification of rMOMP inclusion bodies
It is generally thought that insoluble recombinant
proteins accumulate in E.coli in the discrete form of inclusion
bodies (Marston, 1987). Since MOMP occurs in the outer membrane
as a structural protein, its solubility was expected to be low.
The highly refractile inclusion bodies observed in recombinant
bacteria bearing pD or pC, but not in bacteria bearing the
parent plasmid, are very similar to those in the phase contrast
photomicrograph of Marston (1987). It is likely that these
inclusion bodies contained aggregates of rMOMP. The presence
of these inclusion bodies appeared to distort the normal
rod-shaped morphology of some bacteria. It is possible that the
large size of these bodies may also have interfered with the
normal processes of cell division, causing the formation of
undivided rods with a filamentous appearance.
Preliminary experiments in exploring useful methods of
purifying these aggregates indicated that sonication with or
without lysozyme pretreatment can release them for sedimentation
by low speed centrifugation. Washes in buffer can selectively
remove contaminating host material to yield sufficiently pure
rMOMP for immunogenicity tests. Further experiments will be
required to determine the optimum conditions and procedures for
a greater degree of purification. Since both recombinant
polypeptide chains appeared not to be covalently cross-linked to
each other by disulphide bridges, it may be possible to
solubilise these rMOMPs for further purification by liquid
chromatography. Purified products may be renatured in the
attempt to regain the native configuration of MOMP.
The ease with which large quantities of rMOMPs can be
produced suggests that the necessary amounts in a sufficiently
purified state can be achieved. This will enable further
experiments to determine the role and efficacy of MOMP in
protection against ovine enzootic abortion, which is the
main objective of this cloning exercise.
CHAPTER 8
GENERAL DISCUSSION
A summary of the findings of this project and the
reasoning behind the experiments that were carried out are
presented in this chapter. The significance of these findings
is also discussed from a broader perspective, in terms of
mechanisms of chlamydial pathogenesis, abortion and immunity,
of diagnosis and detection and of the molecular aspects of MOMP.
Ways of advancing research in the field of ovine enzootic
abortion are also suggested where appropriate.
SUMMARY
Identification of chlamydial antigens
With respect to the aim of identifying the antigens of OEA
isolates of C.psittaci as recognised by the ovine immune system,
an extensive list of nearly two dozen antigens out of more than
80 separate bands in SDS-PAGE has been compiled from
immunoblotting analyses of sera from sheep of different immune
status (Table 3.1). The more commonly visible bands included
high M antigens from 85kDa and above, a 60kDa antigen
(possibly the 60kDa cysteine-rich protein), a 50kDa antigen
(detected in OEA strains only), an immunodominant 39-40kDa
antigen corresponding to the MOMP in SDS-PAGE gels, and several
bands at 30kDa and 18kDa (possibly the adhesins).
A degree of variability in the specificity of the antibody
response among sheep of similar immune status was observed,
similar to the findings of McClenaghan et al (1986). A possible
explanation might be the previous exposure of such sheep to
other strains of C.psittaci such as intestinal strains which do
possess cross-reactive epitopes (Figure 4.2B). However, in ewes
that had been vaccinated with purified EBs and completely
protected against experimentally induced OEA, a strikingly
consistent and vigorous response to the putative MOMP was
detected. MOMP was thus implicated as an immunoprotective
antigen and a candidate for vaccine efficacy tests (Chapter 3).
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Biochemical characterisation of MOMP
Although the original aim was to characterise various
antigens of C.psittaci, subsequent work was thus focussed on
MOMP. At the close of this project, data had accumulated which
confirmed the identity of this putative immunoprotective antigen
as MOMP, such as its predominance in the outer membrane, its
susceptibility to proteolytic digestion, its surface exposure,
its ability to form disulphide-linked oligomers in vitro and
finally, its N-terminal amino acid sequence (Chapter 4). These
properties were consistent with the MOMP of all known chlamydial
strains. In particular, the N-terminus sequence was identical
to that of MOMP from C.trachomatis serovar L2.
Isolation of MOMP and assessment of vaccine efficacy
Some of these characterisation experiments showed that
MOMP could be highly enriched by a two-step detergent extraction
procedure modified after Caldwell et al (1981), Caldwell and
Schachter (1982) and Bavoil et al (1984) using anionic
detergent, Sarkosyl and reducing agent, DTT. Imnunoblotting
with convalescent sheep serum showed that this subcellular
preparation contained predominantly MOMP as the antigenic
molecule although LPS was also present. Electron microscopy
revealed that the preparation consisted mainly of membrane
fragments of fine knob-like particles arranged in an array which
appeared hexagonal at some locations. Such an appearance was
also detected on the OM of intact EBs. Other minor but
conspicuous structures were rosettes, some of which were
attached to membrane fragments (Chapter 4).
Since further attempts to solubilise this subcellular
preparation of MOMP with octylglucoside and to purify MOMP using
column chromatography resulted in very poor yields, the
two-step procedure was adopted for preparing MOMP for a
vaccination-challenge experiment in pregnant ewes. A further
advantage of this preparation was the ultrastructural evidence
that it contained MOMP in a native state. This feature was
thought vital at that stage of research because nothing was
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known about the nature of the immunoprotective epitopes in OEA.
This subcellular vaccine was tested with a purified EB
preparation identical to that which had initially led to the
identification of MOMP as the potentially immunoprotective
antigen. Results showed that both vaccines protected ewes from
infection and abortion in a single dose. Vaccinated ewes
produced a statistically significant improvement in the lamb
survival ratio compared with the control animals which were
sham-inoculated with a placebo vaccine containing uninfected
culture cells (Chapter 5).
Having demonstrated that the protective components of all
previous OEA vaccines resided on the EB outer membrane, it was
reasoned that MOMP, being the major component of the
preparation, is likely to carry immunoprotective epitopes. Much
evidence in the literature, already discussed in the discussion
sections of the appropriate chapters, supported this as a
reasonable hypothesis worthy of testing. One constraint was the
limited quantities of MOMP that could be obtained. A
recombinant DNA approach to express MOMP in E.coli was adopted
because it could facilitate the following. Firstly, if MOMP was
indeed immunoprotective, then it would be needed in large
quantities for probing the immune mechanisms operating in
chlamydial infections. Secondly, further manipulation of the
MOMP molecule to isolate and characterise the regions
responsible for eliciting such immune mechanisms may be
required. Thirdly, studies on the genetic regulation of such a
highly synthesised and developmentally critical protein as MOMP
will lead to a better understanding of the biology of
chlamydiae.
Sequencing and expression of the MOMP gene
A final and practical reason for adopting the recombinant
DNA approach was because the MOMP gene had been isolated and
cloned by then (Herring et al, 1989). The efforts of this
author were hence channelled towards the restriction mapping and
DNA sequencing of this gene for the purpose of devising ways of
expressing this gene in E.coli (Chapter 6). Partly as a result
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of the extensive analysis of the sequence in comparison with
other known chlamydial MOMPs, the procedures and strategies for
expressing recombinant MOMP were successfully carried out, as
detailed in Chapter 7. The sequence analyses showed that even
if MOMP were not immunoprotective, it is still of value as an
immunological probe because it contains variable domains
analogous to other chlamydial MOMPs which have been shown to be
antigenically important sites. Computer predictions also showed
the presence of potentially amphipathic a-helical regions in
MOMP, thought to be ideal candidates for T-cell epitopes.
Initial characterisation and purification studies showed
that rMOMP is produced in vast quantities compared to native
MOMP from chlamydial EB cultures. This would provide the
quantities of sufficiently pure MOMP needed for immunological
analyses such as enzyme-linked antibody assays and T-cell
proliferation assays, for isolating specific T-cell clones from
MOMP- or EB-vaccinated ewes, and for generating monospecific
anti-MOMP polyclonal or monoclonal antibodies.
Experiments need to be carried out to identify possible
ways of renaturing rMOMP. In this respect, efforts to
characterise the putative hierarchy of disulphide-linkages in
native MOMP are essential in the absence of mAbs recognising
conformational epitopes on native MOMP. A knowledge of this
pattern, which has so far not been assigned for any chlamydial
MOMP, will provide an assay criterion for the degree of
similarity of rMOMP to native MOMP. At the same time, such an
approach should also assist the elucidation of the
three-dimensional structure of MOMP in the native state.
The EM study in this thesis has correlated ultrastructure
with biochemical content and immunological characteristics.
Further work on optical diffraction and image enhancement of the
regular arrays of fine particles on the OM that was observed may
facilitate the determination of the folding pattern of MOMP in
the intact OM. This may provide vital clues as to how the
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various MOMP domains are involved in structural and permeability
functions that are critical in the developmental cycle of
chlamydiae.
This project has laid the foundation and provided the
tools for the probing the immune mechanisms operating in the
immunity of sheep to OEA strains of C.psittaci. It has also
provided the material for testing the hypothesis that MOMP is
necessary and sufficient for eliciting immunity in ewes.
Moreover, these possibilities also have important repercussions
for the wider field of C. trachomatis and Chlamydia TWAR
(C.pneumoniae) infections by providing in the sheep a model
system to study systemic, conjunctival, intestinal, synovial
and placental infection, "latency" or "persistence", lymph node
responses and lymphocyte traffic, humoral and cell mediated
mechanisms of immunity. Some aspects of the findings briefly or
not mentioned above are discussed in conjunction with broader
issues in the sections that follow.
THE DISEASE
Infectious cycle and characteristics of OEA
Buxton et al (in press) have recently suggested a probable
sequence of events during the infectious cycle of OEA strains of
C.psittaci. Susceptible ewes become initially infected by
ingesting and/or inhaling C.psittaci from a contaminated
environment during the previous or current lambing season
(Wilsmore et al, 1984b; Blewett et al, 1982). Infection is
established first in the tonsils (Jones and Anderson, 1988) and
may subsequently migrate via the lymph or blood to an unknown
site where it can exist in a "latent" or "persistent" state
(McEwen et al, 1951a; Munro and Hunter, 1981; Wilsmore et al,
1984b). Blood-borne chlamydiae may then gain access to the
placentome via the localised haemorrhages (haematomas - Figure
1.1) that occur naturally in the hilar zone of the placentome
from the 60th day of gestation. Around the 90th day of
gestation, the infection establishes itself at the placental
trophoblastic epithelia lining these haemotomas (Studdert,
1968) and gradually spreads to contiguous epithelia. Maternal
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and fetal immune systems respond to the chronic nature of the
infection. Eventually, the overwhelming infection results in
insufficiency of maternal-fetal transfer, fetal death,
abortion or premature birth of non-viable lambs. Ewes once
aborted, are immune to the disease in subsequent pregnancies
although they may continue to shed organisms (Stamp et al, 1950;
Aitken, 1983). However, it is not known if the shed organisms
are of the same strain as the causative organism.
Thus, ovine enzootic abortion differs in several aspects
from other well-studied human chlamydial infections such as
trachoma, genital disease and their respective laboratory animal
models in that infection only affects the pregnant ewe at a
specific stage of pregnancy, involves localised pathology that
results in abortion and provides lasting immunity against
reinfection in subsequent pregnancies. Infected pregnant ewes
are also relatively symptomless and do not appear to suffer
adverse effects before or after the abortion.
Mechanism of pathogenesis
With respect to the intriguing timing and localisation of
chlamydial pathology at the placenta, it seems plausible to
speculate that some host cell receptor whose expression is
coupled to the regulation of pregnancy may explain tropism and
the temporal behaviour of the infection. The initial
identification of chlamydial adhesins described in Chapter 4 may
provide some basis for further research on the identification of
host cell receptors that may be involved in mediating tropism.
Alternatively, it is speculated that the tissue tropism of the
OEA EBs may involve some metabolic aspect of trophoblastic cells
that favour chlamydial growth and replication.
Another possible explanation for the timing of placental
colonisation is that the complex balance between the apparently
quiescent organisms at some unknown location with the host
immune system is altered by the immunosuppression that is known
to occur during pregnancy. This may trigger the recrudescence of
infectious organisms which migrate to the placenta. The latter
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concept is attractive because it is already known that
gamma-interferon has bacteriostatic activity on the replication
of C.psittaci in macrophages (Byrne and Faubion, 1982; Byrne
and Krueger, 1983; Rothermel et al, 1983). As explained in
Chapter 1, bacteriostatic and bactericidal antibiotics,
although of therapeutic value in other chlamydial infections,
are not considered a viable approach against OEA. Hence, no
attempt will be made to discuss this topic except to pose
intriguing questions such as the following. If chlamydial
organisms do not possess peptidoglycan, where is the
alternative site of inhibition by penicillin? Are
penicillin-binding proteins involved and what are their
functions?
Mechanism of abortion
The mechanism involved in the induction of abortion in
ewes by OEA strains of C.psittaci is not clearly understood.
Since C.psittaci is a Gram-negative bacterium, the LPS that is
present in its outer membrane may be involved. Both smooth and
rough LPS have been shown to induce abortion in pregnant
laboratory animals (Zahl and Bjerknes, 1943; Rieder and
Thomas, 1960 and references therein). This endotoxin-induced
abortion can be prevented by antisera directed against LPS or
the Lipid A moiety of LPS but not by the polysaccharide moiety
(Rioux-Darrieulat et al, 1978). Moreover, antagonists of
serotonin such as chlorpromazine or methysergide can partially
prevent abortion suggesting that LPS may interrupt pregnancy by
inducing the release of serotonin or some related substance
(Parant and Chedid, 1964). This protection by serotonin
antagonists can be potentiated with anti-LPS antiserum
(Rioux-Darrieulat et al, 1978). Cortisone, however, did not
prevent endotoxic abortion in mice despite being highly
effective against endotoxic shock (Rieder and Thomas, 1960).
These data indicate that the toxic and abortive effects of LPS
may be mediated by different biological pathways.
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Ewes infected by OEA strains of C.psittaci do not exhibit
the classic symptoms of endotoxic shock. It is speculated that
the syndesmochorial placentation in sheep may limit the amount
of chlamydial LPS released into the circulation, thereby
reducing endotoxic reactions such as disseminated intravascular
coagulation (DIC), renal cortical necrosis and vasomotor
shock. Secondly, the infection appears to be chronic and does
not resemble the rapid onset of abortion brought about by
endotoxin in mice and rabbits (Zahl and Bjerknes, 1943; Rieder
and Thomas, 1960). Whether chlamydial LPS directly causes ovine
abortion awaits further investigations. It is possible,
however, that it plays only a minor role (if any) in a complex
chain of events leading to abortion and that the primary lesion
is caused by the colonisation and multiplication of infectious
EBs at the placenta.
A recent study of infected sheep during late gestation has
demonstrated that such lesions may cause changes in the pattern
of placental hormone secretion (Leaver et al, 1989). In
infected ewes compared to uninfected control ewes, progesterone,
which maintains pregnancy, declined prematurely while
oestradiol 1713 and prostaglandin E2, which stimulate uterine
responses at parturition, appeared much earlier. Interestingly,
oestradiol 17)3 and prostaglandin E2 have been demonstrated to
enhance the growth of C.trachomatis in cell culture (Bose and
Goswami, 1986; Sugarman and Epps, 1982; Ward and Salari,
1980). If this hormonal aspect of OEA proves important, then
any prophylactic agent should be targetted at a stage before
colonisation of the placenta to prevent abnormal changes in the
hormonal balance that favour chlamydial replication.
In contrast to OEA, the zoonotic infection of pregnant
women by ovine abortion strains of C.psittaci is acute, and
results in abortion and post-partal symptoms of DIC and renal
involvement (Chapter 1). It is reminiscent of the dual but
separate effects of endotoxin on pregnant laboratory animals
mentioned above. While it is not known whether chlamydial LPS is
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involved in abortion, LPS is likely to play a role in causing
DIC, although thromoboplastic products of degenerating tissues
at the site of infection may be a contributory factor (reviewed
by Lester and Roth, 1977; Wong et al, 1985; Johnson et al,
1985) . The spread of LPS endotoxin and thromboplastic material
is probably facilitated by the haemochorial placentation in
pregnant women. In this respect, the mAbs isolated with
anti-LPS activity (Chapter 4) may be further characterised to
compare or contrast their efficacies in preventing LPS-induced
or C.psittaci-induced abortion in a mouse model or in sheep.
IMMUNITY
Immune mechanisms
Little is known about the immune mechanisms operating in
post-abortion ewes that provide long-term protection against
subsequent abortion. Despite this, vaccines have been
developed and successfully used in the control of OEA (McEwen et
al, 1951b and 1955; McEwen, 1954; McEwen and Foggie, 1954 and
1956; Foggie, 1973). The immunity to OEA afforded by
vaccination is thought to last at least three years (McEwen and
Foggie, 1956) but annual vaccination is recommended for current
vaccines. Unfortunately, even less is known about how the
vaccine works.
Both humoral and cellular responses are known to occur
during infection (Huang et al, in press; Buxton et al, in press;
Wilsmore et al, 1984b; Dawson et al, 1986a and 1986b). CF
antibodies, however, are not thought to be involved in
immunity (McEwen and Foggie, 1954; Dawson et al, 1986b;
Buzoni-Gatel et al, 1987). Antibody specificities as
determined by immunoblotting do not provide evidence as to the
involvement of antibodies in protection but showed that
generally, post-abortion ewes carried a wider range of antibody
specificities compared to vaccinated ewes (Chapter 3). Although
serum neutralisation of OEA C.psittaci infectivity has been
demonstrated in vitro (I.E.Anderson, unpublished data), recent
data do not show any evidence that ammonium sulphate-
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precipitated antibodies from post-abortion ewes when passively
transferred to pregnant ewes can protect against challenge with
live organisms (G.E.Jones, personal communication).
With the availability of essentially unlimited amounts of
rMOMPs and the possibility of a high degree of purification, it
may be possible to overcome the problems of cross-reactivity and
effects associated with using LPS-containing whole organism
preparations in the DTH skin tests and lymphocyte transformation
(or proliferation) assays of Wilsmore et al, (1984) and Dawson
et al (1986a; 1986b). Such tests of the involvement of cell-
mediated immunity should form an adjunct to future
vaccination-challenge experiments involving rMOMPs or other
formulations.
Current experiments to assess the induction of lymphocyte
proliferation in vitro by fractionated chlamydial antigens
should shed light on the relative role of each antigen
(C.M.McCafferty and D.M.Haig, personal communication) but may
net indicate the importance of the cellular response in vivo.
Nonetheless, the role of each antigen may be correlated with the
immunoblotting data of this thesis, and potentially
immunoprotective antigens in addition to MOMP may be identified.
However, progress is hampered by the lack of sufficient
antigenic mass essential for such proliferation assays.
Computer algorithms predict that the MOMP sequence
contains T-cell epitopes (Chapter 6). Since T-cell responses do
not usually distinguish between native and denatured forms of a
protein (Gell and Benacerraf, 1959; Mills, 1986), the
non-native but biochemically defined rMOMP will be useful for
priming sheep lymphocytes and for selecting specific T-cell
lines. These cell lines can be characterised for function and
phenotype, and correlated with their protective efficacy in
transfer experiments described below. They can be further
characterised to identify the specific T-cell epitopes on the
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MOMP sequence by testing synthetic peptides of the predicted
sequences (Chapter 6) or a panel of truncated rMOMPs (such as
those described in Chapter 7) in in vitro proliferation assays.
Experimental transfer of cellular immunity of the type
performed by Buzoni-Gatel et al (1987) on mice will be difficult
but not impossible to perform on sheep although inbred sheep are
not available. Experimental sheep can be matched by haplotyping
or alternatively, ewes can be induced to produce identical
twins, triplet, quadruplet or quintuplet lambs for such
transfer of immunity (Smith et al, 1986). A sibling vaccinated
with purified EBs or subcellular MOMP preparations may be used
as a source of primed T-cells for transfer to the unimmunised
syngeneic sibling which can be mated and challenged with live
chlamydiae. Similarly, T-cells from post-abortion siblings may
be used. Phenotypic markers for ovine helper and
cytotoxic/suppressor T-cells are available and it is possible to
separate them by fluorescence-activated cell sorting (FACS) or
in larger numbers, by panning. Thus the role of each T-cell
sub-population may be analysed in sheep in a manner analogous to
the experiments of transferring cell-mediated immunity in mice
(reviewed by Williams, 1988 and Rank, 1988).
Potential sites of immunity
Vaccination or immunity acquired from a previous abortion
may inhibit chlamydial infection at the following stages:
induction of mucosal immunity to prevent the initial infection
at the tonsil or other sites; prevention of migration to unknown
site(s) of putative "latency"; suppression of recrudescence
from these sites; prevention of haematogenous migration to the
placenta; or bolstering of the humoral and cellular response at
the placenta to limit the multiplication and spread of
infectious EBs and to lessen the effects of pathology (Figure
1.2). It is presently premature to speculate about the relative
importance of each potential locus of action. Nevertheless, the
advent of highly sensitive techniques such as PCR (discussed
below) that can potentially detect single genomes, suggests the
possibility that some of these potential sites of action may be
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tested. The progress or lack of progress of chlamydial
infection as monitored by PCR detection may be compared in
susceptible, vaccinated and convalescent ewes.
Limitations of current vaccine
The minimum criterion for a satisfactory vaccine is the
ability to limit the extent of the pathology at the placenta or
to delay it sufficiently so that the ewe can give birth to
viable lambs. All early vaccines improved the lamb survival
ratio by reducing the number of abortions due to chlamydial
infection to levels which were acceptable to farmers. For
example, an early study involving 110 flocks showed the
reduction in incidence from 5 - 6% in unvaccinated flocks to 1 -
2% in vaccinated flocks (Littlejohn et al, 1952). Despite
extensive use, the vaccine does not eradicate the disease
within a flock (Aitken et al, 1986). It is possible that
current vaccines do not protect against infection and operate
close to the minimum criterion such that any reduction in
vaccine efficacy due to insufficient antigenic matter, change
in animal husbandry and stress, or slight antigenic variation
of the pathogen in the field, could easily lead to vaccine
breakdown. A potential alternative to the inactivated vaccine
is the temperature-sensitive live vaccine developed by Rodolakis
(Rodolakis, 1983; Rodalakis and Bernard, 1984) but its
usefulness or stability in the field has yet to be demonstrated.
In recent vaccination experiments (Anderson et al,
submitted; this thesis), various criteria of vaccine efficacy
have been used including placental infection, abortion rate and
lamb survival ratio. It should be noted that no adequate
criterion of infection can be obtained without a clearer
understanding of the stages of chlamydial infection in ewes.
Similarly, no criterion for quality assessment in commercial
vaccines is adequate so long as the critical antigens that
provide immunoprotection are not known.
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Current methods of titrating infectious EBs for vaccine
production suffer a drawback in that OEA C.psittaci EBs have a
strong tendency to aggregate. Assays using polyclonal
antibodies to whole organisms or the monoclonal antibody to LPS
(Chapter 4) are not useful because of the LPS activity. Unlike
LPS which can be over-produced and found on the membranes of the
infected cell, the MOMP content per organism is likely to be
fairly constant (Richmond and Stirling, 1981; Karimi et al,
1989). Whether MOMP is the immunoprotective antigen or not,
polyclonal antibodies raised against the rMOMP may be used as
assay for antigenic mass in the vaccine production of current
whole organism vaccines. Alternatively, the PCR technique can
be adapted in a quantitative assay to "count" genomes. Other
complications to the question of vaccine efficacy is the
problem of antigenic variation in the field which is discussed
next.
DIAGNOSIS, DETECTION AND TAXONOMY
Serological tests for diagnosis
Currently, there is no simple and reliable serological
test which can identify infections caused by ovine abortion
C.psittaci as opposed to infections caused by C.trachomatis,
Chlamydia TWAR (C.pneumoniae) or avian C.psittaci. The
limitations of a recent epidemiological survey on the extent of
zoonotic infection by OEA C.psittaci illustrates the problem
(Hobson and Morgan-Capner, 1988). The traditionally used
complement fixation (CF) test, which relies on
chlamydia-specific antibodies as serological markers of
infection, lacks sensitivity and specificity for OEA
C.psittaci. Presently, 40% of all sheep fetopathies are
undiagnosed. Whether these are caused by OEA C.psittaci is not
known. Another complication is that several serologically
cross-reactive but biologically different types of C.psittaci
can infect sheep. One aspect in the control of OEA thus appears
to be the development of better tests for distinguishing OEA
C.psittaci from other disease types as well as for identifying
susceptible or infected animals.
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5' end of MOMP ORF
S26/3 ATG AAA AAA CTC TTG AAA TCG GcA
A22/M ATG AAA AAA CTC TTG AAA TCG GcA
CAL10 ATG AAA AAA CTC TTG AAA TCG GcA
GPIC ATG AAA AAA CTC TTG AAA TCG GcA
L2 ATG AAA AAA CTC TTG AAA TCG GtA
A ATG AAA AAA CTC TTG AAA TCG GtA
B ATG AAA AAA CTC TTG AAA TCG GtA
C ATG AAA AAA CTC TTG AAA TCG GtA
UnivPri 5'-ATG AAA AAA CTC TTG AAA TCG G-3
5' end of processed MOMP
S26/3 tTG CCT GTa GGG AAc CCa GCT GAA CCA
A22/M tTG CCT GTa GGG AAc CCa GCT GAA CCA
CAL10 tTG CCT GTa GGG AAc CCa GCT GAA CCA
GPIC tTG CCT GTa GGG AAt CCa GCT GAA CCA
L2 cTG CCT GTg GGG AAt CCt GCT GAA CCA
A cTG CCT GTg GGG AAt CCt GCT GAA CCA
B cTG CCT GTg GGG AAt CCt GCT GAA CCA
C cTG CCT GTg GGG AAt CCt GCT GAA CCA
UnivPri 5'-YTG CCT GTR GGG AAY CCW GCT GAA CC-3'
3' end of MOMP ORF
S26/3 GCT CAC aTg AAt GCt CAA TTC aGa TTC TAA
A22/M GCT CAC aTg AAt GCt CAA TTC aGa TTC TAA
CAL10 GCT CAC aTg AAt GCt CAA TTC aGa TTC TAA
GPIC GCT CAC gTa AAc GCt CAA TTC aGa TTC TAA
L2 GCT CAC gTa AAt GCa CAA TTC cGc TTC TAA
A GCT CAC gTa AAt GCa CAA TTC cGc TTC TAA
B GCT CAC gTa AAt GCa CAA TTC cGc TTC TAA
C GCT CAC gTa AAt GCa CAA TTC cGg TTC TAA
Consen 5'-GCT CAC RTR AAY GCW CAA TTC MGV TTC TAA- 3
UnivPri 3'-CGA GTG YAY TTR CGW GTT AAG KCB AAG ATT- 5
Figure 8.1. Comparison of selected nucleotide sequences of
primers based on these sequences may be reasonably expected to
amplify any chlamydial MOMP. The ambiguity code used is based on
the IUB recommendations (Nomenclature Committee, 1985, European
Journal of Biochemistry, 150, 1-5). Consen = consensus. UnivPri=
universal primer. C.psittaci strains are S26/3 (OEA), A22/M
(Pickett et al, 1988a), CallO meningopneumonitis strain and GPIC
guinea pig inclusion conjunctivitis strain (Zhang et al, 1989a).
C.trachomatis strains are serotypes L2 (lymphogranuloma venereum
strain), A, B and C (Stephens et al, 1986; 1988b).
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Antigens useful for serological tests should not contain
genus- or species-specific epitopes, thus ruling out LPS and
MOMP. The 50kDa antigen of OEA C.psittaci appears to be
specific to OEA isolates (Figure 4.2B) and should be further
investigated for its potential as a serological marker. However,
such potentially type-specific antigens may not elicit a
detectable antibody response at the time of serum sampling.
Nevertheless, work is in progress to develop a competitive
ELISA using type - specific monoclonal antibodies directed against
OEA MOMP (J.Dooley, personal communication). Recombinant MOMPs
specifically designed to contain desired epitopes should provide
useful antigenic material for future development of such tests.
MOMP and MOMP gene as a locus for taxonomy and detection
MOMP is a useful locus for taxonomic classification of
Chlamydia spp. It is present in all types of chlamydiae. Each
MOMP bears distinctive epitopes at various taxonomic levels
which have their basis in the pattern of variation and
conservation within the amino acid sequence of the protein and
hence, in the nucleotide sequence of the gene (Chapter 6 and
references therein). Fortuitously, the conserved sequences
flank the variable sequences thereby allowing the possibility of
PCR amplification of the variable gene sequences using a limited
set of oligonucleotide primers. Recently, Dutilh et al
(1989) have amplified short
segments of conserved sequences of C.trachomatis MOMP genes.
Figure 8.1 shows a set of 'universal' primers that may be used
for amplifying any MOMP gene.
More recently, S.Baxter (PhD thesis in preparation) has
shown that amplified MOMP gene sequences can be analysed by
restriction endonuclease profiling, by Southern blot
hybridisation using specific probes, or by DNA sequencing. A
classification table of such nucleotide sequence data for each
chlamydial strain may be quickly built up. Furthermore, the PCR
technique is extremely sensitive, often reaching the ultimate
in detection by amplifying single molecules of DNA. Tests may
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be performed on material obtained from swabs, mouth rinses,
bodily secretions and excretions without having to culture the
organism (reviews by Bell, 1989; White et al, 1989).
The expression work described in this thesis illustrates
the possibility of cloning other PCR-amplified MOMP sequences
into expression vectors to produce polypeptides. By designing
the appropriate primers tailed with restriction sites, the VSs
of new strains can be cloned into expression vector systems such
as the pRIT Protein A fusion system. Recombinant polypeptide
bearing specific epitopes of the corresponding VD attached to
Protein A can be conveniently purified and chemically or
enzymatically cleaved to produce MOMP peptide epitopes for
antibody detection in an ELISA system that can also type the
chlamydial infection.
Such is the versatility and power of the PCR method that
if a standard protocol can be agreed upon and adopted by various
workers in this field, an additional basis of chlamydial
svstematics providing a comprehensive classification of diverse
C.psittaci isolates can reasonably be expected in the near
future. The functional and immunological significance of MOMP
suggest that a classification based on the MOMP gene may provide
a useful indicator of host specificity, the type of disease
caused or the degree of cross-protection of vaccines.
Variation in OEA C.psittaci
Despite indications of limited cross-protection in sheep
(Aitken et al, 1981) and in mouse models (Russo et al, 1979;
Johnson and Clarkson, 1986), OEA isolates of C.psittaci do not
appear to be distinguishable by the following criteria:
virulence and cultural characteristics (Anderson, 1986a;
1986b); SDS-PAGE, immunoblot and restriction endonuclease
profiles (McClenaghan and Herring, in preparation; Chapters 3
and 4; McClenaghan et al, 1984); MOMP gene sequencing, Southern
hybridisation and hybrid duplex RNA analysis (S.Baxter, PhD
thesis in preparation). Thus the basis of variation, if any,
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OmpA MOMP BRHO PhoE OmpF OmpC NGO:
N= 346 389 262 351 362 368 326
Ala 37 54 30 31 34 29 33
Cys 2 7 0 0 0 0 0
Asp 22 21 10 31 27 32 17
Glu 13 11 11 14 14 11 13
Phe 9 18 13 21 19 19 15
Gly 38 30 26 37 49 48 37
His 5 4 0 1 1 1 12
He 16 22 15 14 14 10 7
Lys 19 20 7 25 19 17 22
Leu 23 35 39 23 23 27 20
Met 6 7 10 9 5 4 2
Asn 19 19 3 27 32 32 16
Pro 19 17 12 3 5 4 6
Gin 17 13 4 17 13 21 15
Arg 13 13 7 12 12 13 16
Ser 16 25 14 21 16 17 24
Thr 23 30 19 24 22 24 19
Val 27 21 23 16 26 25 29
Trp 5 10 8 3 2 4 5
Tyr 17 12 11 22 29 29 18
Table 8.I.. Composition of prokaryotic outer membrane proteins
(precursor proteins). OmpA, PhoE, OmpF and OmpC are E.coli
outer membrane proteins. The composition of bacteriorhodopsin
(BRHO) of Halobacterium halobium and OmpI of Neisseria
gonorrhoeae (NGOmpI) are also displayed with MOMP of C.psittaci
S26/3.
remains to be determined in order to facilitate epidemiological
studies into the incidence of OEA and to determine the valency
and composition of improved vaccines.
MAJOR OUTER MEMBRANE PROTEIN
Structure and Function of MOMP
Transmembrane proteins may be categorised by the nature of
the membrane-spanning segments in relation to other protein
domains (Paul and Rosenbusch, 1985 and references therein). For
example, cytochrome b5 has soluble domains anchored to the
membrane by a short peptide while others such as glycophorin
possess two soluble domains separated by a single
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membrane-spanning peptide. Yet others like the reaction centre
of photosynthetic bacteria possess more bulky membrane-spanning
domains. Outer membrane proteins in bacteria such as
bacteriorhodopsin and enterobacterial porins OmpF, OmpC and PhoE
are subclasses of compact transmembrane proteins where the
polypeptide chain is thought to traverse the membrane several
times, exposing only small peptide segments to the surface. The
porins are very hydrophilic and possess a high degree of /3-sheet
structure. The polypeptide chain of PhoE, for example, is
thought to traverse the OM in an anti-parallel (3-sheet pattern
exposing eight segments to the cell surface, each segment about
40-45 residues long (van der Ley et al, 1987a; 1987b and
references therein). By contrast, bacteriorhodopsin is highly
hydrophobic, possesses a completely a-helical structure with
seven hydrophobic helices forming the transmembrane segments
(Engelman et al, 1980).
MOMP, itself possessing porin-like function, appears to
resemble these porins of Enterobacteriaceae in amino acid
composition (Table 8 .■$.) . These porins have in the 36 to
45kDa range (Hall and Silhavy, 1981 - review). Their signal
peptides are of similar length, 20-21 residues with 2 to 3 Lys
residues at the N-terminus. Enterobacterial porins, for
example, exist as trimers; different porins can also form
hetero-trimers (Gehring and Nikaido, 1989). OmpF forms a
regular two-dimensional array on the surface of the OM,
reminiscent of the ultrastructure of the MOMP-enriched OM
preparations (Chapter 4). Comparison of PhoE of different
enterobacterial species showed that they possessed 4 variable
domains but much smaller in length than and located differently
from the MOMP VDs (van der Ley et al, 1987a).
While MOMP may possess many features of porins, it
also performs a vital structural role in the chlamydial OM,
analogous to the peptidoglycan of other Gram-negative bacteria.
E.coli porins, OmpF, OmpC and PhoE, and Neisseria gonorrhoeae
protein I (major outer membrane protein/porin) (EMBL databank)
do not possess cysteine residues whereas E.coli OmpA, a
Chapter 8 General Discussion 218
structural OM protein possesses two (Morona et al, 1984). These
porins are passive diffusion channels whereas the permeability
function of MOMP appears to be regulated by redox potential.
Although up to about five major outer membrane proteins
are present in the OM of E.coli (Hall & Silhavy, 1981), MOMP is
pre-dominant in the OM of C.psittaci and is thought to be
involved in a supramacromolecular network of disulphide linkages
with other chlamydial cysteine-rich proteins (CRPs). It seems
reasonable to suggest that MOMP is a fairly unique OM protein
that combines structural and permeability functions. It is
likely that MOMP is a porin that has been adapted to perform a
structural role. Evidently, the structure-function
relationship of this intriguing protein deserves a closer
examination. In this respect, the availability of the MOMP
gene cloned into an E.coli plasmid vector facilitates the
construction of porin-MOMP hybrids which may reveal the
functional aspects of the MOMP sequence (see van der Ley et al,
1987b). Comparative renaturation and reconstitution of MOMP,
rMOMP and its truncated versions as porins in artificial
vesicles may possibly be used to identify the channel forming
sequences in the polypeptide chain. Detergent extraction,
analysis of the solubilised components and cross-linking
experiments of the type reported by Birkelund et al (1988) may
reveal the molecular composition and architecture of the OM.
Immunogenicity of MOMP and vaccine development
While it is clear that MOMP possesses many B-cell epitopes
of different specificities, there is no experimental evidence
for the presence of T-cell epitopes on MOMP. The demonstration
of T-cell epitopes on the MOMP sequence is important because
these epitopes may stimulate helper T-cells in vivo (Chapter 6 -
discussion). Helper T-cell immunity is necessary not only for
the initial antibody response but is also essential for an
anamnestic (memory) response to the relevant B-cell epitopes.
Additionally, the specific helper T-cell may possess cytolytic
activity on antigen-bearing cells expressing class II major
histocompatibility complex (MHC) molecules (Berzofsky et al,
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1987). Identification of such epitopes in MOMP or other
antigens by the methods described earlier in this chapter may
result in the inclusion of such epitopes in improved vaccines.
Moreover, some cytotoxic T-cell epitopes of influenza virus
nucleoprotein have been predicted using the "Rothbardian" motifs
described in Chapter 6 (Bastin et al, 1987), suggesting that
some of the predicted epitopes on MOMP may also stimulate MHC
class-I-restricted cytotoxic T-cell activity. An efficient
cytotoxic T-cell response is generally thought to be required
for the clearance of persistently infected cells in viral
infections and may be
important in chlamydial infections.
The general trend in the quest for a vaccine against
C.trachomatis infection has been to locate specific MOMP
sequences recognised by protective mAbs and to synthesise them
either chemically (Conlan et al, 1988 and 1989) or by
recombinant techniques (Baehr et al, 1988; Stephens et al,
1988b; Pickett et al, 1988b) as target antigens for synthetic
peptide or recombinant subunit vaccines. The motivation for
this selectiveness originates from the findings of early vaccine
trials in man and primate models. These indicate that immunity
is serovar-specific but short-lived while immunopathological
reactions upon reinfection are genus-specific (Wang et al, 1967;
Mordhurst, 1967; Grayston et al, 1985 - review). However,
recent data show that purified MOMP does not induce deleterious
ocular DTH responses in experimental monkeys (Taylor et al,
1988) and that a 57 kDa genus-specific antigen is likely to be
responsible (Morrison et al, 1989).
The approach in the case of OEA has been different. It is
possible to trace a logical progression of vaccine development
beginning with crude whole organisms from infected tissues, egg
culture and cell monolayer culture to the purified EB and the
subcellular OM fraction of this thesis. The protective
components of the EB has thus been narrowed down from more than
a dozen antigens to a few including MOMP located in the OM. The
next step would be to test individual antigens, particularly
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MOMP, as subunit vaccines. The cloning and expression of the OEA
MOMP gene is expected to facilitate the testing of the
hypothesis that MOMP bears immunoprotective B- or T-cell
epitope(s). If MOMP is indeed immunoprotective, modification
of the MOMP gene constructs to express selected domains of MOMP
can be conveniently performed. This would allow the critical
epitopes to be identified, if necessary, for the development of
peptide vaccines. At the same time, novel and improved methods
of presenting immunogens to the ovine immune system form an
important part of vaccine design. In this respect, the
recombinant plasmids, pD and pC, have recently been
transformed into Salmonella typhimurium aroA mutants which are
known to be useful carriers of foreign antigens that can elicit
humoral and cellular immune responses (Brown et al, 1987).
Initial data showed good expression of rMOMP (J.J.Oliver,
A.J.Herring and S.Dunbar, personal communication).
It is envisaged that testing such vaccines in the well
established situation of OEA will not only result in improved
OEA vaccines but will also converge with and contribute to the
research in tackling the serious and relatively complicated
disease situations of blinding trachoma or sexually
transmissible diseases caused by C. trachomatis.
CONCLUDING REMARKS
Although it has been nearly 40 years since the causative
agent of OEA has been identified as C.psittaci, much still
remains to be known about the pathogenesis of the disease. The
immune mechanisms responsible for protection in post-abortion or
vaccinated ewes are presently not understood although both
antibody and cell-mediated responses are thought to be involved.
The reasons for the re-emergence of the disease in the past two
decades are not clear. The characterisation of the antigenic
structure of OEA C.psittaci has been initiated only in recent
years. The work reported in this thesis has extensively
catalogued the antigens of the organism and provided the basis
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for further characterisation of individual antigens to identify
their function and their possible involvement in immunity. In
particular, this project has carried the work of characterising
MOMP, a dominant antigen strongly implicated as having
immunoprotective properties, to the point where it can be
tested for vaccine efficacy in the form of a recombinant subunit
vaccine.
From the sequence analyses and other data, it was
inferred that MOMP is a mosaic of B-cell and T-cell epitopes,
and rMOMPs would provide the important tools for probing the
immune mechanisms that are responsible for protection.
Moreover, the introduction of the PCR technique into the field
of chlamydiology has opened up exciting possibilities in the
taxonomy and typing of C.psittaci isolates, in the detection of
chlamydial organisms and the definition of the pathogenetic
events of OEA, and in the manipulation of the MOMP gene and the
manufacture of specific polypeptide segments.
Finally, it is hoped that research will continue in the
characterisation of MOMP and other chlamydial antigens
identified in this project and to relate the fascinating
structures observed in the outer membrane preparations to their
function in the biology of chlamydiae. An increasing
understanding of chlamydiae and the diseases they cause will no
doubt establish the basis for rational design of chlamydial
vaccines in the future. With regard to OEA, better vaccines
will not only increase sheep production but will also lead to
the improved health and well-being of the sheep and the sheep
farming community.
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APPENDIX 1: NUCLEOTIDE AND AMINO ACID SEQUENCE SYMBOLS
The letter codes for amino acids and nucleotide ambiguity proposed by
the International Union of Biochemistry (IUB) (Nomenclature Committee,
1985, Eur. J. Biochem., 150: 1-5) were used in this thesis. Occasionally,






M A or C aMino group
R A or G puRine
U A or T Weak hydrogen bonding
S C or G Strong hydrogen bonding
Y C or T pYrimidine
K G or T Keto group
V A or C or G not T V follows T and U
H A or C or T not G H follows G
D A or G or T not C D follows C
B C or G or T not A B follows A
N G or A or T or C aNy
Amino acids Back translation
A Ala Alanine GCT,GCC,GCA,GCG GCX
B Asp,Asn GAT,GAC,AAT,AAC RAY
C Cys Cysteine TGT,TGC TGY
D Asp aspart(D)ic acid GAT.GAC GAY
E Glu Glutamic acid GAA,GAG GAR
F Phe ph(F)enylalanine TTT,TTC TTY
G Gly Glycine GGT,GGC,GGA,GGG GGX
H His Histidine CAT,CAC CAY
I I le I so Ieucine ATT,ATC,ATA ATH
K Lys lysine (K before L) AAA,AAG AAR
L Leu Leucine TTG,TTA,CTT,CTC,CTA,CTG TTR.CTX,YTR.YTX
M Met Methionine ATG ATG
N Asn asparagiNe AAT,AAC AAY
P Pro Proline CCT,CCC,CCA,CCG CCX
Q Gin g(Q)lutamine CAA,CAG CAR
R Arg aRginine CGT,CGC,CGA,CGG,AGA,AGG CGX,AGR,MGR,MGX
S Ser Serine TCT,TCC,TCA,TCG,AGT,AGC TCX,AGY,WSX
T Thr Threonine ACT,ACC,ACA,ACG ACX
V Val VaIine GTT,GTC,GTA,GTG GTX
W Trp tr(W)ptophan TGG TGG
X Xxx unknown XXX
Y Tyr tYrosine TAT,TAC TAY
z Glu,Gin GAA,GAG,CAA,CAG SAR
* End terminator TAA,TAG,TGA TAR,TRA,TRR
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. SUMMARY
The major outer membrane protein (MOMP)
ene from an ovine abortion strain of Chlamydia
sittaci (S26/3) has been cloned and sequenced,
'he gene shows the features of other chlamydial
JOMPs but comparison with the previously re-
orted sequence for the ovine abortion isolate
,22/M has revealed substantial sequence diver-
ence which is clustered into the same four in-
amolecular regions as the sequence variation
)und between C. trachomatis serovars. Subse-
uent restriction enzyme analysis of A22/M DNA
as shown that it has an avian-type genomic pro¬
le and thus the comparison is between types
ither than between strains.
INTRODUCTION
Enzootic abortion of ewes (EAE) is the most
revalent infection causing lamb loss in the UK
id is due to infection with Chlamydia psittaci [1],
he disease was controlled for many years by an
trrespondence to: A.J. Herring, Moredun Research Institute,
t8 Gilmerton Road, Edinburgh EH17 7JH, U.K.
inactivated vaccine but recently has re-emerged as
a problem thereby focusing attention on the im¬
mune mechanisms and possible strain variants
involved in the infection [2,3]. It is also now
established that the EAE strain can cause abortion
in women [4] which lends further importance to
the study of this pathogen.
The species C. psittaci is a diverse grouping
within which, until recently, types have been de¬
fined only by their origin of isolation and biologi¬
cal properties. A recent DNA/DNA reassociation
study has shown substantial differences within the
group suggesting that separate species status for
some types may be applicable [5]. Restriction en-
donuclease (RE) analysis [6,7], micro-im-
munofluorescence (MIF) [8], and monoclonal an¬
tibody studies [9,10] have also been used to dem¬
onstrate variation.
Studies on the human pathogen C. trachomatis
have shown that variable epitopes which de¬
termine the serovars defined by the MIF test
reside in the major outer membrane protein
(MOMP) [11] and that antibodies to this protein
can neutralise chlamydial infectivitiy both 'in vitro'
and 'in vivo' [12,13]. This dual involvement of
MOMP in both immunity and strain variation has
prompted us to clone and sequence the MOMP
gene from an EAE strain.
>78-1097/89/$03.50 © 1989 Federation of European Microbiological Societies
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3. MATERIALS AND METHODS
3.1. Sources of chlamydial DNA
Several of the strains used in this work, includ¬
ing C. psittaci S26/3 used as the source of DNA
for cloning, have been described previously as has
the method for DNA extraction [6]. S57/3 is a
more recent abortion isolate from the same farm
as S26/3. A22/M DNA was the kind gift of Ian
Clarke, Southampton University.
Two overlapping plasmid clones (pUC-18)
which separately contain the 5' and 3' ends of the
MOMP gene from C. trachomatis serovar L2, to¬
gether with flanking sequences covering a total of
2.35 kb, were the kind gift of Richard Stephens,
University of California, San Francisco.
3.2. Nucleic acid manipulations and cloning
Restriction endonucleases, T4 DNA ligase and
calf intestinal phosphatase (CAP) were obtained
from Boehringer Corporation (London) Ltd. or
Gibco BRL Ltd. (Paisley, Scotland) and used as
recommended by the manufacturer. DNA frag¬
ments from agarose gels were recovered using
'Geneclean' (BiolOl, Calfornia) and labelled with
12P by the random priming procedure [14], 'South¬
ern' transfers and hybridisations were carried out
as described by Meinkoth and Wahl [15] using
'Hybond N' membranes (Amersham Int., U.K.).
Genomic library construction in the bacterio¬
phage A. vector EMBL-3 was carried out by the
methods described by Kaiser and Murray [16]. A
partial Mbo-1 digest of S26/3 DNA was treated
with CAP and ligated into RaraHI-digested vec¬
tor. After packaging and initial growth in E. coli
strain C600, recombinants were selected by growth
on E. coli strain Q359 r~ mjj" su(j 80RP2, a P2
lsyogen. The library was then screened with the L2
MOMP DNA probes using standard methods [17],
Sub-cloning into bacteriophage Ml 3 vectors
mpl8 and mpl9 using E. coli strain JM101 as a
host was performed as described by Messing [18]
using DNA fragments recovered from agarose gels.
Subsequent sequencing was performed using the
dideoxynucleotide chain termination method [19]
using [35S]dATP (Amersham Int. Ltd., U.K.) as a
label.
4. RESULTS AND DISCUSSION
The C. psittaci MOMP gene was identified 1
first constructing a genomic library with S26,
DNA in EMBL-3 and screening with two DN
probes spanning the whole C. trachomatis I-
MOMP gene. It had been previously demo
strated that, while there is less than 10% relate
ness between the two chlamydial species, there a
conserved regions in the MOMP gene [20].
single clone was identified which reacted wi
both probes. Subsequent blotting studies shows
that this hybridisation could be localised to a 2
kb Sst-1 fragment. This fragment was then su
cloned into M13 mpl9 to avoid problems
plasmid instability encountered previously wi
this gene [21]. The resulting clone was mappt
using several restriction enzymes compatible wi
the polylinker cloning sites and further sub-clont
into M13, mpl8 and mpl9 for sequencing.
The deduced nucleotide sequence for stra
S26/3 and its translation are shown in Fig. 1. T1
sequence shows the features previously demo
strated for the MOMP gene [22], These inclui
typical promoter elements (although with a long
spacing between the cognate elements than
found in E. coli), an open reading frame of tl
expected length, containing 7 cysteine residue
and an inverted repeated with a structure simil
to that of typical rho-independent transcriptic
terminators (inverted repeat followed by 8 T r
sidues) [23]. Provisional analysis upstream of tl
first promoter region has confirmed the presen
of a double promoter as reported for C. trachom
tis [24] (data not shown).
The first C. psittaci MOMP sequence was r
ported by Pickett et al. for strain A22/M, al
designated as an ovine abortion isolate [25]. Th
the S26/3 sequence is shown in Fig. 1 aligm
with that of A22/M. The variation between S26,
and A22/M at the amino acid level is shown
Fig. 2 which also includes data for the L2
trachomatis MOMP [22]. There is substantial co
servation evident in the three sequences especial"
at the amino and carboxyl termini of the C. ps
taci genes. However, in the central part of tl
molecule there are 4 regions in which S26/3 ai




•35 REGION -10 REGION SO
ACTTGGACGTG GrGCCG CCAGAAGAGCAAATTAGAATAGCGAG CACAAA AAGAAAAGATACTAAGCATAATCTTTA GAGG TGAGT
S26/3
A22/H
Met Lys Lys Leu Leu Lys Ser Ala Leu Leu Phe Ala Ala Thr Gly Ser Ala Leu Ser Leu Gin Ala Leu Pro
ATG AAA AAA CTC TTG AAA TCG CCA TTA TTG TTT GCC GCT ACQ GGT TCC GCT CTC TCC TTA CAA GCC TTG CCT
S26/3
A22/M
Val Gly Asn Pro Ala Glu Pro Ser Leu Leu He Asp Gly Thr Met Trp Glu Gly Ala Ser Gly Asp Pro Cys
GTA GGG AAC CCA GCT GAA CCA ACT TTA TTA ATC GAT GGC ACT ATG TGG GAA GGT GCT TCA GGT GAT CCT TGC
S26/3
A22/M
27 Asp Pro Cys Ser Thr Trp Cys Asp Ala lie Ser lie Arg Ala Gly Tyr Tyr Gly Asp Tyr Val Phe Asp Arg
145 GAT CCT TGC TCT ACT TGG TGT GAT GCT ATC AGC ATC CGC GCA GGA TAC TAC GGA GAT TAT GTT TTC GAT CGT
51 Val Leu Lys Val Asp Val Asn Lys Thr He Thr Gly Met Gly Ala Val Pro .. Thr Gly Thr Ala
S26/3 217 GTA TTA AAA GTT GAT GTG AAT AAA ACT ATC ACC GGC ATG GGT GCA GTT CCT ... ACA GGA ACC GCA
A22/M 217 T T G C AC ACG CAG GCT T A
72 Ala Ala Asn Tyr Lys Thr Pro Thr Asp Arg Pro Asn He Ala Tyr Gly Lys His Leu Gin Asp Ala Glu
S26/3 280 GCA GCT AAT TAC AAA ACT CCT ACG GAT AGA CCC AAC ATC GCT TAC GGC AAA CAC TTA CAA GAC GCC GAA
A22/M 289 AGT AAT A C G CC GAA G A AT GC G A GG T A G T A G
95 Trp Phe Thr Asn Ala Ala Phe Leu Ala Leu Asn He Trp Asp Arg Phe Asp He Phe Cys Thr Leu Gly Ala
S26/3 349 TCG TTC ACC AAT GCA GCT TTC CTC GCA TTG AAT ATC TGG GAT CGC TTT GAT ATT TTC TGC ACA TTA GGC GCT
A22/M 361 T T A C A C A C T C C C G A
119 Ser Asn Gly Tyr Phe Lys Ala Ser Ser Ala Ala Phe Asn Leu Val Gly Leu He Gly Val Lys Gly ... Ser
S26/3 421 TCT AAT GGG TAC TTC AAA GCT AGT TCT GCG GCA TTC AAC CTC GTT GGT TTG ATT GGT GTT AAA GGA ... TCC
A22/M 433 C A T A G T T G A A G T TC CT ACC AG
142 Ser lie Ala Ala Asp Gin Leu Pro Asn Val Gly lie Thr Gin Gly lie Val Glu Phe Tyr Thr
S26/3 490 TCC ATA GCA GCT GAT CAG CTT CCC AAT GTA GGC ATC ACT CAA GGA ATC GTT GAA TTT TAT ACA
A22/M 505 A CC T T A C GAG CTT CCA ATG A T C T C T G T G
163 Asp Thr Thr Phe Ser Trp Ser Val Gly Ala Arg Gly Ala Leu Trp Glu Cys Gly Cys Ala Thr Leu Gly Ala
S26/3 553 GAT ACA ACA TTC TCT TGG AGT GTA GGT GCA CGC GGA GCT TTA TGG GAG TGT GGT TGT GCG ACT TTA GGA GCA
A22/H 577 C T T C T A A T
187 Glu Phe Gin Tyr Ala Gin Ser Asn Pro Lys lie Glu Met Leu Asn Val Val Ser Ser Pro Ala Gin Phe Val
S26/3 625 GAG TTC CAA TAC GCT CAG TCT AAT CCT AAA ATT GAA ATG TTG AAT GTA GTC TCC AGC CCA GCA CAA TTT GTG
A22/M 649 A G G C C C C ACT A
211 Val His Lys Pro Arg Gly Tyr Lys Gly Thr Ala Phe Pro Leu Pro Leu Thr Ala Gly Thr Asp Gin
S26/3 697 GTT CAC AAG CCT AGA GGA TAC AAG GGA ACA GCA TTT CCT TTA CCT CTA ACA GCT GGT ACT GAT CAG
A22/M 721 A A A C T A GCT AGC T G AAT A G A A ACA G A
233 Ala Thr Asp Thr Lys Ser Ala Thr He Lys Tyr His Glu Trp Gin Val Gly Leu Ala Leu Ser Tyr Arg Leu
S26/3 763 GCA ACT GAC ACT AAG TCG GCT ACA ATT AAA TAC CAC GAA TGG CAA GTT GGT TTA GCG CTC TCT TAT CGA TTG
A22/M 793 T A C A A T A CCC C G C A
257 Asn Met Leu Val Pro Tyr He Ser Val Asn Trp Ser Arg Ala Thr Phe Asp Ala Asp Ala He Arg He Ala
S26/3 835 AAC ATG CTT GTT CCT TAC ATT AGC GTA AAC TGG TCA AGA GCA ACT TTT GAT GCT GAC GCT ATC CGC ATC GCT
A22/M 865 T A T G T A T
281 Gin Pro Lys Leu Ala Ala Ala Val Leu Asn Leu Thr Thr Trp Asn Pro Thr Leu Leu Gly Glu Ala Thr Ala
S26/3 907 CAA CCT AAA TTA GCT GCT GCT GTG TTA AAC TTG ACC ACA TGG AAC CCA ACC CTT TTA GGA GAA GCT ACA GCT
A22/M 937 AAA T G AG A T C T A T T G C TC A C T A
305 Leu Asp Thr Ser Asn Lys Phe Ala Asp Phe Leu Gin He Ala Ser He Gin lie Asn Lys Met
S26/3 979 TTA GAT ACT AGC AAC AAA TTC GCT GAC TTC TTG CAA ATT GCT TCG ATT CAG ATC AAC AAA ATG
A22/M 1009 G CCC AAT AAT G GG AG G T GTT C A T T G
326 Lys Ser Arg Lys Ala Cys Gly Val Ala Val Gly Ala Thr Leu He Asp Ala Asp Lys Trp Ser He Thr Gly
S26/3 1042 AAG TCT AGA AAA GCT TGT GGT GTA GCT GTT GGT GCA ACG TTA ATC GAC GCT GAC AAA TGG TCA ATC ACT GGT
A22/M 1081
350 Glu Ala Arg Leu He Asn Glu Arg Ala Ala His Met Asn Ala Gin Phe Arg Phe End






GGA TTT ACT TTA TAC TAT CCT AAC TTT TTG TCC CGC TA TCAGAACCTAGGAATCTCTGGCTTCTGA TTTTTTTT GCTCTCAT
ig. 1. Nucleotide sequence and translation of the major outer membrane protein from C. psittaci S26/3 ovine abortion strain
jmpared to that of the A22/M strain [22], Only differences are shown. Dots in the sequences indicate gaps inserted for optimal
ignment. Numbering of the nucleotide sequence begins at the start codon while that of the deduced amino acid sequence begins at
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Fig. 2. Comparison of the deduced amino acid sequence of the major outer membrane proteins from C. psittaci strains S26/3 (S) an
A22/M (A) [22] and C. trachomatis serovar L2 [25], Dots in the sequence indicate the gaps introduced for alignment. The conserve
cysteine residues are marked with asterisks and the four variable domains [26] are shown.
tramolecular location of this variation is very simi¬
lar to that which has already been described by
Stephens et al. [26] who determined the sequence
differences between the serovars of C. trachomatis
and described 4 variable domains (VD1-4). Epi¬
tope mapping using recombinant proteins and
synthetic peptides has shown that important
serovar specific and subgroup specific epitopes lie
within VD1, VD2 and VD4 [27-29], This com¬
parison of C. psittaci MOMP sequences shows
that sequence variation is largely confined to thes
same VDs. A similar finding has been reporte
recently by Zhang et al. [30] who compared th
MOMP sequence of the guinea pig inclusion cor
junctivitis strain with that of the avian isolate Ct
10.
The degree of variation between C. psittai
S26/3 and A22/M was unexpected. Compariso
of a number of isolates from cases of ovine aboi
tion using RE profiling of total genomic DNA ha
157
jvealed only very minor differences [4,6], More-
ver, no interstrain differences were revealed when
le DNAs from 12 independent abortion strains
rere digested with REs (which cut within the
40MP coding sequence) and analysed by South-
rn blotting using the Sst-1 MOMP fragment as
robe. However, when A22/M was compared with
vo abortion strains, including the original A22
date, in a similar Southern blotting experiment,
lear differences were seen, as shown in Fig. 3.
'he hybridising bands seen in the A22/M strain
'ere similar to those of the Cal 10 strain. Com-
arison of the A22/M strain with abortion strains,
'al 10 and an avian isolate by RE profiling of
)tal genomic DNA [6] confirmed that A22/M
'as very similar, but not identical, to Cal 10 (data
ot shown). Comparison of the A22/M sequence
with that published by Zhang et al. for Cal 10
shows only a 3% difference at the amino acid
level.
Since the Cal 10 strain is avian in type as
judged by its origin from a case of presumptive
ornithosis [31], RE profile [6] and DNA reassocia-
tion properties [5], the A22/M strain appears to
be avian also. The comparison of MOMP se¬
quences in Fig. 1 above is thus an inter-type rather
than an inter-strain comparison. A full history of
the A22/M strain is not available but we have
established that it should have been identical to
A22 which is the original type strain isolated at
the Moredun Institute [1]. The isolate has passed
through several laboratories and has been grown
for many passes in embryonated hen's eggs. It is






i Cla-1 1 i——Msp-1——i i Pvu-2 1
g. 3. Southern blot analysis of genomic DNA from strains S57/3 (S) Cal 10 (C) A22 (A) and A22/M (M) digested with Cla-1.
sp-1 and Pvu-11 as indicated and hybridised with a 2.6 kb Sst-1 fragment containing the complete S26/3 MOMP gene. The
position of molecular weight markers is indicated (kilobase pairs).
158
taminated with an avian strain which has subse¬
quently overgrown.
The above findings only serve to emphasise the
urgent requirement for a simple and widely acces¬
sible method to classify C. psittaci strains. The
sequence conservation at the termini of the MOMP
gene clearly make it an ideal target for amplifica¬
tion by the polymerase chain reaction (PCR) [32],
Preliminary results using PCR on purified DNA
samples have shown that it is possible to amplify
the MOMP sequences from a wide range of C.
psittaci types. Thus our present efforts are directed
towards the development of a generally applicable
PCR based test for use with clinical samples which
can both detect and type C. psittaci infections. We
are also attempting to express the MOMP gene in
E. coli.
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